JAX Mouse Strain Datasheet - 016622

STOCK Utrn^tm1Jrs Dmd^mdx/J

Stock No:: 016622 |; mdx/utrn -

Cryo Recovery

Overview

Also Known As: mdx/utrn -

Mice homozygous for the Utrn^tm1Jrs and Dmd^mdx exhibit an onset of skeletal muscle dystrophy as early as 4 weeks of age and are a model for Duchenne Type Muscular Dystrophy.

Donating Investigator

Suzanne Berry, University of Illinois

Genetic overview

Genetic Background	Generation

Dmd^mdx

Allele Type	Gene Symbol	Gene Name
Spontaneous	Dmd	dystrophin, muscular dystrophy

Allele Type	Gene Symbol	Gene Name
Targeted (Null/Knockout)	Utrn	utrophin

Research Applications

Cardiovascular Research
Neurobiology Research
Research Tools
Cell Biology Research
Sensorineural Research

View All Research Applications

Base Price

Starting at:

$2,595.00 Domestic price Cryo Recovery

View Price List

Details

Detailed Description

Mice homozygous for the Utrn^tm1Jrs and Dmd^mdx alleles have a lifespan of 4 to 20 weeks, with only 50% surviving beyond 8 weeks of age. As early as 3 weeks of age homozygotes display growth delays, are smaller than wildtype controls and exhibit skeletal muscle dystrophy with abnormal waddling gait at 4 weeks of age. At 10 weeks of age, double mutants exhibit skeletal muscle degeneration, necrosis and interstitial fibrosis, as well as abnormal echocardiography results. By 15 weeks of age, the double homozygotes develop dilated cardiomyopathy. The double mutants exhibit kyphosis, compromised systolic and diastolic function, progressive fibrosis throughout the heart, cardiomyocyte membrane damage, ventricular cellular necrosis, and disorganized mitochondria and myofibrils in cardiomyocytes.

Development

These double mutant mice were produced by breeding mice carrying the Utrn^tm1Jrs targeted mutation and the Dmd^mdx spontaneous mutation.

To generate the Utrn^tm1Jrs targeted mutation, a targeting vector containing PGK-Neo cassette was used to disrupt an exon encoding the beginning of the cysteine-rich region of the protein. The construct was electroporated into 129 derived R1 embryonic stem (ES) cells. Correctly targeted ES cells were injected into recipient blastocysts. The mice were maintained on a mixed B6;129 background.

The Dmd^mdx spontaneous mutation arose just prior to 1977 at the Agricultural Research Council's Poultry Research Centre, U.K., in C57BL/10ScSn mice obtained from M. Festing (MRC Laboratory Animals Centre, Carshalton, Surrey, U.K.). Mice carrying the Dmd^mdx allele were imported to The Jackson Laboratory in 1984 by Dr. Thomas Roderick, who received them from Dr. Karen Moore (Department of Genetics, University of California, Berkley). A C-to-T transition occurred at position 3185, resulting in a termination codon in place of a glutamine codon.

Control Suggestions

Please Inquire

Additional Information

Considerations for Choosing Controls

Selected References

Chun JL; O'Brien R; Berry SE. 2012. Cardiac dysfunction and pathology in the dystrophin and utrophin-deficient mouse during development of dilated cardiomyopathy. Neuromuscul Disord 22(4):368-79. PubMed: 22266080 MGI: J:187876

View All References

Genetics

Dmd^mdx

Allele Symbol: Dmd^mdx

Allele Name	X linked muscular dystrophy
Allele Type	Spontaneous
Allele Synonym(s)	mdx; pke; pyruvate kinase expression
Gene Symbol and Name	Dmd, dystrophin, muscular dystrophy
Gene Synonym(s)	BMD; CMD3B; DXS142; DXS164; DXS206; DXS230; DXS239; DXS268; DXS269; DXS270; DXS272; Dp427; Dp71; Duchenne muscular dystrophy; MRX85; X-linked muscular dystrophy; X-linked muscular dystrophy; dys; mdx; mdx; pke; pke; pyruvate kinase expression
Strain of Origin	C57BL/10ScSn
Chromosome	X
Molecular Note	This mutation arose in 1981 in a C57BL/10ScSn colony at University of Leicester. A C-to-T transition occurred at position 3185, resulting in a termination codon in place of a glutamine codon. This mutation is predicted to produce a truncated protein.

Utrn^tm1Jrs

Allele Symbol: Utrn^tm1Jrs

Allele Name	targeted mutation 1, Joshua R Sanes
Allele Type	Targeted (Null/Knockout)
Allele Synonym(s)	uko; utrn-
Gene Symbol and Name	Utrn, utrophin
Gene Synonym(s)	AA589569; DMDL; DRP; DRP1; Dmdl; Dmdl; G-utrophin; dystrophin-like; expressed sequence AA589569
Strain of Origin	(129X1/SvJ x 129S1/Sv)F1-Kitl<+>
Chromosome	10
Molecular Note	A neomycin resistance cassette replaced 2.7 kb of sequence including 52 bp of the exon that encodes the beginning of the C-terminal cysteine rich region. RT-PCR analysis demonstrated that a mutant transcript carrying the deletion was made in homozygous and heterozygous mice. Western blot analysis on extracts of muscle or lung tissue derived from homozygous mice confirmed that no detectable protein was expressed from this allele.

Disease/Phenotype

Disease Terms

Research Areas By Genotype

This mouse can be used to support research in many areas including:

Cardiovascular Research
- Heart Abnormalities
- Other
Neurobiology Research
- Muscular Dystrophy
  - Duchenne type
Research Tools
- Cardiovascular Research
- Neurobiology Research

Genotype: Dmd^mdx related

Cell Biology Research
- Signal Transduction
Neurobiology Research
- Muscular Dystrophy
  - Duchenne type
Sensorineural Research
- Cataracts

Mammalian Phenotype Terms by Genotype

The following phenotype information is associated with a similar, but not exact match to this JAX^® Mice strain

Genotype: Dmd^mdx/Dmd^mdx Utrn^tm1Jrs/Utrn^tm1Jrs
involves: 129S1/Sv * 129X1/SvJ * C57BL/10ScSn

mortality/aging

premature death
- die between 4 and 14 weeks of age, with only half surviving beyond 8 weeks
- lifespan is 4-20 weeks

growth/size/body region phenotype

decreased body size
- significantly smaller by 4 weeks of age

postnatal growth retardation
- grow more slowly after 3 weeks of age

muscle phenotype

abnormal muscle physiology

abnormal muscle relaxation
- relaxation time of muscle (time from peak force to baseline) is greatly prolonged

cardiomyopathy
- develop moderate to severe cardiomyopathy

dystrophic muscle
- begin to exhibit symptoms of skeletal muscle disease at 4 weeks of age and severity progresses with age
- develop severe skeletal muscle dystrophy

muscle degeneration
- muscle degeneration begins earlier than in single Dmd mutants

muscle weakness
- sternomastoid muscle generates only 40-60% as much tension as controls in response to stimulation of its nerve, indicating weakness

myocardial necrosis
- large areas of necrotic myocytes with infiltrating mononuclear cells are present in 5 of 9 mutant hearts examined at 8 to 11 weeks of age
- necrosis is most prominent in the epicardial surface of the right ventricle, but is seen throughout both ventricles, however ventricles are not dilated or hypertrophic

skeletal muscle interstitial fibrosis
- seen by 10 weeks of age

skeletal muscle necrosis
- necrosis begins earlier and persists longer than in single Dmd mutants and leads to fibrosis

cardiovascular system phenotype

cardiomyopathy
- develop moderate to severe cardiomyopathy

myocardial necrosis
- large areas of necrotic myocytes with infiltrating mononuclear cells are present in 5 of 9 mutant hearts examined at 8 to 11 weeks of age
- necrosis is most prominent in the epicardial surface of the right ventricle, but is seen throughout both ventricles, however ventricles are not dilated or hypertrophic

nervous system phenotype

abnormal neuromuscular synapse morphology
- distribution of acetylcholine receptors within the synapse branches is abnormal, with a patchy distribution
- exhibit fewer junctional folds in the neuromuscular junction

limbs/digits/tail phenotype

abnormal limb morphology
- exhibit contracted and stiff limbs at 4 weeks of age
- severe limb contractures

skeleton phenotype

kyphosis

behavior/neurological phenotype

abnormal gait
- abnormal waddling gait is seen at 4 weeks of age

References

Chun JL; O'Brien R; Berry SE. 2012. Cardiac dysfunction and pathology in the dystrophin and utrophin-deficient mouse during development of dilated cardiomyopathy. Neuromuscul Disord 22(4):368-79. PubMed: 22266080 MGI: J:187876

Additional - Dmd^mdx related

't Hoen PA; de Meijer EJ; Boer JM; Vossen RH; Turk R; Maatman RG; Davies KE; van Ommen GJ; van Deutekom JC; den Dunnen JT. 2008. Generation and characterization of transgenic mice with the full-length human DMD gene. J Biol Chem 283(9):5899-907. PubMed: 18083704 MGI: J:132320
Abmayr S; Crawford RW; Chamberlain JS. 2004. Characterization of ARC, apoptosis repressor interacting with CARD, in normal and dystrophin-deficient skeletal muscle. Hum Mol Genet 13(2):213-21. PubMed: 14645204 MGI: J:87688
Abou-Samra M; Boursereau R; Lecompte S; Noel L; Brichard SM. 2017. Potential Therapeutic Action of Adiponectin in Duchenne Muscular Dystrophy. Am J Pathol 187(7):1577-1585. PubMed: 28463682 MGI: J:243433
Acharyya S; Butchbach ME; Sahenk Z; Wang H; Saji M; Carathers M; Ringel MD; Skipworth RJ; Fearon KC; Hollingsworth MA; Muscarella P; Burghes AH; Rafael-Fortney JA; Guttridge DC. 2005. Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia. Cancer Cell 8(5):421-32. PubMed: 16286249 MGI: J:103953
Acharyya S; Villalta SA; Bakkar N; Bupha-Intr T; Janssen PM; Carathers M; Li ZW; Beg AA; Ghosh S; Sahenk Z; Weinstein M; Gardner KL; Rafael-Fortney JA; Karin M; Tidball JG; Baldwin AS; Guttridge DC. 2007. Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. J Clin Invest 117(4):889-901. PubMed: 17380205 MGI: J:121279
Acuna MJ; Pessina P; Olguin H; Cabrera D; Vio CP; Bader M; Munoz-Canoves P; Santos RA; Cabello-Verrugio C; Brandan E. 2014. Restoration of muscle strength in dystrophic muscle by angiotensin-1-7 through inhibition of TGF-beta signalling. Hum Mol Genet 23(5):1237-49. PubMed: 24163134 MGI: J:206216
Agbulut O; Noirez P; Butler-Browne G; Jockusch H. 2004. Specific isomyosin proportions in hyperexcitable and physiologically denervated mouse muscle. FEBS Lett 561(1-3):191-4. PubMed: 15013776 MGI: J:117992
Ahmad A; Brinson M; Hodges BL; Chamberlain JS; Amalfitano A. 2000. Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for duchenne muscular dystrophy Hum Mol Genet 9(17):2507-15. PubMed: 11030755 MGI: J:65413
Al-Rewashdy H; Ljubicic V; Lin W; Renaud JM; Jasmin BJ. 2015. Utrophin A is essential in mediating the functional adaptations of mdx mouse muscle following chronic AMPK activation. Hum Mol Genet 24(5):1243-55. PubMed: 25324540 MGI: J:219231
Alameddine HS; Quantin B; Cartaud A; Dehaupas M; Mandel JL; Fardeau M. 1994. Expression of a recombinant dystrophin in mdx mice using adenovirus vector. Neuromuscul Disord 4(3):193-203. PubMed: 7919968 MGI: J:19384
Alfaro LA; Dick SA; Siegel AL; Anonuevo AS; McNagny KM; Megeney LA; Cornelison DD; Rossi FM. 2011. CD34 promotes satellite cell motility and entry into proliferation to facilitate efficient skeletal muscle regeneration. Stem Cells 29(12):2030-41. PubMed: 21997891 MGI: J:190197
Altamirano F; Perez CF; Liu M; Widrick J; Barton ER; Allen PD; Adams JA; Lopez JR. 2014. Whole body periodic acceleration is an effective therapy to ameliorate muscular dystrophy in mdx mice. PLoS One 9(9):e106590. PubMed: 25181488 MGI: J:223267
Altamirano F; Valladares D; Henriquez-Olguin C; Casas M; Lopez JR; Allen PD; Jaimovich E. 2013. Nifedipine treatment reduces resting calcium concentration, oxidative and apoptotic gene expression, and improves muscle function in dystrophic mdx mice. PLoS One 8(12):e81222. PubMed: 24349043 MGI: J:209732
Amenta AR; Yilmaz A; Bogdanovich S; McKechnie BA; Abedi M; Khurana TS; Fallon JR. 2011. Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx mice. Proc Natl Acad Sci U S A 108(2):762-7. PubMed: 21187385 MGI: J:170566
Amirouche A; Tadesse H; Lunde JA; Belanger G; Cote J; Jasmin BJ. 2013. Activation of p38 signaling increases utrophin A expression in skeletal muscle via the RNA-binding protein KSRP and inhibition of AU-rich element-mediated mRNA decay: implications for novel DMD therapeutics. Hum Mol Genet 22(15):3093-111. PubMed: 23575223 MGI: J:198527
Anderson JE. 1991. Dystrophic changes in mdx muscle regenerating from denervation and devascularization. Muscle Nerve 14(3):268-79. PubMed: 2041548 MGI: J:116345
Anderson JE. 2000. A role for nitric oxide in muscle repair: nitric oxide-mediated activation of muscle satellite cells. Mol Biol Cell 11(5):1859-74. PubMed: 10793157 MGI: J:120497
Anderson JE; Bressler BH; Ovalle WK. 1988. Functional regeneration in the hindlimb skeletal muscle of the mdx mouse. J Muscle Res Cell Motil 9(6):499-515. PubMed: 3209690 MGI: J:152749
Anderson JE; Garrett K; Moor A; McIntosh L; Penner K. 1998. Dystrophy and myogenesis in mdx diaphragm muscle. Muscle Nerve 21(9):1153-65. PubMed: 9703441 MGI: J:116331
Anderson JE; Kao L; Bressler BH; Gruenstein E. 1990. Analysis of dystrophin in fast- and slow-twitch skeletal muscles from mdx and dy2J mice at different ages. Muscle Nerve 13(1):6-11. PubMed: 2183046 MGI: J:116019
Anderson JE; Lentz DL; Johnson RB. 1993. Recovery from disuse osteopenia coincident to restoration of muscle strength in mdx mice. Bone 14(4):625-34. PubMed: 8274305 MGI: J:17563
Anderson JE; Liu L; Kardami E. 1994. The effects of hyperthyroidism on muscular dystrophy in the mdx mouse: greater dystrophy in cardiac and soleus muscle. Muscle Nerve 17(1):64-73. PubMed: 8264704 MGI: J:115865
Anderson JE; Liu L; Kardami E; Murphy LJ. 1994. The pituitary-muscle axis in mdx dystrophic mice. J Neurol Sci 123(1-2):80-7. PubMed: 8064326 MGI: J:18080
Anderson JE; McIntosh LM; Moor AN; Yablonka-Reuveni Z. 1998. Levels of MyoD protein expression following injury of mdx and normal limb muscle are modified by thyroid hormone. J Histochem Cytochem 46(1):59-67. PubMed: 9407021 MGI: J:45263
Anderson JL; Head SI; Morley JW. 2003. Altered inhibitory input to Purkinje cells of dystrophin-deficient mice. Brain Res 982(2):280-3. PubMed: 12915262 MGI: J:85437
Anderson JL; Head SI; Morley JW. 2004. Long-term depression is reduced in cerebellar Purkinje cells of dystrophin-deficient mdx mice. Brain Res 1019(1-2):289-92. PubMed: 15306266 MGI: J:91994
Angoli D; Corona P; Baresi R; Mora M; Wanke E. 1997. Laminin-alpha2 but not -alpha1-mediated adhesion of human (Duchenne) and murine (mdx) dystrophic myotubes is seriously defective. FEBS Lett 408(3):341-4. PubMed: 9188790 MGI: J:40762
Annese T; Corsi P; Ruggieri S; Tamma R; Marinaccio C; Picocci S; Errede M; Specchia G; De Luca A; Frassanito MA; Desantis V; Vacca A; Ribatti D; Nico B. 2016. Isolation and characterization of neural stem cells from dystrophic mdx mouse. Exp Cell Res :. PubMed: 27015747 MGI: J:230853
Apolinario LM; De Carvalho SC; Santo Neto H; Marques MJ. 2015. Long-Term Therapy With Omega-3 Ameliorates Myonecrosis and Benefits Skeletal Muscle Regeneration in Mdx Mice. Anat Rec (Hoboken) 298(9):1589-96. PubMed: 26011009 MGI: J:224775
Ardite E; Perdiguero E; Vidal B; Gutarra S; Serrano AL; Munoz-Canoves P. 2012. PAI-1-regulated miR-21 defines a novel age-associated fibrogenic pathway in muscular dystrophy. J Cell Biol 196(1):163-75. PubMed: 22213800 MGI: J:179966
Asai A; Sahani N; Kaneki M; Ouchi Y; Martyn JA; Yasuhara SE. 2007. Primary role of functional ischemia, quantitative evidence for the two-hit mechanism, and phosphodiesterase-5 inhibitor therapy in mouse muscular dystrophy. PLoS One 2(8):e806. PubMed: 17726536 MGI: J:129397
Ascah A; Khairhallah M; Daussin F; Bourcier-Lucas C; Godin R; Allen BG; Petrof BJ; Des Rosiers C; Burelle Y. 2010. STRESS-INDUCED OPENING OF THE PERMEABILITY TRANSITION PORE IN THE DYSTROPHIN-DEFICIENT HEART IS ATTENUATED BY ACUTE TREATMENT WITH SILDENAFIL. Am J Physiol Heart Circ Physiol :. PubMed: 20971771 MGI: J:166227
Asselin I; Tremblay M; Vilquin JT; Guerette B; Roy R; Tremblay JP. 1995. Quantification of normal dystrophin mRNA following myoblast transplantation in mdx mice. Muscle Nerve 18(9):980-6. PubMed: 7643878 MGI: J:28866
Asselin I; Tremblay M; Vilquin JT; Guerette B; Tremblay JP. 1994. Polymerase chain reaction-based assay to assess the success of myoblast transplantation in mdx mice. Transplant Proc 26(6):3389. PubMed: 7527970 MGI: J:21945
Attal P; Lambert F; Marchand-Adam S; Bobin S; Pourny JC; Chemla D; Lecarpentier Y; Coirault C. 2000. Severe mechanical dysfunction in pharyngeal muscle from adult mdx mice. Am J Respir Crit Care Med 162(1):278-81. PubMed: 10903254 MGI: J:103161
Auda-Boucher G; Rouaud T; Lafoux A; Levitsky D; Huchet-Cadiou C; Feron M; Guevel L; Talon S; Fontaine-Perus J; Gardahaut MF. 2007. Fetal muscle-derived cells can repair dystrophic muscles in mdx mice. Exp Cell Res 313(5):997-1007. PubMed: 17275812 MGI: J:119767
Augustin M; Klopp N; Ewald K; Jockusch H. 1998. A multicopy c-Myc transgene as a nuclear label: overgrowth of Myctg50 cells in allophenic mice. Cell Biol Int 22(6):401-11. PubMed: 10328848 MGI: J:127669
Austin L; Bower JJ; Bennett TM; Lynch GS; Kapsa R; White JD; Barnard W; Gregorevic P; Byrne E. 2000. Leukemia inhibitory factor ameliorates muscle fiber degeneration in the mdx mouse. Muscle Nerve 23(11):1700-5. PubMed: 11054748 MGI: J:116201
Azzena GB; Mancinelli R. 1999. Nitric oxide regenerates the normal colonic peristaltic activity in mdx dystrophic mouse. Neurosci Lett 261(1-2):9-12. PubMed: 10081914 MGI: J:107984
Baccari MC; Romagnani P; Calamai F. 2000. Impaired nitrergic relaxations in the gastric fundus of dystrophic (mdx) mice. Neurosci Lett 282(1-2):105-8. PubMed: 10713407 MGI: J:107938
Badalamente MA; Stracher A. 2000. Delay of muscle degeneration and necrosis in mdx mice by calpain inhibition. Muscle Nerve 23(1):106-11. PubMed: 10590413 MGI: J:116195
Bagher P; Duan D; Segal SS. 2011. Evidence for impaired neurovascular transmission in a murine model of Duchenne muscular dystrophy. J Appl Physiol 110(3):601-9. PubMed: 21109597 MGI: J:185890
Baker PE; Kearney JA; Gong B; Merriam AP; Kuhn DE; Porter JD; Rafael-Fortney JA. 2006. Analysis of gene expression differences between utrophin/dystrophin-deficient vs mdx skeletal muscles reveals a specific upregulation of slow muscle genes in limb muscles. Neurogenetics 7(2):81-91. PubMed: 16525850 MGI: J:249265
Bakker AJ; Head SI; Williams DA; Stephenson DG. 1993. Ca2+ levels in myotubes grown from the skeletal muscle of dystrophic (mdx) and normal mice. J Physiol 460:1-13. PubMed: 8487190 MGI: J:15813
Ballarino M; Cazzella V; D'Andrea D; Grassi L; Bisceglie L; Cipriano A; Santini T; Pinnaro C; Morlando M; Tramontano A; Bozzoni I. 2015. Novel long noncoding RNAs (lncRNAs) in myogenesis: a miR-31 overlapping lncRNA transcript controls myoblast differentiation. Mol Cell Biol 35(4):728-36. PubMed: 25512605 MGI: J:224300
Ballmann C; Denney TS; Beyers RJ; Quindry T; Romero M; Amin R; Selsby JT; Quindry JC. 2017. Lifelong quercetin enrichment and cardioprotection in Mdx/Utrn+/- mice. Am J Physiol Heart Circ Physiol 312(1):H128-H140. PubMed: 27836895 MGI: J:239409
Baltgalvis KA; Jaeger MA; Fitzsimons DP; Thayer SA; Lowe DA; Ervasti JM. 2011. Transgenic overexpression of gamma-cytoplasmic actin protects against eccentric contraction-induced force loss in mdx mice. Skelet Muscle 1(1):32. PubMed: 21995957 MGI: J:183731
Banks GB; Chamberlain JS; Froehner SC. 2009. Truncated dystrophins can influence neuromuscular synapse structure. Mol Cell Neurosci 40(4):433-41. PubMed: 19171194 MGI: J:146866
Banks GB; Combs AC; Chamberlain JR; Chamberlain JS. 2008. Molecular and cellular adaptations to chronic myotendinous strain injury in mdx mice expressing a truncated dystrophin. Hum Mol Genet 17(24):3975-86. PubMed: 18799475 MGI: J:142565
Barker RG; Wyckelsma VL; Xu H; Murphy RM. 2018. Mitochondrial content is preserved throughout disease progression in the mdx mouse model of Duchenne muscular dystrophy, regardless of taurine supplementation. Am J Physiol Cell Physiol 314(4):C483-C491. PubMed: 29351413 MGI: J:260647
Barnabei MS; Metzger JM. 2012. Ex vivo stretch reveals altered mechanical properties of isolated dystrophin-deficient hearts. PLoS One 7(3):e32880. PubMed: 22427904 MGI: J:186918
Barton ER. 2006. Impact of sarcoglycan complex on mechanical signal transduction in murine skeletal muscle. Am J Physiol Cell Physiol 290(2):C411-9. PubMed: 16162659 MGI: J:104967
Barton ER; Morris L; Musaro A; Rosenthal N; Sweeney HL. 2002. Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice. J Cell Biol 157(1):137-48. PubMed: 11927606 MGI: J:75770
Barton-Davis ER; Cordier L; Shoturma DI; Leland SE; Sweeney HL. 1999. Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice [see comments] J Clin Invest 104(4):375-81. PubMed: 10449429 MGI: J:56908
Barzilai-Tutsch H; Bodanovsky A; Maimon H; Pines M; Halevy O. 2016. Halofuginone promotes satellite cell activation and survival in muscular dystrophies. Biochim Biophys Acta 1862(1):1-11. PubMed: 26454207 MGI: J:255618
Bates G; Sigurdardottir S; Kachmar L; Zitouni NB; Benedetti A; Petrof BJ; Rassier D; Lauzon AM. 2013. Molecular, cellular, and muscle strip mechanics of the mdx mouse diaphragm. Am J Physiol Cell Physiol 304(9):C873-80. PubMed: 23426972 MGI: J:196389
Beastrom N; Lu H; Macke A; Canan BD; Johnson EK; Penton CM; Kaspar BK; Rodino-Klapac LR; Zhou L; Janssen PM; Montanaro F. 2011. mdx(5cv) Mice Manifest More Severe Muscle Dysfunction and Diaphragm Force Deficits than Do mdx Mice. Am J Pathol 179(5):2464-74. PubMed: 21893021 MGI: J:177391
Bechir N; Pecchi E; Vilmen C; Le Fur Y; Amthor H; Bernard M; Bendahan D; Giannesini B. 2016. ActRIIB blockade increases force-generating capacity and preserves energy supply in exercising mdx mouse muscle in vivo. FASEB J 30(10):3551-3562. PubMed: 27416839 MGI: J:239706
Beedle AM; Nienaber PM; Campbell KP. 2007. Fukutin-related protein associates with the sarcolemmal dystrophin-glycoprotein complex. J Biol Chem 282(23):16713-7. PubMed: 17452335 MGI: J:122734
Belanto JJ; Mader TL; Eckhoff MD; Strandjord DM; Banks GB; Gardner MK; Lowe DA; Ervasti JM. 2014. Microtubule binding distinguishes dystrophin from utrophin. Proc Natl Acad Sci U S A 111(15):5723-8. PubMed: 24706788 MGI: J:208636
Belanto JJ; Olthoff JT; Mader TL; Chamberlain CM; Nelson DM; McCourt PM; Talsness DM; Gundersen GG; Lowe DA; Ervasti JM. 2016. Independent variability of microtubule perturbations associated with dystrophinopathy. Hum Mol Genet 25(22):4951-4961. PubMed: 28171583 MGI: J:241782
Bellinger AM; Reiken S; Carlson C; Mongillo M; Liu X; Rothman L; Matecki S; Lacampagne A; Marks AR. 2009. Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle. Nat Med 15(3):325-30. PubMed: 19198614 MGI: J:146474
Benny Klimek ME; Sali A; Rayavarapu S; Van der Meulen JH; Nagaraju K. 2016. Effect of the IL-1 Receptor Antagonist Kineret(R) on Disease Phenotype in mdx Mice. PLoS One 11(5):e0155944. PubMed: 27213537 MGI: J:253175
Bentzinger CF; Romanino K; Cloetta D; Lin S; Mascarenhas JB; Oliveri F; Xia J; Casanova E; Costa CF; Brink M; Zorzato F; Hall MN; Ruegg MA. 2008. Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. Cell Metab 8(5):411-24. PubMed: 19046572 MGI: J:143748
Bertoni C; Lau C; Rando TA. 2003. Restoration of dystrophin expression in mdx muscle cells by chimeraplast-mediated exon skipping. Hum Mol Genet 12(10):1087-99. PubMed: 12719373 MGI: J:83434
Bhagwati S; Ghatpande A; Shafiq SA; Leung B. 1996. In situ hybridization analysis for expression of myogenic regulatory factors in regenerating muscle of mdx mouse. J Neuropathol Exp Neurol 55(5):509-14. PubMed: 8627340 MGI: J:33889
Bia BL; Cassidy PJ; Young ME; Rafael JA; Leighton B; Davies KE; Radda GK; Clarke K. 1999. Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy. J Mol Cell Cardiol 31(10):1857-62. PubMed: 10525423 MGI: J:102663
Bittner RE; Streubel B; Shorny S; Schaden G; Voit T; Hoger H. 1994. Coisogenic all-plus-one immunization: a model for identifying missing proteins in null-mutant conditions. Antibodies to dystrophin in mdx mouse after transplantation of muscle from normal coisogenic donor. Neuropediatrics 25(4):176-82. PubMed: 7824089 MGI: J:23190
Blaauw B; Agatea L; Toniolo L; Canato M; Quarta M; Dyar KA; Danieli-Betto D; Betto R; Schiaffino S; Reggiani C. 2010. Eccentric contractions lead to myofibrillar dysfunction in muscular dystrophy. J Appl Physiol 108(1):105-11. PubMed: 19910334 MGI: J:185865
Blaauw B; Mammucari C; Toniolo L; Agatea L; Abraham R; Sandri M; Reggiani C; Schiaffino S. 2008. Akt activation prevents the force drop induced by eccentric contractions in dystrophin-deficient skeletal muscle. Hum Mol Genet 17(23):3686-96. PubMed: 18753145 MGI: J:141001
Blain A; Greally E; Laval S; Blamire A; Straub V; MacGowan GA. 2013. Beta-blockers, left and right ventricular function, and in-vivo calcium influx in muscular dystrophy cardiomyopathy. PLoS One 8(2):e57260. PubMed: 23437355 MGI: J:199333
Blanchet E; Annicotte JS; Pradelli LA; Hugon G; Matecki S; Mornet D; Rivier F; Fajas L. 2012. E2F transcription factor-1 deficiency reduces pathophysiology in the mouse model of Duchenne muscular dystrophy through increased muscle oxidative metabolism. Hum Mol Genet 21(17):3910-7. PubMed: 22678059 MGI: J:185978
Bloom TJ. 2002. Cyclic nucleotide phosphodiesterase isozymes expressed in mouse skeletal muscle. Can J Physiol Pharmacol 80(12):1132-5. PubMed: 12564638 MGI: J:102408
Bloom TJ. 2005. Age-related alterations in cyclic nucleotide phosphodiesterase activity in dystrophic mouse leg muscle. Can J Physiol Pharmacol 83(11):1055-60. PubMed: 16391714 MGI: J:110508
Bobet J; Mooney RF; Gordon T. 1998. Force and stiffness of old dystrophic (mdx) mouse skeletal muscles. Muscle Nerve 21(4):536-9. PubMed: 9533791 MGI: J:116778
Boettger T; Wust S; Nolte H; Braun T. 2014. The miR-206/133b cluster is dispensable for development, survival and regeneration of skeletal muscle. Skelet Muscle 4(1):23. PubMed: 25530839 MGI: J:241493
Boland B; Himpens B; Casteels R; Gillis JM. 1993. Lack of dystrophin but normal calcium homeostasis in smooth muscle from dystrophic mdx mice. J Muscle Res Cell Motil 14(1):133-9. PubMed: 8478423 MGI: J:13345
Boland B; Himpens B; Denef JF; Gillis JM. 1995. Site-dependent pathological differences in smooth muscles and skeletal muscles of the adult mdx mouse. Muscle Nerve 18(6):649-57. PubMed: 7753128 MGI: J:26592
Boonsanay V; Zhang T; Georgieva A; Kostin S; Qi H; Yuan X; Zhou Y; Braun T. 2016. Regulation of Skeletal Muscle Stem Cell Quiescence by Suv4-20h1-Dependent Facultative Heterochromatin Formation. Cell Stem Cell 18(2):229-42. PubMed: 26669898 MGI: J:239999
Boppart MD; Burkin DJ; Kaufman SJ. 2011. Activation of AKT signaling promotes cell growth and survival in alpha7beta1 integrin-mediated alleviation of muscular dystrophy. Biochim Biophys Acta 1812(4):439-46. PubMed: 21216283 MGI: J:170661
Bornman L; Rossouw H; Gericke GS; Polla BS. 1998. Effects of iron deprivation on the pathology and stress protein expression in murine X-linked muscular dystrophy. Biochem Pharmacol 56(6):751-7. PubMed: 9751080 MGI: J:49859
Bostick B; Yue Y; Long C; Duan D. 2008. Prevention of dystrophin-deficient cardiomyopathy in twenty-one-month-old carrier mice by mosaic dystrophin expression or complementary dystrophin/utrophin expression. Circ Res 102(1):121-30. PubMed: 17967782 MGI: J:145095
Bostick B; Yue Y; Long C; Marschalk N; Fine DM; Chen J; Duan D. 2009. Cardiac expression of a mini-dystrophin that normalizes skeletal muscle force only partially restores heart function in aged Mdx mice. Mol Ther 17(2):253-61. PubMed: 19066599 MGI: J:163970
Braun U; Paju K; Eimre M; Seppet E; Orlova E; Kadaja L; Trumbeckaite S; Gellerich FN; Zierz S; Jockusch H; Seppet EK. 2001. Lack of dystrophin is associated with altered integration of the mitochondria and ATPases in slow-twitch muscle cells of MDX mice. Biochim Biophys Acta 1505(2-3):258-70. PubMed: 11334790 MGI: J:69364
Brazeau GA; Mathew M; Entrikin RK. 1992. Serum and organ indices of the mdx dystrophic mouse. Res Commun Chem Pathol Pharmacol 77(2):179-89. PubMed: 1439189 MGI: J:3928
Briguet A; Erb M; Courdier-Fruh I; Barzaghi P; Santos G; Herzner H; Lescop C; Siendt H; Henneboehle M; Weyermann P; Magyar JP; Dubach-Powell J; Metz G; Meier T. 2008. Effect of calpain and proteasome inhibition on Ca2+-dependent proteolysis and muscle histopathology in the mdx mouse. FASEB J 22(12):4190-200. PubMed: 18728218 MGI: J:146043
Bueno Junior CR; Pantaleao LC; Voltarelli VA; Bozi LH; Brum PC; Zatz M. 2012. Combined effect of AMPK/PPAR agonists and exercise training in mdx mice functional performance. PLoS One 7(9):e45699. PubMed: 23029189 MGI: J:191984
Bulfield G; Siller WG; Wight PA; Moore KJ. 1984. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci U S A 81(4):1189-92. PubMed: 6583703 MGI: J:7361
Bulfield G; Siller WG; Wight PAL. 1982. Change pke, pyruvate kinase expression to X-linked muscular dystrophy, mdx. Mouse News Lett 66:57. MGI: J:13903
Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ. 2001. Enhanced Expression of the alpha7beta1 Integrin Reduces Muscular Dystrophy and Restores Viability in Dystrophic Mice. J Cell Biol 152(6):1207-18. PubMed: 11257121 MGI: J:68194
Burr AR; Millay DP; Goonasekera SA; Park KH; Sargent MA; Collins J; Altamirano F; Philipson KD; Allen PD; Ma J; Lopez JR; Molkentin JD. 2014. Na+ dysregulation coupled with Ca2+ entry through NCX1 promotes muscular dystrophy in mice. Mol Cell Biol 34(11):1991-2002. PubMed: 24662047 MGI: J:212146
Burzyn D; Kuswanto W; Kolodin D; Shadrach JL; Cerletti M; Jang Y; Sefik E; Tan TG; Wagers AJ; Benoist C; Mathis D. 2013. A special population of regulatory T cells potentiates muscle repair. Cell 155(6):1282-95. PubMed: 24315098 MGI: J:205258
Busse M; Schwarzburger M; Berger F; Hacker C; Munz B. 2008. Strong induction of the Tis11B gene in myogenic differentiation. Eur J Cell Biol 87(1):31-8. PubMed: 17889962 MGI: J:233580
Buttgereit A; Weber C; Garbe CS; Friedrich O. 2013. From chaos to split-ups - SHG microscopy reveals a specific remodelling mechanism in ageing dystrophic muscle. J Pathol 229(3):477-85. PubMed: 23132094 MGI: J:192258
Cacchiarelli D; Incitti T; Martone J; Cesana M; Cazzella V; Santini T; Sthandier O; Bozzoni I. 2011. miR-31 modulates dystrophin expression: new implications for Duchenne muscular dystrophy therapy. EMBO Rep 12(2):136-41. PubMed: 21212803 MGI: J:168844
Call JA; Warren GL; Verma M; Lowe DA. 2013. Acute failure of action potential conduction in mdx muscle reveals new mechanism of contraction-induced force loss. J Physiol 591(Pt 15):3765-76. PubMed: 23753524 MGI: J:212138
Calyjur PC; Almeida Cde F; Ayub-Guerrieri D; Ribeiro AF Jr; Fernandes Sde A; Ishiba R; Santos AL; Onofre-Oliveira P; Vainzof M. 2016. The mdx Mutation in the 129/Sv Background Results in a Milder Phenotype: Transcriptome Comparative Analysis Searching for the Protective Factors. PLoS One 11(3):e0150748. PubMed: 26954670 MGI: J:251729
Camacho P; Fan H; Liu Z; He JQ. 2016. Small mammalian animal models of heart disease. Am J Cardiovasc Dis 6(3):70-80. PubMed: 27679742 MGI: J:243707
Camboni M; Hammond S; Martin LT; Martin PT. 2012. Induction of a regenerative microenvironment in skeletal muscle is sufficient to induce embryonal rhabdomyosarcoma in p53-deficient mice. J Pathol 226(1):40-9. PubMed: 21915858 MGI: J:180024
Cao L; Han G; Gu B; Yin H. 2014. Wild-type mouse models to screen antisense oligonucleotides for exon-skipping efficacy in Duchenne muscular dystrophy. PLoS One 9(11):e111079. PubMed: 25365558 MGI: J:225333
Capote J; DiFranco M; Vergara JL. 2010. Excitation-contraction coupling alterations in mdx and utrophin/dystrophin double knockout mice: a comparative study. Am J Physiol Cell Physiol 298(5):C1077-86. PubMed: 20130206 MGI: J:159256
Capote J; Kramerova I; Martinez L; Vetrone S; Barton ER; Sweeney HL; Miceli MC; Spencer MJ. 2016. Osteopontin ablation ameliorates muscular dystrophy by shifting macrophages to a pro-regenerative phenotype. J Cell Biol 213(2):275-88. PubMed: 27091452 MGI: J:236634
Carlson CG. 1996. Acetylcholine receptor and calcium leakage activity in nondystrophic and dystrophic myotubes (MDX) Muscle Nerve 19(10):1258-67. PubMed: 8808651 MGI: J:117913
Carlson CG; Roshek DM. 2001. Adult dystrophic (mdx) endplates exhibit reduced quantal size and enhanced quantal variation. Pflugers Arch 442(3):369-75. PubMed: 11484767 MGI: J:106311
Carretta D; Santarelli M; Sbriccoli A; Pinto F; Catini C; Minciacchi D. 2004. Spatial analysis reveals alterations of parvalbumin- and calbindin-positive local circuit neurons in the cerebral cortex of mutant mdx mice. Brain Res 1016(1):1-11. PubMed: 15234246 MGI: J:91225
Carretta D; Santarelli M; Vanni D; Carrai R; Sbriccoli A; Pinto F; Minciacchi D. 2001. The organisation of spinal projecting brainstem neurons in an animal model of muscular dystrophy. A retrograde tracing study on mdx mutant mice. Brain Res 895(1-2):213-22. PubMed: 11259780 MGI: J:68354
Carretta D; Santarelli M; Vanni D; Ciabatti S; Sbriccoli A; Pinto F; Minciacchi D. 2003. Cortical and brainstem neurons containing calcium-binding proteins in a murine model of Duchenne's muscular dystrophy: selective changes in the sensorimotor cortex. J Comp Neurol 456(1):48-59. PubMed: 12508313 MGI: J:125669
Carter GT; Abresch RT; Walsh SA; Wineinger MA. 1997. The mdx mouse diaphragm: exercise-induced injury. Muscle Nerve 20(3):393-4. PubMed: 9052828 MGI: J:116363
Carter GT; Wineinger MA; Walsh SA; Horasek SJ; Abresch RT; Fowler WM Jr. 1995. Effect of voluntary wheel-running exercise on muscles of the mdx mouse. Neuromuscul Disord 5(4):323-32. PubMed: 7580246 MGI: J:27376
Cascabulho CM; Correa CB; Cotta-de-Almeida V; Henriques-Pons A. 2012. Defective T-lymphocyte migration to muscles in dystrophin-deficient mice. Am J Pathol 181(2):593-604. PubMed: 22733008 MGI: J:186409
Ceco E; Bogdanovich S; Gardner B; Miller T; DeJesus A; Earley JU; Hadhazy M; Smith LR; Barton ER; Molkentin JD; McNally EM. 2014. Targeting latent TGFbeta release in muscular dystrophy. Sci Transl Med 6(259):259ra144. PubMed: 25338755 MGI: J:225775
Chadwick JA; Bhattacharya S; Lowe J; Weisleder N; Rafael-Fortney JA. 2017. Renin-angiotensin-aldosterone system inhibitors improve membrane stability and change gene-expression profiles in dystrophic skeletal muscles. Am J Physiol Cell Physiol 312(2):C155-C168. PubMed: 27881412 MGI: J:239401
Chadwick JA; Hauck JS; Gomez-Sanchez CE; Gomez-Sanchez EP; Rafael-Fortney JA. 2017. Gene expression effects of glucocorticoid and mineralocorticoid receptor agonists and antagonists on normal human skeletal muscle. Physiol Genomics 49(6):277-286. PubMed: 28432191 MGI: J:248404
Chadwick JA; Swager SA; Lowe J; Welc SS; Tidball JG; Gomez-Sanchez CE; Gomez-Sanchez EP; Rafael-Fortney JA. 2016. Myeloid cells are capable of synthesizing aldosterone to exacerbate damage in muscular dystrophy. Hum Mol Genet :. PubMed: 27798095 MGI: J:239327
Chakkalakal JV; Harrison MA; Carbonetto S; Chin E; Michel RN; Jasmin BJ. 2004. Stimulation of calcineurin signaling attenuates the dystrophic pathology in mdx mice. Hum Mol Genet 13(4):379-88. PubMed: 14681302 MGI: J:88329
Chakkalakal JV; Michel SA; Chin ER; Michel RN; Jasmin BJ. 2006. Targeted inhibition of Ca2+ /calmodulin signaling exacerbates the dystrophic phenotype in mdx mouse muscle. Hum Mol Genet 15(9):1423-35. PubMed: 16551657 MGI: J:108236
Chal J; Oginuma M; Al Tanoury Z; Gobert B; Sumara O; Hick A; Bousson F; Zidouni Y; Mursch C; Moncuquet P; Tassy O; Vincent S; Miyanari A; Bera A; Garnier JM; Guevara G; Hestin M; Kennedy L; Hayashi S; Drayton B; Cherrier T; Gayraud-Morel B; Gussoni E; Relaix F; Tajbakhsh S; Pourquie O. 2015. Differentiation of pluripotent stem cells to muscle fiber to model Duchenne muscular dystrophy. Nat Biotechnol :. PubMed: 26237517 MGI: J:223069
Chalkiadaki A; Igarashi M; Nasamu AS; Knezevic J; Guarente L. 2014. Muscle-specific SIRT1 gain-of-function increases slow-twitch fibers and ameliorates pathophysiology in a mouse model of duchenne muscular dystrophy. PLoS Genet 10(7):e1004490. PubMed: 25032964 MGI: J:228605
Chamberlain JS. 2010. Duchenne muscular dystrophy models show their age. Cell 143(7):1040-2. PubMed: 21183068 MGI: J:167707
Chamberlain JS; Metzger J; Reyes M; Townsend D; Faulkner JA. 2007. Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma. FASEB J 21(9):2195-204. PubMed: 17360850 MGI: J:122706
Chamberlain JS; Phelps SF; Cox GA; Maichele AJ; Greenwood AD. 1993. PCR analysis of muscular dystrophy in mdx mice. Mol Cell Biol Hum Dis Ser 3:167-89. PubMed: 8111539 MGI: J:18427
Chan S; Head SI; Morley JW. 2007. Branched fibers in dystrophic mdx muscle are associated with a loss of force following lengthening contractions. Am J Physiol Cell Physiol 293(3):C985-92. PubMed: 17567750 MGI: J:125837
Chandrasekharan K; Yoon JH; Xu Y; deVries S; Camboni M; Janssen PM; Varki A; Martin PT. 2010. A human-specific deletion in mouse Cmah increases disease severity in the mdx model of Duchenne muscular dystrophy. Sci Transl Med 2(42):42ra54. PubMed: 20668298 MGI: J:164594
Chang WJ; Iannaccone ST; Lau KS; Masters BS; McCabe TJ; McMillan K; Padre RC; Spencer MJ; Tidball JG; Stull JT. 1996. Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy. Proc Natl Acad Sci U S A 93(17):9142-7. PubMed: 8799168 MGI: J:35595
Chao DS; Silvagno F; Bredt DS. 1998. Muscular dystrophy in mdx mice despite lack of neuronal nitric oxide synthase. J Neurochem 71(2):784-9. PubMed: 9681470 MGI: J:48851
Chapman VM; Miller DR; Armstrong D; Caskey CT. 1989. Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice. Proc Natl Acad Sci U S A 86(4):1292-6. PubMed: 2919177 MGI: J:9638
Charan RA; Hanson R; Clemens PR. 2012. Deubiquitinating enzyme A20 negatively regulates NF-kappaB signaling in skeletal muscle in mdx mice. FASEB J 26(2):587-95. PubMed: 22012122 MGI: J:180624
Chaudhari MR; Fallavollita JA; Farkas GA. 2016. The Effects of Experimental Sleep Apnea on Cardiac and Respiratory Functions in 6 and 18 Month Old Dystrophic (mdx) Mice. PLoS One 11(1):e0147640. PubMed: 26808526 MGI: J:251788
Chen G; Bressler BH; Quinn LS. 1994. Extracts from mdx and normal mouse skeletal muscle contain similar levels of mitogenic activity for myoblasts. Cell Biol Int 18(4):229-35. PubMed: 8044140 MGI: J:18325
Chen M; Li HJ; Fang Q; Goodwin TG; Florendo JA; Law PK. 1992. Dystrophin cytochemistry in mdx mouse muscles injected with labeled normal myoblasts. Cell Transplant 1(1):17-22. PubMed: 1344288 MGI: J:18529
Chen TJ; Chen SS; Wang DC; Hsieh YL. 2002. Increased vulnerability of auditory system to noise exposure in mdx mice. Laryngoscope 112(3):520-5. PubMed: 12148865 MGI: J:105938
Cheng X; Zhang X; Gao Q; Ali Samie M; Azar M; Tsang WL; Dong L; Sahoo N; Li X; Zhuo Y; Garrity AG; Wang X; Ferrer M; Dowling J; Xu L; Han R; Xu H. 2014. The intracellular Ca(2)(+) channel MCOLN1 is required for sarcolemma repair to prevent muscular dystrophy. Nat Med 20(10):1187-92. PubMed: 25216637 MGI: J:227741
Cheng YJ; Lang D; Caruthers SD; Efimov IR; Chen J; Wickline SA. 2012. Focal but reversible diastolic sheet dysfunction reflects regional calcium mishandling in dystrophic mdx mouse hearts. Am J Physiol Heart Circ Physiol 303(5):H559-68. PubMed: 22777417 MGI: J:189172
Chirieleison SM; Feduska JM; Schugar RC; Askew Y; Deasy BM. 2012. Human muscle-derived cell populations isolated by differential adhesion rates: phenotype and contribution to skeletal muscle regeneration in Mdx/SCID mice. Tissue Eng Part A 18(3-4):232-41. PubMed: 21854253 MGI: J:181239
Chiu YH; Hornsey MA; Klinge L; Jorgensen LH; Laval SH; Charlton R; Barresi R; Straub V; Lochmuller H; Bushby K. 2009. Attenuated muscle regeneration is a key factor in dysferlin-deficient muscular dystrophy. Hum Mol Genet 18(11):1976-89. PubMed: 19286669 MGI: J:148110
Chu V; Otero JM; Lopez O; Sullivan MF; Morgan JP; Amende I; Hampton TG. 2002. Electrocardiographic findings in mdx mice: a cardiac phenotype of Duchenne muscular dystrophy. Muscle Nerve 26(4):513-9. PubMed: 12362417 MGI: J:116340
Chung HS; Kim GE; Holewinski RJ; Venkatraman V; Zhu G; Bedja D; Kass DA; Van Eyk JE. 2017. Transient receptor potential channel 6 regulates abnormal cardiac S-nitrosylation in Duchenne muscular dystrophy. Proc Natl Acad Sci U S A 114(50):E10763-E10771. PubMed: 29187535 MGI: J:256511
Coccurello R; Castellano C; Paggi P; Mele A; Oliverio A. 2002. Genetically dystrophic mdx/mdx mice exhibit decreased response to nicotine in passive avoidance. Neuroreport 13(9):1219-22. PubMed: 12151773 MGI: J:103674
Coenen-Stass AM; Betts CA; Lee YF; Mager I; Turunen MP; El Andaloussi S; Morgan JE; Wood MJ; Roberts TC. 2016. Selective release of muscle-specific, extracellular microRNAs during myogenic differentiation. Hum Mol Genet 25(18):3960-3974. PubMed: 27466195 MGI: J:238572
Cohn RD; Durbeej M; Moore SA; Coral-Vazquez R; Prouty S; Campbell KP. 2001. Prevention of cardiomyopathy in mouse models lacking the smooth muscle sarcoglycan-sarcospan complex. J Clin Invest 107(2):R1-7. PubMed: 11160141 MGI: J:66973
Cohn RD; Liang HY; Shetty R; Abraham T; Wagner KR. 2007. Myostatin does not regulate cardiac hypertrophy or fibrosis. Neuromuscul Disord 17(4):290-6. PubMed: 17336525 MGI: J:124477
Cohn RD; van Erp C; Habashi JP; Soleimani AA; Klein EC; Lisi MT; Gamradt M; Ap Rhys CM; Holm TM; Loeys BL; Ramirez F; Judge DP; Ward CW; Dietz HC. 2007. Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states. Nat Med 13(2):204-210. PubMed: 17237794 MGI: J:117885
Coirault C; Pignol B; Cooper RN; Butler-Browne G; Chabrier PE; Lecarpentier Y. 2003. Severe muscle dysfunction precedes collagen tissue proliferation in mdx mouse diaphragm. J Appl Physiol 94(5):1744-50. PubMed: 12679345 MGI: J:103042
Cole MA; Rafael JA; Taylor DJ; Lodi R; Davies KE; Styles P. 2002. A quantitative study of bioenergetics in skeletal muscle lacking utrophin and dystrophin. Neuromuscul Disord 12(3):247-57. PubMed: 11801396 MGI: J:103103
Coley WD; Bogdanik L; Vila MC; Yu Q; van der Meulen JH; Rayavarapu S; Novak JS; Nearing M; Quinn JL; Saunders A; Dolan C; Andrews W; Lammert C; Austin A; Partridge TA; Cox GA; Lutz C; Nagaraju K. 2015. Effect of genetic background on the dystrophic phenotype in mdx mice. Hum Mol Genet :. PubMed: 26566673 MGI: J:226314
Collet C; Allard B; Tourneur Y; Jacquemond V. 1999. Intracellular calcium signals measured with indo-1 in isolated skeletal muscle fibres from control and mdx mice. J Physiol 520 Pt 2:417-29. PubMed: 10523411 MGI: J:106307
Colussi C; Gurtner A; Rosati J; Illi B; Ragone G; Piaggio G; Moggio M; Lamperti C; D'Angelo G; Clementi E; Minetti G; Mozzetta C; Antonini A; Capogrossi MC; Puri PL; Gaetano C. 2009. Nitric oxide deficiency determines global chromatin changes in Duchenne muscular dystrophy. FASEB J 23(7):2131-41. PubMed: 19264835 MGI: J:150530
Colussi C; Mozzetta C; Gurtner A; Illi B; Rosati J; Straino S; Ragone G; Pescatori M; Zaccagnini G; Antonini A; Minetti G; Martelli F; Piaggio G; Gallinari P; Steinkulher C; Clementi E; Dell'Aversana C; Altucci L; Mai A; Capogrossi MC; Puri PL; Gaetano C. 2008. HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment. Proc Natl Acad Sci U S A 105(49):19183-7. PubMed: 19047631 MGI: J:142085
Combaret L; Taillandier D; Voisin L; Samuels SE; Boespflug-Tanguy O; Attaix D. 1996. No alteration in gene expression of components of the ubiquitin-proteasome proteolytic pathway in dystrophin-deficient muscles. FEBS Lett 393(2-3):292-6. PubMed: 8814307 MGI: J:35369
Connolly AM; Keeling RM; Mehta S; Pestronk A; Sanes JR. 2001. Three mouse models of muscular dystrophy: the natural history of strength and fatigue in dystrophin-, dystrophin/utrophin-, and laminin alpha2-deficient mice. Neuromuscul Disord 11(8):703-12. PubMed: 11595512 MGI: J:103061
Corrado K; Rafael JA; Mills PL; Cole NM; Faulkner JA; Wang K; Chamberlain JS. 1996. Transgenic mdx mice expressing dystrophin with a deletion in the actin-binding domain display a mild Becker phenotype. J Cell Biol 134(4):873-84. PubMed: 8769413 MGI: J:34924
Coulton GR; Morgan JE; Partridge TA; Sloper JC. 1988. The mdx mouse skeletal muscle myopathy: I. A histological, morphometric and biochemical investigation. Neuropathol Appl Neurobiol 14(1):53-70. PubMed: 2967442 MGI: J:152524
Cox GA; Cole NM; Matsumura K; Phelps SF; Hauschka SD; Campbell KP; Faulkner JA; Chamberlain JS. 1993. Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity [see comments] Nature 364(6439):725-9. PubMed: 8355788 MGI: J:14332
Cox GA; Phelps SF; Chapman VM; Chamberlain JS. 1993. New mdx mutation disrupts expression of muscle and nonmuscle isoforms of dystrophin. Nat Genet 4(1):87-93. PubMed: 8099842 MGI: J:12150
Crisp A; Yin H; Goyenvalle A; Betts C; Moulton HM; Seow Y; Babbs A; Merritt T; Saleh AF; Gait MJ; Stuckey DJ; Clarke K; Davies KE; Wood MJ. 2011. Diaphragm rescue alone prevents heart dysfunction in dystrophic mice. Hum Mol Genet 20(3):413-21. PubMed: 21062902 MGI: J:167240
Crosbie RH; Dovico SA; Flanagan JD; Chamberlain JS; Ownby CL; Campbell KP. 2002. Characterization of aquaporin-4 in muscle and muscular dystrophy. FASEB J 16(9):943-9. PubMed: 12087055 MGI: J:120469
Crosbie RH; Straub V; Yun HY; Lee JC; Rafael JA; Chamberlain JS; Dawson VL; Dawson TM; Campbell KP. 1998. mdx muscle pathology is independent of nNOS perturbation. Hum Mol Genet 7(5):823-9. PubMed: 9536086 MGI: J:47623
Cullen MJ; Jaros E. 1988. Ultrastructure of the skeletal muscle in the X chromosome-linked dystrophic (mdx) mouse. Comparison with Duchenne muscular dystrophy. Acta Neuropathol 77(1):69-81. PubMed: 3239377 MGI: J:152892
Cully TR; Edwards JN; Friedrich O; Stephenson DG; Murphy RM; Launikonis BS. 2012. Changes in plasma membrane Ca-ATPase and stromal interacting molecule 1 expression levels for Ca(2+) signaling in dystrophic mdx mouse muscle. Am J Physiol Cell Physiol 303(5):C567-76. PubMed: 22785116 MGI: J:192667
Cully TR; Launikonis BS. 2016. Leaky ryanodine receptors delay the activation of store overload-induced Ca2+ release, a mechanism underlying malignant hyperthermia-like events in dystrophic muscle. Am J Physiol Cell Physiol 310(8):C673-80. PubMed: 26825125 MGI: J:235698
D'Arcy CE; Feeney SJ; McLean CA; Gehrig SM; Lynch GS; Smith JE; Cowling BS; Mitchell CA; McGrath MJ. 2014. Identification of FHL1 as a therapeutic target for Duchenne muscular dystrophy. Hum Mol Genet 23(3):618-36. PubMed: 24087791 MGI: J:215146
D'Souza VN; Nguyen TM; Morris GE; Karges W; Pillers DA; Ray PN. 1995. A novel dystrophin isoform is required for normal retinal electrophysiology. Hum Mol Genet 4(5):837-42. PubMed: 7633443 MGI: J:25211
Dahiya S; Bhatnagar S; Hindi SM; Jiang C; Paul PK; Kuang S; Kumar A. 2011. Elevated levels of active matrix metalloproteinase-9 cause hypertrophy in skeletal muscle of normal and dystrophin-deficient mdx mice. Hum Mol Genet 20(22):4345-59. PubMed: 21846793 MGI: J:176891
Dahiya S; Givvimani S; Bhatnagar S; Qipshidze N; Tyagi SC; Kumar A. 2011. Osteopontin-stimulated expression of matrix metalloproteinase-9 causes cardiomyopathy in the mdx model of Duchenne muscular dystrophy. J Immunol 187(5):2723-31. PubMed: 21810612 MGI: J:179125
Dallerac G; Perronnet C; Chagneau C; Leblanc-Veyrac P; Samson-Desvignes N; Peltekian E; Danos O; Garcia L; Laroche S; Billard JM; Vaillend C. 2011. Rescue of a dystrophin-like protein by exon skipping normalizes synaptic plasticity in the hippocampus of the mdx mouse. Neurobiol Dis :. PubMed: 21624465 MGI: J:173321
Dangain J; Vrbova G. 1984. Muscle development in mdx mutant mice. Muscle Nerve 7(9):700-4. PubMed: 6543918 MGI: J:8039
Daoud F; Candelario-Martinez A; Billard JM; Avital A; Khelfaoui M; Rozenvald Y; Guegan M; Mornet D; Jaillard D; Nudel U; Chelly J; Martinez-Rojas D; Laroche S; Yaffe D; Vaillend C. 2009. Role of mental retardation-associated dystrophin-gene product Dp71 in excitatory synapse organization, synaptic plasticity and behavioral functions. PLoS One 4(8):e6574. PubMed: 19649270 MGI: J:152485
Darabi R; Gehlbach K; Bachoo RM; Kamath S; Osawa M; Kamm KE; Kyba M; Perlingeiro RC. 2008. Functional skeletal muscle regeneration from differentiating embryonic stem cells. Nat Med 14(2):134-43. PubMed: 18204461 MGI: J:133565
De Backer F; Vandebrouck C; Gailly P; Gillis JM. 2002. Long-term study of Ca(2+) homeostasis and of survival in collagenase-isolated muscle fibres from normal and mdx mice. J Physiol 542(Pt 3):855-65. PubMed: 12154184 MGI: J:106014
De Luca A; Nico B; Liantonio A; Didonna MP; Fraysse B; Pierno S; Burdi R; Mangieri D; Rolland JF; Camerino C; Zallone A; Confalonieri P; Andreetta F; Arnoldi E; Courdier-Fruh I; Magyar JP; Frigeri A; Pisoni M; Svelto M; Conte Camerino D. 2005. A multidisciplinary evaluation of the effectiveness of cyclosporine a in dystrophic mdx mice. Am J Pathol 166(2):477-89. PubMed: 15681831 MGI: J:95973
De Luca A; Pierno S; Camerino DC. 1995. Changes of membrane electrical properties in extensor digitorum longus muscle from dystrophic (mdx) mice. Muscle Nerve 18(10):1196-8. PubMed: 7659114 MGI: J:115862
De Stefano ME; Leone L; Lombardi L; Paggi P. 2005. Lack of dystrophin leads to the selective loss of superior cervical ganglion neurons projecting to muscular targets in genetically dystrophic mdx mice. Neurobiol Dis 20(3):929-42. PubMed: 16023353 MGI: J:104656
Deconinck AE; Rafael JA; Skinner JA; Brown SC; Potter AC; Metzinger L ; Watt DJ ; Dickson JG ; Tinsley JM ; Davies KE. 1997. Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell 90(4):717-27. PubMed: 9288751 MGI: J:42388
Deconinck N; Rafael JA; Beckers-Bleukx G; Kahn D; Deconinck AE; Davies KE; Gillis JM. 1998. Consequences of the combined deficiency in dystrophin and utrophin on the mechanical properties and myosin composition of some limb and respiratory muscles of the mouse. Neuromuscul Disord 8(6):362-70. PubMed: 9713852 MGI: J:110988
Deconinck N; Tinsley J; De Backer F; Fisher R; Kahn D; Phelps S; Davies K; Gillis JM. 1997. Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice. Nat Med 3(11):1216-21. PubMed: 9359695 MGI: J:44111
Decrouy A; Even PC; Chinet A. 1993. Decreased rates of Ca(2+)-dependent heat production in slow- and fast-twitch muscles from the dystrophic (mdx) mouse. Experientia 49(10):843-9. PubMed: 8224098 MGI: J:15722
Demoule A; Divangahi M; Danialou G; Gvozdic D; Larkin G; Bao W; Petrof BJ. 2005. Expression and regulation of CC class chemokines in the dystrophic (mdx) diaphragm. Am J Respir Cell Mol Biol 33(2):178-85. PubMed: 15860797 MGI: J:112940
Deng B; Glanzman D; Tidball JG. 2009. Nitric oxide generated by muscle corrects defects in hippocampal neurogenesis and neural differentiation caused by muscular dystrophy. J Physiol 587(Pt 8):1769-78. PubMed: 19237426 MGI: J:176544
Di Angelantonio S; De Stefano ME; Piccioni A; Lombardi L; Gotti C; Paggi P. 2011. Lack of dystrophin functionally affects alpha3beta2/beta4-nicotinic acethylcholine receptors in sympathetic neurons of dystrophic mdx mice. Neurobiol Dis 41(2):528-37. PubMed: 21056666 MGI: J:168343
Di Certo MG; Corbi N; Strimpakos G; Onori A; Luvisetto S; Severini C; Guglielmotti A; Batassa EM; Pisani C; Floridi A; Benassi B; Fanciulli M; Magrelli A; Mattei E; Passananti C. 2010. The artificial gene Jazz, a transcriptional regulator of utrophin, corrects the dystrophic pathology in mdx mice. Hum Mol Genet 19(5):752-60. PubMed: 19965907 MGI: J:157115
DiFranco M; Woods CE; Capote J; Vergara JL. 2008. Dystrophic skeletal muscle fibers display alterations at the level of calcium microdomains. Proc Natl Acad Sci U S A 105(38):14698-703. PubMed: 18787128 MGI: J:141246
Diaz-Ramos A; Roig-Borrellas A; Garcia-Melero A; Llorens A; Lopez-Alemany R. 2012. Requirement of plasminogen binding to its cell-surface receptor alpha-enolase for efficient regeneration of normal and dystrophic skeletal muscle. PLoS One 7(12):e50477. PubMed: 23239981 MGI: J:195546
Dick J; Vrbova G. 1993. Progressive deterioration of muscles in mdx mice induced by overload. Clin Sci (Colch) 84(2):145-50. PubMed: 8382579 MGI: J:12242
Disatnik MH; Chamberlain JS; Rando TA. 2000. Dystrophin mutations predict cellular susceptibility to oxidative stress. Muscle Nerve 23(5):784-92. PubMed: 10797403 MGI: J:116192
Divet A; Huchet-Cadiou C. 2002. Sarcoplasmic reticulum function in slow- and fast-twitch skeletal muscles from mdx mice. Pflugers Arch 444(5):634-43. PubMed: 12194017 MGI: J:106172
Dominov JA; Kravetz AJ; Ardelt M; Kostek CA; Beermann ML; Miller JB. 2005. Muscle-specific BCL2 expression ameliorates muscle disease in laminin {alpha}2-deficient, but not in dystrophin-deficient, mice. Hum Mol Genet 14(8):1029-40. PubMed: 15757977 MGI: J:98004
Dubois C; Figarella-Branger D; Pastoret C; Rampini C; Karpati G; Rougon G. 1994. Expression of NCAM and its polysialylated isoforms during mdx mouse muscle regeneration and in vitro myogenesis. Neuromuscul Disord 4(3):171-82. PubMed: 7919966 MGI: J:19382
Dudley RW; Danialou G; Govindaraju K; Lands L; Eidelman DE; Petrof BJ. 2006. Sarcolemmal damage in dystrophin deficiency is modulated by synergistic interactions between mechanical and oxidative/nitrosative stresses. Am J Pathol 168(4):1276-87; quiz 1404-5. PubMed: 16565501 MGI: J:107332
Dufresne SS; Boulanger-Piette A; Frenette J. 2017. Osteoprotegerin and beta2-Agonists Mitigate Muscular Dystrophy in Slow- and Fast-Twitch Skeletal Muscles. Am J Pathol 187(3):498-504. PubMed: 28041995 MGI: J:240178
Dufresne SS; Dumont NA; Bouchard P; Lavergne E; Penninger JM; Frenette J. 2015. Osteoprotegerin Protects against Muscular Dystrophy. Am J Pathol 185(4):920-6. PubMed: 25708645 MGI: J:220247
Dunant P; Larochelle N; Thirion C; Stucka R; Ursu D; Petrof BJ; Wolf E; Lochmuller H. 2003. Expression of dystrophin driven by the 1.35-kb MCK promoter ameliorates muscular dystrophy in fast, but not in slow muscles of transgenic mdx mice. Mol Ther 8(1):80-9. PubMed: 12842431 MGI: J:105122
Dunckley MG; Wells KE; Piper TA; Wells DJ; Dickson G. 1994. Independent localization of dystrophin N- and C-terminal regions to the sarcolemma of mdx mouse myofibres in vivo. J Cell Sci 107(Pt 6):1469-75. PubMed: 7962190 MGI: J:19097
Dunn JF; Bannister N; Kemp GJ; Publicover SJ. 1993. Sodium is elevated in mdx muscles: ionic interactions in dystrophic cells. J Neurol Sci 114(1):76-80. PubMed: 8433102 MGI: J:3666
Dunn JF; Tracey I; Radda GK. 1992. A 31P-NMR study of muscle exercise metabolism in mdx mice: evidence for abnormal pH regulation. J Neurol Sci 113(1):108-13. PubMed: 1469448 MGI: J:3269
Dunn JF; Zaim-Wadghiri Y. 1999. Quantitative magnetic resonance imaging of the mdx mouse model of Duchenne muscular dystrophy. Muscle Nerve 22(10):1367-71. PubMed: 10487902 MGI: J:116233
Dupont-Versteegden EE; Baldwin RA; McCarter RJ; Vonlanthen MG. 1994. Does muscular dystrophy affect metabolic rate? A study in mdx mice. J Neurol Sci 121(2):203-7. PubMed: 8158216 MGI: J:16597
Dupont-Versteegden EE; McCarter RJ. 1992. Differential expression of muscular dystrophy in diaphragm versus hindlimb muscles of mdx mice. Muscle Nerve 15(10):1105-10. PubMed: 1406767 MGI: J:116342
Dye WW; Gleason RL; Wilson E; Humphrey JD. 2007. Altered biomechanical properties of carotid arteries in two mouse models of muscular dystrophy. J Appl Physiol 103(2):664-72. PubMed: 17525297 MGI: J:148308
Ebihara S; Guibinga GH; Gilbert R; Nalbantoglu J; Massie B; Karpati G; Petrof BJ. 2000. Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice Physiol Genomics 3(3):133-44. PubMed: 11015608 MGI: J:65385
Edwards JN; Friedrich O; Cully TR; von Wegner F; Murphy RM; Launikonis BS. 2010. Upregulation of store-operated Ca2+ entry in dystrophic mdx mouse muscle. Am J Physiol Cell Physiol 299(1):C42-50. PubMed: 20427714 MGI: J:162510
Elsherif L; Huang MS; Shai SY; Yang Y; Li RY; Chun J; Mekany MA; Chu AL; Kaufman SJ; Ross RS. 2008. Combined deficiency of dystrophin and beta1 integrin in the cardiac myocyte causes myocardial dysfunction, fibrosis and calcification. Circ Res 102(9):1109-17. PubMed: 18340010 MGI: J:149030
Enwere EK; Boudreault L; Holbrook J; Timusk K; Earl N; Lacasse E; Renaud JM; Korneluk RG. 2013. Loss of cIAP1 attenuates soleus muscle pathology and improves diaphragm function in mdx mice. Hum Mol Genet 22(5):867-78. PubMed: 23184147 MGI: J:192578
Farini A; Meregalli M; Belicchi M; Battistelli M; Parolini D; D'Antona G; Gavina M; Ottoboni L; Constantin G; Bottinelli R; Torrente Y. 2007. T and B lymphocyte depletion has a marked effect on the fibrosis of dystrophic skeletal muscles in the scid/mdx mouse. J Pathol 213(2):229-38. PubMed: 17668421 MGI: J:125527
Fauconnier J; Thireau J; Reiken S; Cassan C; Richard S; Matecki S; Marks AR; Lacampagne A. 2010. Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy. Proc Natl Acad Sci U S A :. PubMed: 20080623 MGI: J:156537
Fernandez K; Serinagaoglu Y; Hammond S; Martin LT; Martin PT. 2010. Mice lacking dystrophin or alpha sarcoglycan spontaneously develop embryonal rhabdomyosarcoma with cancer-associated p53 mutations and alternatively spliced or mutant Mdm2 transcripts. Am J Pathol 176(1):416-34. PubMed: 20019182 MGI: J:156447
Ferretti R; Neto HS; Marques MJ. 2011. Expression of utrophin at dystrophin-deficient neuromuscular synapses of mdx mice: a study of protected and affected muscles. Anat Rec (Hoboken) 294(2):283-6. PubMed: 21235003 MGI: J:175589
Fiacco E; Castagnetti F; Bianconi V; Madaro L; De Bardi M; Nazio F; D'Amico A; Bertini E; Cecconi F; Puri PL; Latella L. 2016. Autophagy regulates satellite cell ability to regenerate normal and dystrophic muscles. Cell Death Differ 23(11):1839-1849. PubMed: 27447110 MGI: J:258566
Fiore F; Sebille A; Birnbaum D. 2000. Skeletal muscle regeneration is not impaired in Fgf6 -/- mutant mice. Biochem Biophys Res Commun 272(1):138-43. PubMed: 10872817 MGI: J:62522
Fisher R; Tinsley JM; Phelps SR; Squire SE; Townsend ER; Martin JE; Davies KE. 2001. Non-toxic ubiquitous over-expression of utrophin in the mdx mouse. Neuromuscul Disord 11(8):713-21. PubMed: 11595513 MGI: J:103062
Floss T; Arnold HH; Braun T. 1997. A role for FGF-6 in skeletal muscle regeneration. Genes Dev 11(16):2040-51. PubMed: 9284044 MGI: J:42574
Fortier M; Figeac N; White RB; Knopp P; Zammit PS. 2013. Sphingosine-1-phosphate receptor 3 influences cell cycle progression in muscle satellite cells. Dev Biol 382(2):504-16. PubMed: 23911934 MGI: J:202223
Franco A Jr; Lansman JB. 1990. Calcium entry through stretch-inactivated ion channels in mdx myotubes. Nature 344(6267):670-3. PubMed: 1691450 MGI: J:12240
Franco-Obregon A; Lansman JB. 2002. Changes in mechanosensitive channel gating following mechanical stimulation in skeletal muscle myotubes from the mdx mouse. J Physiol 539(Pt 2):391-407. PubMed: 11882673 MGI: J:105953
Friedrich O; Both M; Gillis JM; Chamberlain JS; Fink RH. 2004. Mini-dystrophin restores L-type calcium currents in skeletal muscle of transgenic mdx mice. J Physiol 555(Pt 1):251-65. PubMed: 14594987 MGI: J:105401
Frigeri A; Nicchia GP; Balena R; Nico B; Svelto M. 2004. Aquaporins in skeletal muscle: reassessment of the functional role of aquaporin-4. FASEB J 18(7):905-7. PubMed: 15033928 MGI: J:118506
Frigeri A; Nicchia GP; Nico B; Quondamatteo F; Herken R; Roncali L; Svelto M. 2001. Aquaporin-4 deficiency in skeletal muscle and brain of dystrophic mdx mice. FASEB J 15(1):90-98. PubMed: 11149896 MGI: J:66891
Froehner SC; Reed SM; Anderson KN; Huang PL; Percival JM. 2015. Loss of nNOS inhibits compensatory muscle hypertrophy and exacerbates inflammation and eccentric contraction-induced damage in mdx mice. Hum Mol Genet 24(2):492-505. PubMed: 25214536 MGI: J:217207
Fuenzalida M; Espinoza C; Perez MA; Tapia-Rojas C; Cuitino L; Brandan E; Inestrosa NC. 2016. Wnt signaling pathway improves central inhibitory synaptic transmission in a mouse model of Duchenne muscular dystrophy. Neurobiol Dis 86(None):109-20. PubMed: 26626079 MGI: J:259320
Fujita R; Tamai K; Aikawa E; Nimura K; Ishino S; Kikuchi Y; Kaneda Y. 2015. Endogenous mesenchymal stromal cells in bone marrow are required to preserve muscle function in mdx mice. Stem Cells 33(3):962-75. PubMed: 25408548 MGI: J:223657
Fukada S; Morikawa D; Yamamoto Y; Yoshida T; Sumie N; Yamaguchi M; Ito T; Miyagoe-Suzuki Y; Takeda S; Tsujikawa K; Yamamoto H. 2010. Genetic background affects properties of satellite cells and mdx phenotypes. Am J Pathol 176(5):2414-24. PubMed: 20304955 MGI: J:160773
Gaedigk R; Law DJ; Fitzgerald-Gustafson KM; McNulty SG; Nsumu NN; Modrcin AC; Rinaldi RJ; Pinson D; Fowler SC; Bilgen M; Burns J; Hauschka SD; White RA. 2006. Improvement in survival and muscle function in an mdx/utrn(-/-) double mutant mouse using a human retinal dystrophin transgene. Neuromuscul Disord 16(3):192-203. PubMed: 16487708 MGI: J:112787
Gailly P; Boland B; Himpens B; Casteels R; Gillis JM. 1993. Critical evaluation of cytosolic calcium determination in resting muscle fibres from normal and dystrophic (mdx) mice. Cell Calcium 14(6):473-83. PubMed: 8358771 MGI: J:16250
Gailly P; Hermans E; Octave JN; Gillis JM. 1993. Specific increase of genetic expression of parvalbumin in fast skeletal muscles of mdx mice. FEBS Lett 326(1-3):272-4. PubMed: 8325378 MGI: J:13734
Gang EJ; Darabi R; Bosnakovski D; Xu Z; Kamm KE; Kyba M; Perlingeiro RC. 2009. Engraftment of mesenchymal stem cells into dystrophin-deficient mice is not accompanied by functional recovery. Exp Cell Res 315(15):2624-36. PubMed: 19460366 MGI: J:154502
Gannoun-Zaki L; Fournier-Bidoz S; Le Cam G; Chambon C; Millasseau P; Leger JJ; Dechesne CA. 1995. Down-regulation of mitochondrial mRNAs in the mdx mouse model for Duchenne muscular dystrophy. FEBS Lett 375(3):268-72. PubMed: 7498514 MGI: J:29965
Gao HL; Li C; Nabeka H; Shimokawa T; Kobayashi N; Saito S; Wang ZY; Cao YM; Matsuda S. 2013. Decrease in prosaposin in the Dystrophic mdx mouse brain. PLoS One 8(11):e80032. PubMed: 24244600 MGI: J:209694
Garrett KL; Anderson JE. 1995. Colocalization of bFGF and the myogenic regulatory gene myogenin in dystrophic mdx muscle precursors and young myotubes in vivo. Dev Biol 169(2):596-608. PubMed: 7781901 MGI: J:26128
Garry DJ; Meeson A; Elterman J; Zhao Y; Yang P; Bassel-Duby R; Williams RS. 2000. Myogenic stem cell function is impaired in mice lacking the forkhead/winged helix protein MNF. Proc Natl Acad Sci U S A 97(10):5416-21. PubMed: 10792059 MGI: J:62225
Gawlik KI; Holmberg J; Durbeej M. 2014. Loss of Dystrophin and beta-Sarcoglycan Significantly Exacerbates the Phenotype of Laminin alpha2 Chain-Deficient Animals. Am J Pathol 184(3):740-52. PubMed: 24393714 MGI: J:206359
Gawlik KI; Oliveira BM; Durbeej M. 2011. Transgenic Expression of Laminin alpha1 Chain Does Not Prevent Muscle Disease in the mdx Mouse Model for Duchenne Muscular Dystrophy. Am J Pathol 178(4):1728-37. PubMed: 21435454 MGI: J:169848
Gehrig SM; Koopman R; Naim T; Tjoakarfa C; Lynch GS. 2010. Making fast-twitch dystrophic muscles bigger protects them from contraction injury and attenuates the dystrophic pathology. Am J Pathol 176(1):29-33. PubMed: 19959813 MGI: J:156505
Gehrig SM; van der Poel C; Sayer TA; Schertzer JD; Henstridge DC; Church JE; Lamon S; Russell AP; Davies KE; Febbraio MA; Lynch GS. 2012. Hsp72 preserves muscle function and slows progression of severe muscular dystrophy. Nature 484(7394):394-8. PubMed: 22495301 MGI: J:183833
Gervasio OL; Whitehead NP; Yeung EW; Phillips WD; Allen DG. 2008. TRPC1 binds to caveolin-3 and is regulated by Src kinase - role in Duchenne muscular dystrophy. J Cell Sci 121(Pt 13):2246-55. PubMed: 18544631 MGI: J:139759
Ghahramani Seno MM; Graham IR; Athanasopoulos T; Trollet C; Pohlschmidt M; Crompton MR; Dickson G. 2008. RNAi-mediated knockdown of dystrophin expression in adult mice does not lead to overt muscular dystrophy pathology. Hum Mol Genet 17(17):2622-32. PubMed: 18511456 MGI: J:138171
Ghedini PC; Avellar MC; De Lima TC; Lima-Landman MT; Lapa AJ; Souccar C. 2012. Quantitative changes of nicotinic receptors in the hippocampus of dystrophin-deficient mice. Brain Res 1483:96-104. PubMed: 22995368 MGI: J:193571
Gibbs EM; Marshall JL; Ma E; Nguyen TM; Hong G; Lam JS; Spencer MJ; Crosbie-Watson RH. 2016. High levels of sarcospan are well tolerated and act as a sarcolemmal stabilizer to address skeletal muscle and pulmonary dysfunction in DMD. Hum Mol Genet :. PubMed: 27798107 MGI: J:239326
Gilbert R; Dudley RW; Liu AB; Petrof BJ; Nalbantoglu J; Karpati G. 2003. Prolonged dystrophin expression and functional correction of mdx mouse muscle following gene transfer with a helper-dependent (gutted) adenovirus-encoding murine dystrophin. Hum Mol Genet 12(11):1287-99. PubMed: 12761044 MGI: J:83809
Gillet B; Doan BT; Verre-Serrie C; Barbere B; Berenger G; Morin S; Koenig J; Peres M; Sebille A; Beloeil JC. 1993. In vivo 2D 1H NMR of mdx mouse muscle and myoblast cells during fusion: evidence for a characteristic signal of long chain fatty acids. Neuromuscul Disord 3(5-6):433-8. PubMed: 8186688 MGI: J:19036
Giordano C; Mojumdar K; Liang F; Lemaire C; Li T; Richardson J; Divangahi M; Qureshi S; Petrof BJ. 2015. Toll-like receptor 4 ablation in mdx mice reveals innate immunity as a therapeutic target in Duchenne muscular dystrophy. Hum Mol Genet 24(8):2147-62. PubMed: 25552658 MGI: J:220602
Gladman JT; Yadava RS; Mandal M; Yu Q; Kim YK; Mahadevan MS. 2015. NKX2-5, a modifier of skeletal muscle pathology due to RNA toxicity. Hum Mol Genet 24(1):251-64. PubMed: 25168381 MGI: J:216510
Godfraind JM; Tekkok SB; Krnjevic K. 2000. Hypoxia on hippocampal slices from mice deficient in dystrophin (mdx) and isoforms (mdx3cv). J Cereb Blood Flow Metab 20(1):145-52. PubMed: 10616803 MGI: J:60086
Godfrey C; Muses S; McClorey G; Wells KE; Coursindel T; Terry RL; Betts C; Hammond S; O'Donovan L; Hildyard J; El Andaloussi S; Gait MJ; Wood MJ; Wells DJ. 2015. How much dystrophin is enough: the physiological consequences of different levels of dystrophin in the mdx mouse. Hum Mol Genet 24(15):4225-37. PubMed: 25935000 MGI: J:223941
Godin R; Daussin F; Matecki S; Li T; Petrof BJ; Burelle Y. 2012. Peroxisome proliferator-activated receptor gamma coactivator1- gene alpha transfer restores mitochondrial biomass and improves mitochondrial calcium handling in post-necrotic mdx mouse skeletal muscle. J Physiol 590(Pt 21):5487-502. PubMed: 22907054 MGI: J:202448
Goldspink G; Fernandes K; Williams PE; Wells DJ. 1994. Age-related changes in collagen gene expression in the muscles of mdx dystrophic and normal mice. Neuromuscul Disord 4(3):183-91. PubMed: 7919967 MGI: J:19383
Golumbek PT; Keeling RM; Connolly AM. 2007. Strength and corticosteroid responsiveness of mdx mice is unchanged by RAG2 gene knockout. Neuromuscul Disord 17(5):376-84. PubMed: 17452104 MGI: J:124559
Gonzalez DR; Treuer AV; Lamirault G; Mayo V; Cao Y; Dulce RA; Hare JM. 2014. NADPH oxidase-2 inhibition restores contractility and intracellular calcium handling and reduces arrhythmogenicity in dystrophic cardiomyopathy. Am J Physiol Heart Circ Physiol 307(5):H710-21. PubMed: 25015966 MGI: J:214630
Gonzalez-Barriga A; Kranzen J; Croes HJ; Bijl S; van den Broek WJ; van Kessel ID; van Engelen BG; van Deutekom JC; Wieringa B; Mulders SA; Wansink DG. 2015. Cell membrane integrity in myotonic dystrophy type 1: implications for therapy. PLoS One 10(3):e0121556. PubMed: 25799359 MGI: J:229190
Goodall MH; Ward CW; Pratt SJ; Bloch RJ; Lovering RM. 2012. Structural and functional evaluation of branched myofibers lacking intermediate filaments. Am J Physiol Cell Physiol 303(2):C224-32. PubMed: 22592402 MGI: J:191363
Gosselin LE; Barkley JE; Spencer MJ; McCormick KM; Farkas GA. 2003. Ventilatory dysfunction in mdx mice: impact of tumor necrosis factor-alpha deletion. Muscle Nerve 28(3):336-43. PubMed: 12929194 MGI: J:116208
Gotic I; Leschnik M; Kolm U; Markovic M; Haubner BJ; Biadasiewicz K; Metzler B; Stewart CL; Foisner R. 2010. Lamina-associated polypeptide 2alpha loss impairs heart function and stress response in mice. Circ Res 106(2):346-53. PubMed: 19926876 MGI: J:170061
Goyenvalle A; Babbs A; Wright J; Wilkins V; Powell D; Garcia L; Davies KE. 2012. Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping. Hum Mol Genet 21(11):2559-71. PubMed: 22388933 MGI: J:183897
Goyenvalle A; Griffith G; Babbs A; El Andaloussi S; Ezzat K; Avril A; Dugovic B; Chaussenot R; Ferry A; Voit T; Amthor H; Buhr C; Schurch S; Wood MJ; Davies KE; Vaillend C; Leumann C; Garcia L. 2015. Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers. Nat Med 21(3):270-5. PubMed: 25642938 MGI: J:227938
Graciotti L; Becker J; Granata AL; Procopio AD; Tessarollo L; Fulgenzi G. 2011. Dystrophin Is Required for the Normal Function of the Cardio-Protective K(ATP) Channel in Cardiomyocytes. PLoS One 6(10):e27034. PubMed: 22066028 MGI: J:178064
Grady RM; Grange RW; Lau KS; Maimone MM; Nichol MC; Stull JT; Sanes JR. 1999. Role for alpha-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies. Nat Cell Biol 1(4):215-20. PubMed: 10559919 MGI: J:59675
Grady RM; Teng H; Nichol MC; Cunningham JC; Wilkinson RS; Sanes JR. 1997. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell 90(4):729-38. PubMed: 9288752 MGI: J:42389
Grady RM; Wozniak DF; Ohlemiller KK; Sanes JR. 2006. Cerebellar synaptic defects and abnormal motor behavior in mice lacking alpha- and beta-dystrobrevin. J Neurosci 26(11):2841-51. PubMed: 16540561 MGI: J:106640
Grady RM; Zhou H; Cunningham JM; Henry MD; Campbell KP; Sanes JR. 2000. Maturation and maintenance of the neuromuscular synapse: genetic evidence for roles of the dystrophin--glycoprotein complex. Neuron 25(2):279-93. PubMed: 10719885 MGI: J:60776
Granchelli JA; Pollina C; Hudecki MS. 1995. Duchenne-like myopathy in double-mutant mdx mice expressing exaggerated mast cell activity. J Neurol Sci 131(1):1-7. PubMed: 7561939 MGI: J:26738
Grange RW; Gainer TG; Marschner KM; Talmadge RJ; Stull JT. 2002. Fast-twitch skeletal muscles of dystrophic mouse pups are resistant to injury from acute mechanical stress. Am J Physiol Cell Physiol 283(4):C1090-101. PubMed: 12225973 MGI: J:107767
Greenberg DS; Schatz Y; Levy Z; Pizzo P; Yaffe D; Nudel U. 1996. Reduced levels of dystrophin associated proteins in the brains of mice deficient for Dp71. Hum Mol Genet 5(9):1299-303. PubMed: 8872469 MGI: J:35275
Greenberg DS; Sunada Y; Campbell KP; Yaffe D; Nudel U. 1994. Exogenous Dp71 restores the levels of dystrophin associated proteins but does not alleviate muscle damage in mdx mice [see comments] Nat Genet 8(4):340-4. PubMed: 7894483 MGI: J:22142
Gregorevic P; Allen JM; Minami E; Blankinship MJ; Haraguchi M; Meuse L; Finn E; Adams ME; Froehner SC; Murry CE; Chamberlain JS. 2006. rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice. Nat Med 12(7):787-9. PubMed: 16819550 MGI: J:111980
Griffin JL; Sang E; Evens T; Davies K; Clarke K. 2002. Metabolic profiles of dystrophin and utrophin expression in mouse models of Duchenne muscular dystrophy. FEBS Lett 530(1-3):109. PubMed: 12387876 MGI: J:79770
Griffin JL; Williams HJ; Sang E; Clarke K; Rae C; Nicholson JK. 2001. Metabolic profiling of genetic disorders: a multitissue (1)H nuclear magnetic resonance spectroscopic and pattern recognition study into dystrophic tissue. Anal Biochem 293(1):16-21. PubMed: 11373073 MGI: J:102707
Grounds MD; McGeachie JK. 1992. Skeletal muscle regeneration after crush injury in dystrophic mdx mice: an autoradiographic study. Muscle Nerve 15(5):580-6. PubMed: 1584249 MGI: J:1466
Guido AN; Campos GE; Neto HS; Marques MJ; Minatel E. 2010. Fiber type composition of the sternomastoid and diaphragm muscles of dystrophin-deficient mdx mice. Anat Rec (Hoboken) 293(10):1722-8. PubMed: 20730859 MGI: J:175593
Guiraud S; Squire SE; Edwards B; Chen H; Burns DT; Shah N; Babbs A; Davies SG; Wynne GM; Russell AJ; Elsey D; Wilson FX; Tinsley JM; Davies KE. 2015. Second-generation compound for the modulation of utrophin in the therapy of DMD. Hum Mol Genet 24(15):4212-24. PubMed: 25935002 MGI: J:223940
Guo C; Willem M; Werner A; Raivich G; Emerson M; Neyses L; Mayer U. 2006. Absence of alpha7 integrin in dystrophin-deficient mice causes a myopathy similar to Duchenne muscular dystrophy. Hum Mol Genet 15(6):989-98. PubMed: 16476707 MGI: J:106836
Guo Y; Petrof BJ; Hussain SN. 2001. Expression and localization of protein inhibitor of neuronal nitric oxide synthase in Duchenne muscular dystrophy. Muscle Nerve 24(11):1468-75. PubMed: 11745948 MGI: J:116637
Gurpur PB ; Liu J ; Burkin DJ ; Kaufman SJ. 2009. Valproic acid activates the PI3K/Akt/mTOR pathway in muscle and ameliorates pathology in a mouse model of Duchenne muscular dystrophy. Am J Pathol 174(3):999-1008. PubMed: 19179609 MGI: J:146661
Gussoni E; Soneoka Y; Strickland CD; Buzney EA; Khan MK; Flint AF; Kunkel LM; Mulligan RC. 1999. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401(6751):390-4. PubMed: 10517639 MGI: J:57901
Gutpell KM; Hrinivich WT; Hoffman LM. 2015. Skeletal muscle fibrosis in the mdx/utrn+/- mouse validates its suitability as a murine model of Duchenne muscular dystrophy. PLoS One 10(1):e0117306. PubMed: 25607927 MGI: J:225657
Hack AA; Lam MY; Cordier L; Shoturma DI; Ly CT; Hadhazy MA; Hadhazy MR; Sweeney HL; McNally EM. 2000. Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex. J Cell Sci 113(Pt 14):2535-44. PubMed: 10862711 MGI: J:76730
Haenggi T; Schaub MC; Fritschy JM. 2005. Molecular heterogeneity of the dystrophin-associated protein complex in the mouse kidney nephron: differential alterations in the absence of utrophin and dystrophin. Cell Tissue Res 319(2):299-313. PubMed: 15565469 MGI: J:105083
Hager M; Bigotti MG; Meszaros R; Carmignac V; Holmberg J; Allamand V; Akerlund M; Kalamajski S; Brancaccio A; Mayer U; Durbeej M. 2008. Cib2 binds integrin alpha7Bbeta1D and is reduced in laminin alpha2 chain-deficient muscular dystrophy. J Biol Chem 283(36):24760-9. PubMed: 18611855 MGI: J:142018
Hainsey TA; Senapati S; Kuhn DE; Rafael JA. 2003. Cardiomyopathic features associated with muscular dystrophy are independent of dystrophin absence in cardiovasculature. Neuromuscul Disord 13(4):294-302. PubMed: 12868498 MGI: J:132534
Han R; Bansal D; Miyake K; Muniz VP; Weiss RM; McNeil PL; Campbell KP. 2007. Dysferlin-mediated membrane repair protects the heart from stress-induced left ventricular injury. J Clin Invest 117(7):1805-13. PubMed: 17607357 MGI: J:124212
Han R; Frett EM; Levy JR; Rader EP; Lueck JD; Bansal D; Moore SA; Ng R; Beltran-Valero de Bernabe D; Faulkner JA; Campbell KP. 2010. Genetic ablation of complement C3 attenuates muscle pathology in dysferlin-deficient mice. J Clin Invest 120(12):4366-74. PubMed: 21060153 MGI: J:171870
Han R; Rader EP; Levy JR; Bansal D; Campbell KP. 2011. Dystrophin deficiency exacerbates skeletal muscle pathology in dysferlin-null mice. Skelet Muscle 1(1):35. PubMed: 22132688 MGI: J:183725
Handschin C; Kobayashi YM; Chin S; Seale P; Campbell KP; Spiegelman BM. 2007. PGC-1alpha regulates the neuromuscular junction program and ameliorates Duchenne muscular dystrophy. Genes Dev 21(7):770-83. PubMed: 17403779 MGI: J:120376
Hanft LM; Bogan DJ; Mayer U; Kaufman SJ; Kornegay JN; Ervasti JM. 2007. Cytoplasmic gamma-actin expression in diverse animal models of muscular dystrophy. Neuromuscul Disord 17(7):569-74. PubMed: 17475492 MGI: J:124551
Hanft LM; Rybakova IN; Patel JR; Rafael-Fortney JA; Ervasti JM. 2006. Cytoplasmic gamma-actin contributes to a compensatory remodeling response in dystrophin-deficient muscle. Proc Natl Acad Sci U S A 103(14):5385-90. PubMed: 16565216 MGI: J:108299
Hara H; Nolan PM; Scott MO; Bucan M; Wakayama Y; Fischbeck KH. 2002. Running endurance abnormality in mdx mice. Muscle Nerve 25(2):207-11. PubMed: 11870688 MGI: J:116636
Harcourt LJ; Holmes AG; Gregorevic P; Schertzer JD; Stupka N; Plant DR; Lynch GS. 2005. Interleukin-15 Administration Improves Diaphragm Muscle Pathology and Function in Dystrophic mdx Mice. Am J Pathol 166(4):1131-41. PubMed: 15793293 MGI: J:97063
Harper SQ; Crawford RW; DelloRusso C; Chamberlain JS. 2002. Spectrin-like repeats from dystrophin and alpha-actinin-2 are not functionally interchangeable. Hum Mol Genet 11(16):1807-15. PubMed: 12140183 MGI: J:118411
Harper SQ; Hauser MA; DelloRusso C; Duan D; Crawford RW; Phelps SF; Harper HA; Robinson AS; Engelhardt JF; Brooks SV; Chamberlain JS. 2002. Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy. Nat Med 8(3):253-61. PubMed: 11875496 MGI: J:109823
Hartel JV; Granchelli JA; Hudecki MS; Pollina CM; Gosselin LE. 2001. Impact of prednisone on TGF-beta1 and collagen in diaphragm muscle from mdx mice. Muscle Nerve 24(3):428-32. PubMed: 11353432 MGI: J:116196
Hartigan-O'Connor D; Kirk CJ; Crawford R; Mule JJ; Chamberlain JS. 2001. Immune evasion by muscle-specific gene expression in dystrophic muscle. Mol Ther 4(6):525-33. PubMed: 11735336 MGI: J:127849
Haslett JN; Kang PB; Han M; Kho AT; Sanoudou D; Volinski JM; Beggs AH; Kohane IS; Kunkel LM. 2005. The influence of muscle type and dystrophin deficiency on murine expression profiles. Mamm Genome 16(10):739-48. PubMed: 16261416 MGI: J:102635
Hathout Y; Marathi RL; Rayavarapu S; Zhang A; Brown KJ; Seol H; Gordish-Dressman H; Cirak S; Bello L; Nagaraju K; Partridge T; Hoffman EP; Takeda S; Mah JK; Henricson E; McDonald C. 2014. Discovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients. Hum Mol Genet 23(24):6458-69. PubMed: 25027324 MGI: J:216196
Hawke TJ; Atkinson DJ; Kanatous SB; Van der Ven PF; Goetsch SC; Garry DJ. 2007. Xin, an actin binding protein, is expressed within muscle satellite cells and newly regenerated skeletal muscle fibers. Am J Physiol Cell Physiol 293(5):C1636-44. PubMed: 17855775 MGI: J:128715
Haws CM; Lansman JB. 1991. Developmental regulation of mechanosensitive calcium channels in skeletal muscle from normal and mdx mice. Proc R Soc Lond B Biol Sci 245(1314):173-7. PubMed: 1684042 MGI: J:3912
Hayashiji N; Yuasa S; Miyagoe-Suzuki Y; Hara M; Ito N; Hashimoto H; Kusumoto D; Seki T; Tohyama S; Kodaira M; Kunitomi A; Kashimura S; Takei M; Saito Y; Okata S; Egashira T; Endo J; Sasaoka T; Takeda S; Fukuda K. 2015. G-CSF supports long-term muscle regeneration in mouse models of muscular dystrophy. Nat Commun 6:6745. PubMed: 25865621 MGI: J:222723
Hayes A; Lynch GS; Williams DA. 1993. The effects of endurance exercise on dystrophic mdx mice. I. Contractile and histochemical properties of intact muscles. Proc R Soc Lond B Biol Sci 253(1336):19-25. PubMed: 8396774 MGI: J:14058
Hayes A; Williams DA. 1998. Contractile function and low-intensity exercise effects of old dystrophic (mdx) mice. Am J Physiol 274(4 Pt 1):C1138-44. PubMed: 9575811 MGI: J:47176
He WA; Berardi E; Cardillo VM; Acharyya S; Aulino P; Thomas-Ahner J; Wang J; Bloomston M; Muscarella P; Nau P; Shah N; Butchbach ME; Ladner K; Adamo S; Rudnicki MA; Keller C; Coletti D; Montanaro F; Guttridge DC. 2013. NF-kappaB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia. J Clin Invest :. PubMed: 24084740 MGI: J:203988
Head S; Williams D; Stephenson G. 1994. Increased susceptibility of EDL muscles from mdx mice to damage induced by contraction with stretch [letter; comment] J Muscle Res Cell Motil 15(4):490-2. PubMed: 7848493 MGI: J:23202
Head SI; Williams DA; Stephenson DG. 1992. Abnormalities in structure and function of limb skeletal muscle fibres of dystrophic mdx mice. Proc R Soc Lond B Biol Sci 248(1322):163-9. PubMed: 1352891 MGI: J:1202
Heimann P; Augustin M; Wieneke S; Heising S; Jockusch H. 1998. Mutual interference of myotonia and muscular dystrophy in the mouse: a study on ADR-MDX double mutants. Neuromuscul Disord 8(8):551-60. PubMed: 10093061 MGI: J:52182
Henriques-Pons A; Yu Q; Rayavarapu S; Cohen TV; Ampong B; Cha HJ; Jahnke V; Van der Meulen J; Wang D; Jiang W; Kandimalla ER; Agrawal S; Spurney CF; Nagaraju K. 2014. Role of Toll-like receptors in the pathogenesis of dystrophin-deficient skeletal and heart muscle. Hum Mol Genet 23(10):2604-17. PubMed: 24368419 MGI: J:209059
Henriquez-Olguin C; Altamirano F; Valladares D; Lopez JR; Allen PD; Jaimovich E. 2015. Altered ROS production, NF-kappaB activation and interleukin-6 gene expression induced by electrical stimulation in dystrophic mdx skeletal muscle cells. Biochim Biophys Acta 1852(7):1410-9. PubMed: 25857619 MGI: J:230541
Heydemann A; Doherty KR; McNally EM. 2007. Genetic modifiers of muscular dystrophy: implications for therapy. Biochim Biophys Acta 1772(2):216-28. PubMed: 16916601 MGI: J:120629
Hindi SM; Kumar A. 2016. TRAF6 regulates satellite stem cell self-renewal and function during regenerative myogenesis. J Clin Invest 126(1):151-68. PubMed: 26619121 MGI: J:229818
Hindi SM; Sato S; Choi Y; Kumar A. 2014. Distinct roles of TRAF6 at early and late stages of muscle pathology in the mdx model of Duchenne muscular dystrophy. Hum Mol Genet 23(6):1492-505. PubMed: 24163132 MGI: J:206217
Hindi SM; Shin J; Ogura Y; Li H; Kumar A. 2013. Matrix metalloproteinase-9 inhibition improves proliferation and engraftment of myogenic cells in dystrophic muscle of mdx mice. PLoS One 8(8):e72121. PubMed: 23977226 MGI: J:225186
Hirota M; Furukawa Y; Shinoda I; Yoneoka T; Ito T; Furukawa S; Hayashi K. 1994. Changes in nerve growth factor content of the submaxillary gland in the genetically dystrophic (mdx) mouse. J Neurol Sci 121(2):176-82. PubMed: 8158212 MGI: J:16617
Hnia K; Gayraud J; Hugon G; Ramonatxo M; De La Porte S; Matecki S; Mornet D. 2008. L-arginine decreases inflammation and modulates the nuclear factor-kappaB/matrix metalloproteinase cascade in mdx muscle fibers. Am J Pathol 172(6):1509-19. PubMed: 18458097 MGI: J:136234
Hnia K; Hugon G; Masmoudi A; Mercier J; Rivier F; Mornet D. 2006. Effect of beta-dystroglycan processing on utrophin/Dp116 anchorage in normal and mdx mouse Schwann cell membrane. Neuroscience 141(2):607-620. PubMed: 16735092 MGI: J:111763
Hodges BL; Hayashi YK; Nonaka I; Wang W; Arahata K; Kaufman SJ. 1997. Altered expression of the alpha7beta1 integrin in human and murine muscular dystrophies. J Cell Sci 110(Pt 22):2873-81. PubMed: 9427295 MGI: J:45257
Hollinger K; Gardan-Salmon D; Santana C; Rice D; Snella E; Selsby JT. 2013. Rescue of dystrophic skeletal muscle by PGC-1alpha involves restored expression of dystrophin-associated protein complex components and satellite cell signaling. Am J Physiol Regul Integr Comp Physiol 305(1):R13-23. PubMed: 23594613 MGI: J:198510
Hollingworth S; Marshall MW; Robson E. 1990. Excitation contraction coupling in normal and mdx mice. Muscle Nerve 13(1):16-20. PubMed: 2183043 MGI: J:115990
Hourde C; Joanne P; Medja F; Mougenot N; Jacquet A; Mouisel E; Pannerec A; Hatem S; Butler-Browne G; Agbulut O; Ferry A. 2013. Voluntary Physical Activity Protects from Susceptibility to Skeletal Muscle Contraction-Induced Injury But Worsens Heart Function in mdx Mice. Am J Pathol 182(5):1509-18. PubMed: 23465861 MGI: J:195304
Howard PL; Dally GY; Wong MH; Ho A; Weleber RG; Pillers DA; Ray PN. 1998. Localization of dystrophin isoform Dp71 to the inner limiting membrane of the retina suggests a unique functional contribution of Dp71 in the retina. Hum Mol Genet 7(9):1385-91. PubMed: 9700191 MGI: J:115134
Hoyte K; Jayasinha V; Xia B; Martin PT. 2004. Transgenic overexpression of dystroglycan does not inhibit muscular dystrophy in mdx mice. Am J Pathol 164(2):711-8. PubMed: 14742274 MGI: J:88377
Hulmi JJ; Oliveira BM; Silvennoinen M; Hoogaars WM; Pasternack A; Kainulainen H; Ritvos O. 2013. Exercise restores decreased physical activity levels and increases markers of autophagy and oxidative capacity in myostatin/activin-blocked mdx mice. Am J Physiol Endocrinol Metab 305(2):E171-82. PubMed: 23695214 MGI: J:199262
Hutter OF; Burton FL; Bovell DL. 1991. Mechanical properties of normal and mdx mouse sarcolemma: bearing on function of dystrophin. J Muscle Res Cell Motil 12(6):585-9. PubMed: 1791198 MGI: J:2820
Huynh T; Uaesoontrachoon K; Quinn JL; Tatem KS; Heier CR; Van Der Meulen JH; Yu Q; Harris M; Nolan CJ; Haegeman G; Grounds MD; Nagaraju K. 2013. Selective modulation through the glucocorticoid receptor ameliorates muscle pathology in mdx mice. J Pathol 231(2):223-35. PubMed: 23794417 MGI: J:202506
Hyzewicz J; Tanihata J; Kuraoka M; Nitahara-Kasahara Y; Beylier T; Ruegg UT; Vater A; Takeda S. 2017. Low-Intensity Training and the C5a Complement Antagonist NOX-D21 Rescue the mdx Phenotype through Modulation of Inflammation. Am J Pathol 187(5):1147-1161. PubMed: 28315675 MGI: J:241928
Im WB; Phelps SF; Copen EH; Adams EG; Slightom JL; Chamberlain JS. 1996. Differential expression of dystrophin isoforms in strains of mdx mice with different mutations. Hum Mol Genet 5(8):1149-53. PubMed: 8842734 MGI: J:34517
Inanlou MR; Dhillon GS; Belliveau AC; Reid GA; Ying C; Rudnicki MA; Kablar B. 2003. A significant reduction of the diaphragm in mdx:MyoD-/-(9th) embryos suggests a role for MyoD in the diaphragm development. Dev Biol 261(2):324-36. PubMed: 14499644 MGI: J:85548
Inanlou MR; Kablar B. 2003. Abnormal development of the diaphragm in mdx:MyoD-/-(9th) embryos leads to pulmonary hypoplasia. Int J Dev Biol 47(5):363-71. PubMed: 12895031 MGI: J:100052
Ishizaki M; Suga T; Kimura E; Shiota T; Kawano R; Uchida Y; Uchino K; Yamashita S; Maeda Y; Uchino M. 2008. Mdx respiratory impairment following fibrosis of the diaphragm. Neuromuscul Disord 18(4):342-8. PubMed: 18358722 MGI: J:139598
Ito T; Ogawa R; Uezumi A; Ohtani T; Watanabe Y; Tsujikawa K; Miyagoe-Suzuki Y; Takeda S; Yamamoto H; Fukada S. 2013. Imatinib attenuates severe mouse dystrophy and inhibits proliferation and fibrosis-marker expression in muscle mesenchymal progenitors. Neuromuscul Disord 23(4):349-56. PubMed: 23313020 MGI: J:197819
Iwata Y; Katanosaka Y; Arai Y; Shigekawa M; Wakabayashi S. 2009. Dominant-negative inhibition of Ca2+ influx via TRPV2 ameliorates muscular dystrophy in animal models. Hum Mol Genet 18(5):824-34. PubMed: 19050039 MGI: J:145007
Janke A; Upadhaya R; Snow WM; Anderson JE. 2013. A new look at cytoskeletal NOS-1 and beta-dystroglycan changes in developing muscle and brain in control and mdx dystrophic mice. Dev Dyn 242(12):1369-81. PubMed: 23940011 MGI: J:203003
Janssen PM. 2010. Kinetics of cardiac muscle contraction and relaxation are linked and determined by properties of the cardiac sarcomere. Am J Physiol Heart Circ Physiol 299(4):H1092-9. PubMed: 20656885 MGI: J:165683
Janssen PM; Hiranandani N; Mays TA; Rafael-Fortney JA. 2005. Utrophin deficiency worsens cardiac contractile dysfunction present in dystrophin-deficient mdx mice. Am J Physiol Heart Circ Physiol 289(6):H2373-8. PubMed: 16024571 MGI: J:104747
Jasmin BJ; Alameddine H; Lunde JA; Stetzkowski-Marden F; Collin H; Tinsley JM; Davies KE; Tome FM; Parry DJ; Cartaud J. 1995. Expression of utrophin and its mRNA in denervated mdx mouse muscle. FEBS Lett 374(3):393-8. PubMed: 7589578 MGI: J:29669
Joanne P; Hourde C; Ochala J; Cauderan Y; Medja F; Vignaud A; Mouisel E; Hadj-Said W; Arandel L; Garcia L; Goyenvalle A; Mounier R; Zibroba D; Sakamato K; Butler-Browne G; Agbulut O; Ferry A. 2012. Impaired adaptive response to mechanical overloading in dystrophic skeletal muscle. PLoS One 7(4):e35346. PubMed: 22511986 MGI: J:187085
Johnson BD; Scheuer T; Catterall WA. 2005. Convergent regulation of skeletal muscle Ca2+ channels by dystrophin, the actin cytoskeleton, and cAMP-dependent protein kinase. Proc Natl Acad Sci U S A 102(11):4191-6. PubMed: 15753322 MGI: J:97171
Jones GL; Sang E; Goddard C; Mortishire-Smith RJ; Sweatman BC; Haselden JN; Davies K; Grace AA; Clarke K; Griffin JL. 2005. A functional analysis of mouse models of cardiac disease through metabolic profiling. J Biol Chem 280(9):7530-9. PubMed: 15546876 MGI: J:105049
Jorgensen LH; Blain A; Greally E; Laval SH; Blamire AM; Davison BJ; Brinkmeier H; MacGowan GA; Schroder HD; Bushby K; Straub V; Lochmuller H. 2011. Long-term blocking of calcium channels in mdx mice results in differential effects on heart and skeletal muscle. Am J Pathol 178(1):273-83. PubMed: 21224064 MGI: J:168085
Jorgensen LH; Jensen CH; Wewer UM; Schroder HD. 2007. Transgenic overexpression of ADAM12 suppresses muscle regeneration and aggravates dystrophy in aged mdx mice. Am J Pathol 171(5):1599-607. PubMed: 17982130 MGI: J:127259
Jorgensen LH; Jepsen PL; Boysen A; Dalgaard LB; Hvid LG; Ortenblad N; Ravn D; Sellathurai J; Moller-Jensen J; Lochmuller H; Schroder HD. 2017. SPARC Interacts with Actin in Skeletal Muscle in Vitro and in Vivo. Am J Pathol 187(2):457-474. PubMed: 27908613 MGI: J:240042
Jung C; Martins AS; Niggli E; Shirokova N. 2008. Dystrophic cardiomyopathy: amplification of cellular damage by Ca2+ signalling and reactive oxygen species-generating pathways. Cardiovasc Res 77(4):766-73. PubMed: 18056762 MGI: J:161914
Juretic N; Diaz J; Romero F; Gonzalez G; Jaimovich E; Riveros N. 2017. Interleukin-6 and neuregulin-1 as regulators of utrophin expression via the activation of NRG-1/ErbB signaling pathway in mdx cells. Biochim Biophys Acta 1863(3):770-780. PubMed: 27988307 MGI: J:253865
Kaczor JJ; Hall JE; Payne E; Tarnopolsky MA. 2007. Low intensity training decreases markers of oxidative stress in skeletal muscle of mdx mice. Free Radic Biol Med 43(1):145-54. PubMed: 17561103 MGI: J:122382
Kafadar KA; Yi L; Ahmad Y; So L; Rossi F; Pavlath GK. 2009. Sca-1 expression is required for efficient remodeling of the extracellular matrix during skeletal muscle regeneration. Dev Biol 326(1):47-59. PubMed: 19059231 MGI: J:145180
Kainulainen H; Papaioannou KG; Silvennoinen M; Autio R; Saarela J; Oliveira BM; Nyqvist M; Pasternack A; 't Hoen PA; Kujala UM; Ritvos O; Hulmi JJ. 2015. Myostatin/activin blocking combined with exercise reconditions skeletal muscle expression profile of mdx mice. Mol Cell Endocrinol 399:131-42. PubMed: 25304272 MGI: J:220203
Kamogawa Y; Biro S; Maeda M; Setoguchi M; Hirakawa T; Yoshida H; Tei C. 2001. Dystrophin-deficient myocardium is vulnerable to pressure overload in vivo. Cardiovasc Res 50(3):509-15. PubMed: 11376626 MGI: J:162753
Kanai A; Epperly M; Pearce L; Birder L; Zeidel M; Meyers S; Greenberger J; de Groat W; Apodaca G; Peterson J. 2004. Differing roles of mitochondrial nitric oxide synthase in cardiomyocytes and urothelial cells. Am J Physiol Heart Circ Physiol 286(1):H13-21. PubMed: 14684357 MGI: J:87605
Kanai AJ; Pearce LL; Clemens PR; Birder LA; VanBibber MM; Choi SY; de Groat WC; Peterson J. 2001. Identification of a neuronal nitric oxide synthase in isolated cardiac mitochondria using electrochemical detection. Proc Natl Acad Sci U S A 98(24):14126-31. PubMed: 11717466 MGI: J:125463
Karpati G; Zubrzycka-Gaarn EE; Carpenter S; Bulman DE; Ray PN; Worton RG. 1990. Age-related conversion of dystrophin-negative to -positive fiber segments of skeletal but not cardiac muscle fibers in heterozygote mdx mice. J Neuropathol Exp Neurol 49(2):96-105. PubMed: 2407807 MGI: J:121251
Kayali R; Ku JM; Khitrov G; Jung ME; Prikhodko O; Bertoni C. 2012. Read-through compound 13 restores dystrophin expression and improves muscle function in the mdx mouse model for Duchenne muscular dystrophy. Hum Mol Genet 21(18):4007-20. PubMed: 22692682 MGI: J:187428
Kendall GC; Mokhonova EI; Moran M; Sejbuk NE; Wang DW; Silva O; Wang RT; Martinez L; Lu QL; Damoiseaux R; Spencer MJ; Nelson SF; Miceli MC. 2012. Dantrolene enhances antisense-mediated exon skipping in human and mouse models of Duchenne muscular dystrophy. Sci Transl Med 4(164):164ra160. PubMed: 23241744 MGI: J:194409
Kennedy TL; Swiderski K; Murphy KT; Gehrig SM; Curl CL; Chandramouli C; Febbraio MA; Delbridge LM; Koopman R; Lynch GS. 2016. BGP-15 Improves Aspects of the Dystrophic Pathology in mdx and dko Mice with Differing Efficacies in Heart and Skeletal Muscle. Am J Pathol 186(12):3246-3260. PubMed: 27750047 MGI: J:238749
Kerr JP; Robison P; Shi G; Bogush AI; Kempema AM; Hexum JK; Becerra N; Harki DA; Martin SS; Raiteri R; Prosser BL; Ward CW. 2015. Detyrosinated microtubules modulate mechanotransduction in heart and skeletal muscle. Nat Commun 6:8526. PubMed: 26446751 MGI: J:227641
Khairallah M; Khairallah R; Young ME; Dyck JR; Petrof BJ; Des Rosiers C. 2007. Metabolic and signaling alterations in dystrophin-deficient hearts precede overt cardiomyopathy. J Mol Cell Cardiol 43(2):119-29. PubMed: 17583724 MGI: J:123076
Khairallah M; Khairallah RJ; Young ME; Allen BG; Gillis MA; Danialou G; Deschepper CF; Petrof BJ; Des Rosiers C. 2008. Sildenafil and cardiomyocyte-specific cGMP signaling prevent cardiomyopathic changes associated with dystrophin deficiency. Proc Natl Acad Sci U S A 105(19):7028-33. PubMed: 18474859 MGI: J:134880
Khairallah RJ; Shi G; Sbrana F; Prosser BL; Borroto C; Mazaitis MJ; Hoffman EP; Mahurkar A; Sachs F; Sun Y; Chen YW; Raiteri R; Lederer WJ; Dorsey SG; Ward CW. 2012. Microtubules underlie dysfunction in duchenne muscular dystrophy. Sci Signal 5(236):ra56. PubMed: 22871609 MGI: J:258630
Kim JH; Lawler JM. 2012. Amplification of proinflammatory phenotype, damage, and weakness by oxidative stress in the diaphragm muscle of mdx mice. Free Radic Biol Med 52(9):1597-606. PubMed: 22330042 MGI: J:183264
Kinoshita I; Vilquin JT; Tremblay JP. 1995. Pretreatment of myoblast cultures with basic fibroblast growth factor increases the efficacy of their transplantation in mdx mice. Muscle Nerve 18(8):834-41. PubMed: 7630343 MGI: J:115863
Kitamoto T; Hanaoka K. 2010. Notch3 null mutation in mice causes muscle hyperplasia by repetitive muscle regeneration. Stem Cells 28(12):2205-16. PubMed: 20960513 MGI: J:168858
Knuesel I; Mastrocola M; Zuellig RA; Bornhauser B; Schaub MC; Fritschy JM. 1999. Short communication: altered synaptic clustering of GABAA receptors in mice lacking dystrophin (mdx mice). Eur J Neurosci 11(12):4457-62. PubMed: 10594673 MGI: J:89883
Knuesel I; Riban V; Zuellig RA; Schaub MC; Grady RM; Sanes JR; Fritschy JM. 2002. Increased vulnerability to kainate-induced seizures in utrophin-knockout mice. Eur J Neurosci 15(9):1474-84. PubMed: 12028357 MGI: J:89397
Kobayashi K. 1993. Effect of submaximal treadmill running on skeletal muscles of MDX mice Jikeikai Med J 40:453-63. MGI: J:17056
Kobayashi YM; Rader EP; Crawford RW; Iyengar NK; Thedens DR; Faulkner JA; Parikh SV; Weiss RM; Chamberlain JS; Moore SA; Campbell KP. 2008. Sarcolemma-localized nNOS is required to maintain activity after mild exercise. Nature 456(7221):511-5. PubMed: 18953332 MGI: J:144084
Koenig X; Dysek S; Kimbacher S; Mike AK; Cervenka R; Lukacs P; Nagl K; Dang XB; Todt H; Bittner RE; Hilber K. 2011. Voltage-gated ion channel dysfunction precedes cardiomyopathy development in the dystrophic heart. PLoS One 6(5):e20300. PubMed: 21677768 MGI: J:196253
Koenig X; Rubi L; Obermair GJ; Cervenka R; Dang XB; Lukacs P; Kummer S; Bittner RE; Kubista H; Todt H; Hilber K. 2014. Enhanced currents through L-type calcium channels in cardiomyocytes disturb the electrophysiology of the dystrophic heart. Am J Physiol Heart Circ Physiol 306(4):H564-73. PubMed: 24337461 MGI: J:208702
Kogelman B; Khmelinskii A; Verhaart I; Vliet LV; Bink DI; Aartsma-Rus A; Putten MV; Weerd LV. 2018. Influence of full-length dystrophin on brain volumes in mouse models of Duchenne muscular dystrophy. PLoS One 13(3):e0194636. PubMed: 29601589 MGI: J:260654
Kolodziejczyk SM; Walsh GS; Balazsi K; Seale P; Sandoz J; Hierlihy AM; Rudnicki MA; Chamberlain JS; Miller FD; Megeney LA. 2001. Activation of JNK1 contributes to dystrophic muscle pathogenesis. Curr Biol 11(16):1278-82. PubMed: 11525743 MGI: J:71463
Koltgen D; Franke C. 1994. The coexistence of embryonic and adult acetylcholine receptors in sarcolemma of mdx dystrophic mouse muscle: an effect of regeneration or muscular dystrophy? Neurosci Lett 173(1-2):79-82. PubMed: 7936429 MGI: J:21986
Kong J; Anderson JE. 1999. Dystrophin is required for organizing large acetylcholine receptor aggregates. Brain Res 839(2):298-304. PubMed: 10519053 MGI: J:57508
Kong J; Anderson JE. 2001. Dynamic restoration of dystrophin to dystrophin-deficient myotubes. Muscle Nerve 24(1):77-88. PubMed: 11150969 MGI: J:116200
Korner Z; Fontes-Oliveira CC; Holmberg J; Carmignac V; Durbeej M. 2014. Bortezomib Partially Improves Laminin alpha2 Chain-Deficient Muscular Dystrophy. Am J Pathol 184(5):1518-28. PubMed: 24631023 MGI: J:208398
Kossler N; Stricker S; Rodelsperger C; Robinson PN; Kim J; Dietrich C; Osswald M; Kuhnisch J; Stevenson DA; Braun T; Mundlos S; Kolanczyk M. 2011. Neurofibromin (Nf1) is required for skeletal muscle development. Hum Mol Genet 20(14):2697-709. PubMed: 21478499 MGI: J:173779
Krag TO; Bogdanovich S; Jensen CJ; Fischer MD; Hansen-Schwartz J; Javazon EH; Flake AW; Edvinsson L; Khurana TS. 2004. Heregulin ameliorates the dystrophic phenotype in mdx mice. Proc Natl Acad Sci U S A 101(38):13856-60. PubMed: 15365169 MGI: J:92602
Krahn MJ; Anderson JE. 1994. Anabolic steroid treatment increases myofiber damage in mdx mouse muscular dystrophy. J Neurol Sci 125(2):138-46. PubMed: 7807158 MGI: J:19960
Kramer R; Lochmuller H; Abicht A; Rudel R; Brinkmeier H. 1998. Myotonic ADR-MDX mutant mice show less severe muscular dystrophy than MDX mice. Neuromuscul Disord 8(8):542-50. PubMed: 10093060 MGI: J:52181
Krasowska E; Zablocki K; Gorecki DC; Swinny JD. 2014. Aberrant location of inhibitory synaptic marker proteins in the hippocampus of dystrophin-deficient mice: implications for cognitive impairment in duchenne muscular dystrophy. PLoS One 9(9):e108364. PubMed: 25260053 MGI: J:223492
Kronqvist P; Kawaguchi N; Albrechtsen R; Xu X; Schroder HD; Moghadaszadeh B; Nielsen FC; Frohlich C; Engvall E; Wewer UM. 2002. ADAM12 alleviates the skeletal muscle pathology in mdx dystrophic mice. Am J Pathol 161(5):1535-40. PubMed: 12414501 MGI: J:79904
Kueh SL; Dempster J; Head SI; Morley JW. 2011. Reduced postsynaptic GABA(A) receptor number and enhanced gaboxadol induced change in holding currents in Purkinje cells of the dystrophin-deficient mdx mouse. Neurobiol Dis :. PubMed: 21601636 MGI: J:173345
Kumar A; Bhatnagar S; Kumar A. 2010. Matrix metalloproteinase inhibitor batimastat alleviates pathology and improves skeletal muscle function in dystrophin-deficient mdx mice. Am J Pathol 177(1):248-60. PubMed: 20472898 MGI: J:162127
Kumar A; Khandelwal N; Malya R; Reid MB; Boriek AM. 2004. Loss of dystrophin causes aberrant mechanotransduction in skeletal muscle fibers. FASEB J 18(1):102-13. PubMed: 14718391 MGI: J:87819
Kuno A; Hori YS; Hosoda R; Tanno M; Miura T; Shimamoto K; Horio Y. 2013. Resveratrol improves cardiomyopathy in dystrophin-deficient mice through SIRT1 protein-mediated modulation of p300 protein. J Biol Chem 288(8):5963-72. PubMed: 23297412 MGI: J:196087
Kuraitis D; Berardinelli MG; Suuronen EJ; Musaro A. 2013. A necrotic stimulus is required to maximize matrix-mediated myogenesis in mice. Dis Model Mech 6(3):793-801. PubMed: 23471914 MGI: J:196369
Kurek JB; Nouri S; Kannourakis G; Murphy M; Austin L. 1996. Leukemia inhibitory factor and interleukin-6 are produced by diseased and regenerating skeletal muscle. Muscle Nerve 19(10):1291-301. PubMed: 8808655 MGI: J:116333
Kurihara T; Kishi M; Saito N; Komoto M; Hidaka T; Kinoshita M. 1990. Electrical myotonia and cataract in X-linked muscular dystrophy (mdx) mouse. J Neurol Sci 99(1):83-92. PubMed: 2250175 MGI: J:142492
Kyrychenko S; Kyrychenko V; Badr MA; Ikeda Y; Sadoshima J; Shirokova N. 2015. Pivotal role of miR-448 in the development of ROS-induced cardiomyopathy. Cardiovasc Res 108(3):324-34. PubMed: 26503985 MGI: J:258491
Kyrychenko S; Polakova E; Kang C; Pocsai K; Ullrich ND; Niggli E; Shirokova N. 2013. Hierarchical accumulation of RyR post-translational modifications drives disease progression in dystrophic cardiomyopathy. Cardiovasc Res 97(4):666-75. PubMed: 23263329 MGI: J:196427
Lagrota-Candido J; Canella I; Savino W; Quirico-Santos T. 1999. Expression of extracellular matrix ligands and receptors in the muscular tissue and draining lymph nodes of mdx dystrophic mice. Clin Immunol 93(2):143-51. PubMed: 10527690 MGI: J:114168
Lagrota-Candido J; Vasconcellos R; Cavalcanti M; Bozza M; Savino W; Quirico-Santos T. 2002. Resolution of skeletal muscle inflammation in mdx dystrophic mouse is accompanied by increased immunoglobulin and interferon-gamma production. Int J Exp Pathol 83(3):121-32. PubMed: 12383191 MGI: J:79589
Lai Y; Zhao J; Yue Y; Duan D. 2013. alpha2 and alpha3 helices of dystrophin R16 and R17 frame a microdomain in the alpha1 helix of dystrophin R17 for neuronal NOS binding. Proc Natl Acad Sci U S A 110(2):525-30. PubMed: 23185009 MGI: J:192576
Lamar KM; Bogdanovich S; Gardner BB; Gao QQ; Miller T; Earley JU; Hadhazy M; Vo AH; Wren L; Molkentin JD; McNally EM. 2016. Overexpression of Latent TGFbeta Binding Protein 4 in Muscle Ameliorates Muscular Dystrophy through Myostatin and TGFbeta. PLoS Genet 12(5):e1006019. PubMed: 27148972 MGI: J:232558
Lancioni A; Luisa Rotundo I; Monique Kobayashi Y; D'Orsi L; Aurino S; Nigro G; Piluso G; Acampora D; Cacciottolo M; Campbell KP; Nigro V. 2011. Combined deficiency of alpha and epsilon sarcoglycan disrupts the cardiac dystrophin complex. Hum Mol Genet 20(23):4644-54. PubMed: 21890494 MGI: J:177563
Lang JM; Esser KA; Dupont-Versteegden EE. 2004. Altered activity of signaling pathways in diaphragm and tibialis anterior muscle of dystrophic mice. Exp Biol Med (Maywood) 229(6):503-11. PubMed: 15169969 MGI: J:102072
Lansman JB. 2015. Utrophin suppresses low frequency oscillations and coupled gating of mechanosensitive ion channels in dystrophic skeletal muscle. Channels (Austin) 9(3):145-60. PubMed: 25941878 MGI: J:244475
Law DJ; Allen DL; Tidball JG. 1994. Talin, vinculin and DRP (utrophin) concentrations are increased at mdx myotendinous junctions following onset of necrosis. J Cell Sci 107(Pt 6):1477-83. PubMed: 7962191 MGI: J:19098
Laws N; Hoey A. 2004. Progression of kyphosis in mdx mice. J Appl Physiol 97(5):1970-7. PubMed: 15234960 MGI: J:103692
Leal-Junior EC; de Almeida P; Tomazoni SS; de Carvalho Pde T; Lopes-Martins RA; Frigo L; Joensen J; Johnson MI; Bjordal JM. 2014. Superpulsed low-level laser therapy protects skeletal muscle of mdx mice against damage, inflammation and morphological changes delaying dystrophy progression. PLoS One 9(3):e89453. PubMed: 24599021 MGI: J:215130
Lee CC; Pons F; Jones PG; Bies RD; Schlang AM; Leger JJ; Caskey CT. 1993. Mdx transgenic mouse: restoration of recombinant dystrophin to the dystrophic muscle. Hum Gene Ther 4(3):273-81. PubMed: 8338875 MGI: J:21429
Lee YS; Lehar A; Sebald S; Liu M; Swaggart KA; Talbot CC Jr; Pytel P; Barton ER; McNally EM; Lee SJ. 2015. Muscle hypertrophy induced by myostatin inhibition accelerates degeneration in dysferlinopathy. Hum Mol Genet 24(20):5711-9. PubMed: 26206886 MGI: J:226040
Lefaucheur JP; Pastoret C; Sebille A. 1995. Phenotype of dystrophinopathy in old mdx mice. Anat Rec 242(1):70-6. PubMed: 7604983 MGI: J:25057
Lefaucheur JP; Sebille A. 1996. Features of dystrophy in smooth and skeletal muscles of mdx mice. Muscle Nerve 19(6):793-4. PubMed: 8609936 MGI: J:116334
Lemos DR; Babaeijandaghi F; Low M; Chang CK; Lee ST; Fiore D; Zhang RH; Natarajan A; Nedospasov SA; Rossi FM. 2015. Nilotinib reduces muscle fibrosis in chronic muscle injury by promoting TNF-mediated apoptosis of fibro/adipogenic progenitors. Nat Med 21(7):786-94. PubMed: 26053624 MGI: J:224764
Leng Y; Zheng Z; Zhou C; Zhang C; Shi X; Zhang W. 2012. A comparative study of bone marrow mesenchymal stem cell functionality in C57BL and mdx mice. Neurosci Lett 523(2):139-44. PubMed: 22766138 MGI: J:188800
Lenhart KC; O'Neill TJ 4th; Cheng Z; Dee R; Demonbreun AR; Li J; Xiao X; McNally EM; Mack CP; Taylor JM. 2015. GRAF1 deficiency blunts sarcolemmal injury repair and exacerbates cardiac and skeletal muscle pathology in dystrophin-deficient mice. Skelet Muscle 5:27. PubMed: 26301073 MGI: J:243032
Levi S; Grady RM; Henry MD; Campbell KP; Sanes JR; Craig AM. 2002. Dystroglycan is selectively associated with inhibitory GABAergic synapses but is dispensable for their differentiation. J Neurosci 22(11):4274-85. PubMed: 12040032 MGI: J:125567
Lewis C; Ohlendieck K. 2010. Proteomic profiling of naturally protected extraocular muscles from the dystrophin-deficient mdx mouse. Biochem Biophys Res Commun 396(4):1024-9. PubMed: 20471957 MGI: J:162430
Li D; Long C; Yue Y; Duan D. 2009. Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice. Hum Mol Genet 18(7):1209-20. PubMed: 19131360 MGI: J:146188
Li D; Yue Y; Duan D. 2010. Marginal level dystrophin expression improves clinical outcome in a strain of dystrophin/utrophin double knockout mice. PLoS One 5(12):e15286. PubMed: 21187970 MGI: J:168677
Li D; Yue Y; Lai Y; Hakim CH; Duan D. 2011. Nitrosative stress elicited by nNOSmicro delocalization inhibits muscle force in dystrophin-null mice. J Pathol 223(1):88-98. PubMed: 21125668 MGI: J:167308
Li H; Mittal A; Makonchuk DY; Bhatnagar S; Kumar A. 2009. Matrix metalloproteinase-9 inhibition ameliorates pathogenesis and improves skeletal muscle regeneration in muscular dystrophy. Hum Mol Genet 18(14):2584-98. PubMed: 19401296 MGI: J:150030
Li J; Yim S; Pacheck A; Sanchez B; Rutkove SB. 2016. Electrical Impedance Myography to Detect the Effects of Electrical Muscle Stimulation in Wild Type and Mdx Mice. PLoS One 11(3):e0151415. PubMed: 26986564 MGI: J:251705
Li R; Ren M; Chen N; Luo M; Zhang Z; Wu J. 2012. Vitronectin increases vascular permeability by promoting VE-cadherin internalization at cell junctions. PLoS One 7(5):e37195. PubMed: 22606350 MGI: J:187242
Li Y; Zhang S; Zhang X; Li J; Ai X; Zhang L; Yu D; Ge S; Peng Y; Chen X. 2014. Blunted cardiac beta-adrenergic response as an early indication of cardiac dysfunction in Duchenne muscular dystrophy. Cardiovasc Res 103(1):60-71. PubMed: 24812281 MGI: J:229840
Licursi V; Caiello I; Lombardi L; De Stefano ME; Negri R; Paggi P. 2012. Lack of dystrophin in mdx mice modulates the expression of genes involved in neuron survival and differentiation. Eur J Neurosci 35(5):691-701. PubMed: 22309284 MGI: J:184295
Lin B; Govindan S; Lee K; Zhao P; Han R; Runte KE; Craig R; Palmer BM; Sadayappan S. 2013. Cardiac myosin binding protein-C plays no regulatory role in skeletal muscle structure and function. PLoS One 8(7):e69671. PubMed: 23936073 MGI: J:204454
Lin X; Miller JW; Mankodi A; Kanadia RN; Yuan Y; Moxley RT; Swanson MS; Thornton CA. 2006. Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum Mol Genet 15(13):2087-97. PubMed: 16717059 MGI: J:112061
Liu J; Milner DJ; Boppart MD; Ross RS; Kaufman SJ. 2012. beta1D chain increases alpha7beta1 integrin and laminin and protects against sarcolemmal damage in mdx mice. Hum Mol Genet 21(7):1592-603. PubMed: 22180459 MGI: J:181562
Liu N; Garry GA; Li S; Bezprozvannaya S; Sanchez-Ortiz E; Chen B; Shelton JM; Jaichander P; Bassel-Duby R; Olson EN. 2017. A Twist2-dependent progenitor cell contributes to adult skeletal muscle. Nat Cell Biol 19(3):202-213. PubMed: 28218909 MGI: J:246973
Liu N; Williams AH; Maxeiner JM; Bezprozvannaya S; Shelton JM; Richardson JA; Bassel-Duby R; Olson EN. 2012. microRNA-206 promotes skeletal muscle regeneration and delays progression of Duchenne muscular dystrophy in mice. J Clin Invest 122(6):2054-65. PubMed: 22546853 MGI: J:188300
Ljubicic V; Burt M; Lunde JA; Jasmin BJ. 2014. Resveratrol induces expression of the slow, oxidative phenotype in mdx mouse muscle together with enhanced activity of the SIRT1-PGC-1alpha axis. Am J Physiol Cell Physiol 307(1):C66-82. PubMed: 24760981 MGI: J:221743
Ljubicic V; Khogali S; Renaud JM; Jasmin BJ. 2012. Chronic AMPK stimulation attenuates adaptive signaling in dystrophic skeletal muscle. Am J Physiol Cell Physiol 302(1):C110-21. PubMed: 21940670 MGI: J:180633
Ljubicic V; Miura P; Burt M; Boudreault L; Khogali S; Lunde JA; Renaud JM; Jasmin BJ. 2011. Chronic AMPK activation evokes the slow, oxidative myogenic program and triggers beneficial adaptations in mdx mouse skeletal muscle. Hum Mol Genet 20(17):3478-93. PubMed: 21659335 MGI: J:174458
Loehr JA; Wang S; Cully TR; Pal R; Larina IV; Larin KV; Rodney GG. 2018. NADPH oxidase mediates microtubule alterations and diaphragm dysfunction in dystrophic mice. Elife 7(None):None. PubMed: 29381135 MGI: J:256690
Lombardi L; De Stefano ME; Paggi P. 2008. Components of the NGF signaling complex are altered in mdx mouse superior cervical ganglion and its target organs. Neurobiol Dis 32(3):402-11. PubMed: 18725298 MGI: J:142260
Lombardi L; Persiconi I; Gallo A; Hoogenraad CC; De Stefano ME. 2017. NGF-dependent axon growth and regeneration are altered in sympathetic neurons of dystrophic mdx mice. Mol Cell Neurosci 80(None):1-17. PubMed: 28161362 MGI: J:260651
Londhe P; Davie JK. 2013. Interferon-gamma resets muscle cell fate by stimulating the sequential recruitment of JARID2 and PRC2 to promoters to repress myogenesis. Sci Signal 6(305):ra107. PubMed: 24327761 MGI: J:260284
Long C; Amoasii L; Mireault AA; McAnally JR; Li H; Sanchez-Ortiz E; Bhattacharyya S; Shelton JM; Bassel-Duby R; Olson EN. 2016. Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy. Science 351(6271):400-3. PubMed: 26721683 MGI: J:229479
Long C; McAnally JR; Shelton JM; Mireault AA; Bassel-Duby R; Olson EN. 2014. Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA. Science 345(6201):1184-8. PubMed: 25123483 MGI: J:216417
Lorin C; Vogeli I; Niggli E. 2015. Dystrophic cardiomyopathy: role of TRPV2 channels in stretch-induced cell damage. Cardiovasc Res 106(1):153-62. PubMed: 25616416 MGI: J:251315
Louboutin JP; Fichter-Gagnepain V; Thaon E; Fardeau M. 1993. Morphometric analysis of mdx diaphragm muscle fibres. Comparison with hindlimb muscles. Neuromuscul Disord 3(5-6):463-9. PubMed: 8186695 MGI: J:19035
Loufrani L; Levy BI; Henrion D. 2002. Defect in microvascular adaptation to chronic changes in blood flow in mice lacking the gene encoding for dystrophin. Circ Res 91(12):1183-9. PubMed: 12480820 MGI: J:108996
Lovering RM; Michaelson L; Ward CW. 2009. Malformed mdx myofibers have normal cytoskeletal architecture yet altered EC coupling and stress-induced Ca2+ signaling. Am J Physiol Cell Physiol 297(3):C571-80. PubMed: 19605736 MGI: J:152090
Lozanoska-Ochser B; Benedetti A; Rizzo G; Marrocco V; Di Maggio R; Fiore P; Bouche M. 2018. Targeting early PKCtheta-dependent T-cell infiltration of dystrophic muscle reduces disease severity in a mouse model of muscular dystrophy. J Pathol 244(3):323-333. PubMed: 29214629 MGI: J:260649
Lu A; Poddar M; Tang Y; Proto JD; Sohn J; Mu X; Oyster N; Wang B; Huard J. 2014. Rapid depletion of muscle progenitor cells in dystrophic mdx/utrophin-/- mice. Hum Mol Genet 23(18):4786-800. PubMed: 24781208 MGI: J:213595
Lu S; Hoey A. 2000. Changes in function of cardiac receptors mediating the effects of the autonomic nervous system in the muscular dystrophy (MDX) mouse J Mol Cell Cardiol 32(1):143-52. PubMed: 10652198 MGI: J:60523
Lucas-Heron B; Schmitt N; Ollivier B. 1994. Mdx mouse skeletal muscle: could a mitochondrial factor be responsible for the absence of progressive necrosis? Neurosci Lett 169(1-2):97-100. PubMed: 8047301 MGI: J:20768
Lueck JD; Lungu C; Mankodi A; Osborne RJ; Welle SL; Dirksen RT; Thornton CA. 2007. Chloride channelopathy in myotonic dystrophy resulting from loss of posttranscriptional regulation for CLCN1. Am J Physiol Cell Physiol 292(4):C1291-7. PubMed: 17135300 MGI: J:125885
Luz MA; Marques MJ; Santo Neto H. 2002. Impaired regeneration of dystrophin-deficient muscle fibers is caused by exhaustion of myogenic cells. Braz J Med Biol Res 35(6):691-5. PubMed: 12045834 MGI: J:102527
Lynch GS; Hayes A; Lam MH; Williams DA. 1993. The effects of endurance exercise on dystrophic mdx mice. II. Contractile properties of skinned muscle fibres. Proc R Soc Lond B Biol Sci 253(1336):27-33. PubMed: 8396775 MGI: J:15490
Lynch GS; Hinkle RT; Chamberlain JS; Brooks SV; Faulkner JA. 2001. Force and power output of fast and slow skeletal muscles from mdx mice 6-28 months old. J Physiol 535(Pt 2):591-600. PubMed: 11533147 MGI: J:106518
Lynch GS; Hinkle RT; Faulkner JA. 2000. Power output of fast and slow skeletal muscles of mdx (dystrophic) and control mice after clenbuterol treatment. Exp Physiol 85(3):295-9. PubMed: 10825417 MGI: J:62414
Lynch GS; Rafael JA; Chamberlain JS; Faulkner JA. 2000. Contraction-induced injury to single permeabilized muscle fibers from mdx, transgenic mdx, and control mice Am J Physiol Cell Physiol 279(4):C1290-4. PubMed: 11003610 MGI: J:65220
Lynch GS; Rafael JA; Hinkle RT; Cole NM; Chamberlain JS; Faulkner JA. 1997. Contractile properties of diaphragm muscle segments from old mdx and old transgenic mdx mice. Am J Physiol 272(6 Pt 1):C2063-8. PubMed: 9227435 MGI: J:113048
Lyons PR; Slater CR. 1991. Structure and function of the neuromuscular junction in young adult mdx mice. J Neurocytol 20(12):969-81. PubMed: 1686056 MGI: J:121319
Macedo AB; Moraes LH; Mizobuti DS; Fogaca AR; Moraes Fdos S; Hermes Tde A; Pertille A; Minatel E. 2015. Low-Level Laser Therapy (LLLT) in Dystrophin-Deficient Muscle Cells: Effects on Regeneration Capacity, Inflammation Response and Oxidative Stress. PLoS One 10(6):e0128567. PubMed: 26083527 MGI: J:237800
Madaro L; Pelle A; Nicoletti C; Crupi A; Marrocco V; Bossi G; Soddu S; Bouche M. 2012. PKC theta ablation improves healing in a mouse model of muscular dystrophy. PLoS One 7(2):e31515. PubMed: 22348094 MGI: J:261470
Maillet M; Lynch JM; Sanna B; York AJ; Zheng Y; Molkentin JD. 2009. Cdc42 is an antihypertrophic molecular switch in the mouse heart. J Clin Invest 119(10):3079-88. PubMed: 19741299 MGI: J:154646
Mallouk N; Jacquemond V; Allard B. 2000. Elevated subsarcolemmal Ca2+ in mdx mouse skeletal muscle fibers detected with Ca2+-activated K+ channels. Proc Natl Acad Sci U S A 97(9):4950-5. PubMed: 10781103 MGI: J:126699
Mancinelli R; Tonali P; Romani R; Tringali A; Vargiu R; AZZENA GB. 1999. Mechanical properties of smooth muscle portal vein in normal and dystrophin-deficient (mdx) mice. Exp Physiol 84(5):929-40. PubMed: 10502660 MGI: J:106559
Mancio RD; Hermes TA; Macedo AB; Mizobuti DS; Rupcic IF; Minatel E. 2017. Dystrophic phenotype improvement in the diaphragm muscle of mdx mice by diacerhein. PLoS One 12(8):e0182449. PubMed: 28787441 MGI: J:248583
Mann CJ; Honeyman K; Cheng AJ; Ly T; Lloyd F; Fletcher S; Morgan JE; Partridge TA; Wilton SD. 2001. Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse. Proc Natl Acad Sci U S A 98(1):42-7. PubMed: 11120883 MGI: J:66709
Marques MJ; Minatel E; Guimaraes AO; Neto HS. 2004. Distribution of calcitonin gene-related peptide at the neuromuscular junction of mdx mice. Anat Rec A Discov Mol Cell Evol Biol 279(2):798-803. PubMed: 15278951 MGI: J:174186
Marques MJ; Taniguti AP; Minatel E; Neto HS. 2007. Nerve terminal contributes to acetylcholine receptor organization at the dystrophic neuromuscular junction of mdx mice. Anat Rec (Hoboken) 290(2):181-7. PubMed: 17441210 MGI: J:174176
Marshall JL; Holmberg J; Chou E; Ocampo AC; Oh J; Lee J; Peter AK; Martin PT; Crosbie-Watson RH. 2012. Sarcospan-dependent Akt activation is required for utrophin expression and muscle regeneration. J Cell Biol 197(7):1009-27. PubMed: 22734004 MGI: J:185346
Marshall JL; Oh J; Chou E; Lee JA; Holmberg J; Burkin DJ; Crosbie-Watson RH. 2015. Sarcospan integration into laminin-binding adhesion complexes that ameliorate muscular dystrophy requires utrophin and alpha7 integrin. Hum Mol Genet 24(7):2011-22. PubMed: 25504048 MGI: J:219598
Martin PT; Xu R; Rodino-Klapac LR; Oglesbay E; Camboni M; Montgomery CL; Shontz K; Chicoine LG; Clark KR; Sahenk Z; Mendell JR; Janssen PM. 2009. Overexpression of Galgt2 in skeletal muscle prevents injury resulting from eccentric contractions in both mdx and wild-type mice. Am J Physiol Cell Physiol 296(3):C476-88. PubMed: 19109526 MGI: J:146366
Martins PC; Ayub-Guerrieri D; Martins-Bach AB; Onofre-Oliveira P; Malheiros JM; Tannus A; de Sousa PL; Carlier PG; Vainzof M. 2013. Dmdmdx/Largemyd: a new mouse model of neuromuscular diseases useful for studying physiopathological mechanisms and testing therapies. Dis Model Mech 6(5):1167-74. PubMed: 23798567 MGI: J:201690
Martins-Bach AB; Malheiros J; Matot B; Martins PC; Almeida CF; Caldeira W; Ribeiro AF; Loureiro de Sousa P; Azzabou N; Tannus A; Carlier PG; Vainzof M. 2015. Quantitative T2 combined with texture analysis of nuclear magnetic resonance images identify different degrees of muscle involvement in three mouse models of muscle dystrophy: mdx, Largemyd and mdx/Largemyd. PLoS One 10(2):e0117835. PubMed: 25710816 MGI: J:226297
Matecki S; Guibinga GH; Petrof BJ. 2004. Regenerative capacity of the dystrophic (mdx) diaphragm after induced injury. Am J Physiol Regul Integr Comp Physiol 287(4):R961-8. PubMed: 15191902 MGI: J:109378
Matsakas A; Yadav V; Lorca S; Narkar V. 2013. Muscle ERRgamma mitigates Duchenne muscular dystrophy via metabolic and angiogenic reprogramming. FASEB J 27(10):4004-4016. PubMed: 23781095 MGI: J:201176
Matsumura CY; Menezes de Oliveira B; Durbeej M; Marques MJ. 2013. Isobaric Tagging-Based Quantification for Proteomic Analysis: A Comparative Study of Spared and Affected Muscles from Mice at the Early Phase of Dystrophy. PLoS One 8(6):e65831. PubMed: 23823696 MGI: J:203463
Matsumura CY; Taniguti AP; Pertille A; Neto HS; Marques MJ. 2011. Stretch-activated calcium channel protein TRPC1 is correlated with the different degrees of the dystrophic phenotype in mdx mice. Am J Physiol Cell Physiol 301(6):C1344-50. PubMed: 21900691 MGI: J:178321
Matsumura K; Ervasti JM; Ohlendieck K; Kahl SD; Campbell KP. 1992. Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle. Nature 360(6404):588-91. PubMed: 1461282 MGI: J:3426
Matsuzaka Y; Tanihata J; Komaki H; Ishiyama A; Oya Y; Ruegg U; Takeda SI; Hashido K. 2016. Characterization and Functional Analysis of Extracellular Vesicles and Muscle-Abundant miRNAs (miR-1, miR-133a, and miR-206) in C2C12 Myocytes and mdx Mice. PLoS One 11(12):e0167811. PubMed: 27977725 MGI: J:254885
Mazala DA; Grange RW; Chin ER. 2015. The role of proteases in excitation-contraction coupling failure in muscular dystrophy. Am J Physiol Cell Physiol 308(1):C33-40. PubMed: 25298424 MGI: J:223583
Mazala DA; Pratt SJ; Chen D; Molkentin JD; Lovering RM; Chin ER. 2015. SERCA1 overexpression minimizes skeletal muscle damage in dystrophic mouse models. Am J Physiol Cell Physiol 308(9):C699-709. PubMed: 25652448 MGI: J:224014
McArdle A; Edwards RH; Jackson MJ. 1992. Accumulation of calcium by normal and dystrophin-deficient mouse muscle during contractile activity in vitro. Clin Sci (Colch) 82(4):455-9. PubMed: 1315657 MGI: J:4056
McArdle A; Edwards RH; Jackson MJ. 1994. Time course of changes in plasma membrane permeability in the dystrophin-deficient mdx mouse. Muscle Nerve 17(12):1378-84. PubMed: 7969238 MGI: J:21964
McCarthy JJ; Esser KA; Andrade FH. 2007. MicroRNA-206 is overexpressed in the diaphragm but not the hindlimb muscle of mdx mouse. Am J Physiol Cell Physiol 293(1):C451-7. PubMed: 17459947 MGI: J:125844
McDonald AA; Hebert SL; Kunz MD; Ralles SJ; McLoon LK. 2015. Disease course in mdx:utrophin+/- mice: comparison of three mouse models of Duchenne muscular dystrophy. Physiol Rep 3(4):. PubMed: 25921779 MGI: J:229245
McDonald AA; Kunz MD; McLoon LK. 2014. Dystrophic changes in extraocular muscles after gamma irradiation in mdx:utrophin(+/-) mice. PLoS One 9(1):e86424. PubMed: 24466085 MGI: J:212562
McGeachie JK; Grounds MD. 1999. The timing between skeletal muscle myoblast replication and fusion into myotubes, and the stability of regenerated dystrophic myofibres: an autoradiographic study in mdx mice. J Anat 194(Pt 2):287-95. PubMed: 10337961 MGI: J:54955
McIntosh LM; Anderson JE. 1995. Hypothyroidism prolongs and increases mdx muscle precursor proliferation and delays myotube formation in normal and dystrophic limb muscle. Biochem Cell Biol 73(3-4):181-90. PubMed: 7576492 MGI: J:28051
McIntosh LM; Pernitsky AN; Anderson JE. 1994. The effects of altered metabolism (hypothyroidism) on muscle repair in the mdx dystrophic mouse. Muscle Nerve 17(4):444-53. PubMed: 8170492 MGI: J:19048
McNally EM; Kaltman JR; Benson DW; Canter CE; Cripe LH; Duan D; Finder JD; Groh WJ; Hoffman EP; Judge DP; Kertesz N; Kinnett K; Kirsch R; Metzger JM; Pearson GD; Rafael-Fortney JA; Raman SV; Spurney CF; Targum SL; Wagner KR; Markham LW. 2015. Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular Dystrophy. Circulation 131(18):1590-8. PubMed: 25940966 MGI: J:234452
Meadows E; Flynn JM; Klein WH. 2011. Myogenin regulates exercise capacity but is dispensable for skeletal muscle regeneration in adult mdx mice. PLoS One 6(1):e16184. PubMed: 21264243 MGI: J:169466
Mechalchuk CL; Bressler BH. 1992. Contractility of mdx skeletal muscle after denervation and devascularization. Muscle Nerve 15(3):310-7. PubMed: 1557078 MGI: J:116343
Meech R; Gonzalez KN; Barro M; Gromova A; Zhuang L; Hulin JA; Makarenkova HP. 2012. Barx2 is expressed in satellite cells and is required for normal muscle growth and regeneration. Stem Cells 30(2):253-65. PubMed: 22076929 MGI: J:187799
Meeson AP; Shi X; Alexander MS; Williams RS; Allen RE; Jiang N; Adham IM; Goetsch SC; Hammer RE; Garry DJ. 2007. Sox15 and Fhl3 transcriptionally coactivate Foxk1 and regulate myogenic progenitor cells. EMBO J 26(7):1902-12. PubMed: 17363903 MGI: J:122510
Megeney LA; Kablar B; Garrett K; Anderson JE; Rudnicki MA. 1996. MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes Dev 10(10):1173-83. PubMed: 8675005 MGI: J:33260
Megeney LA; Kablar B; Perry RL; Ying C; May L; Rudnicki MA. 1999. Severe cardiomyopathy in mice lacking dystrophin and MyoD. Proc Natl Acad Sci U S A 96(1):220-5. PubMed: 9874799 MGI: J:52248
Meinen S; Lin S; Ruegg MA; Punga AR. 2012. Fatigue and muscle atrophy in a mouse model of myasthenia gravis is paralleled by loss of sarcolemmal nNOS. PLoS One 7(8):e44148. PubMed: 22952904 MGI: J:191651
Menazza S; Blaauw B; Tiepolo T; Toniolo L; Braghetta P; Spolaore B; Reggiani C; Di Lisa F; Bonaldo P; Canton M. 2010. Oxidative stress by monoamine oxidases is causally involved in myofiber damage in muscular dystrophy. Hum Mol Genet 19(21):4207-15. PubMed: 20716577 MGI: J:164888
Merrick D; Stadler LK; Larner D; Smith J. 2009. Muscular dystrophy begins early in embryonic development deriving from stem cell loss and disrupted skeletal muscle formation. Dis Model Mech 2(7-8):374-88. PubMed: 19535499 MGI: J:150127
Messina S; Altavilla D; Aguennouz M; Seminara P; Minutoli L; Monici MC; Bitto A; Mazzeo A; Marini H; Squadrito F; Vita G. 2006. Lipid peroxidation inhibition blunts nuclear factor-kappaB activation, reduces skeletal muscle degeneration, and enhances muscle function in mdx mice. Am J Pathol 168(3):918-26. PubMed: 16507907 MGI: J:106560
Messina S; Bitto A; Aguennouz M; Minutoli L; Monici MC; Altavilla D; Squadrito F; Vita G. 2006. Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice. Exp Neurol 198(1):234-41. PubMed: 16410003 MGI: J:107902
Mijares A; Altamirano F; Kolster J; Adams JA; Lopez JR. 2014. Age-dependent changes in diastolic Ca(2+) and Na(+) concentrations in dystrophic cardiomyopathy: Role of Ca(2+) entry and IP3. Biochem Biophys Res Commun 452(4):1054-9. PubMed: 25242522 MGI: J:220083
Millay DP; Goonasekera SA; Sargent MA; Maillet M; Aronow BJ; Molkentin JD. 2009. Calcium influx is sufficient to induce muscular dystrophy through a TRPC-dependent mechanism. Proc Natl Acad Sci U S A 106(45):19023-8. PubMed: 19864620 MGI: J:154908
Millay DP; Sargent MA; Osinska H; Baines CP; Barton ER; Vuagniaux G; Sweeney HL; Robbins J; Molkentin JD. 2008. Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy. Nat Med 14(4):442-7. PubMed: 18345011 MGI: J:133679
Miller G; Moore CJ; Terry R; La Riviere T; Mitchell A; Piggott R; Dear TN; Wells DJ; Winder SJ. 2012. Preventing phosphorylation of dystroglycan ameliorates the dystrophic phenotype in mdx mouse. Hum Mol Genet 21(20):4508-20. PubMed: 22810924 MGI: J:187750
Minatel E; Neto HS; Marques MJ. 2003. Acetylcholine receptor distribution and synapse elimination at the developing neuromuscular junction of mdx mice. Muscle Nerve 28(5):561-9. PubMed: 14571457 MGI: J:105143
Minatel E; Santo Neto H; Marques MJ. 2001. Acetylcholine receptors and neuronal nitric oxide synthase distribution at the neuromuscular junction of regenerated muscle fibers. Muscle Nerve 24(3):410-6. PubMed: 11353428 MGI: J:116197
Minciacchi D; Del Tongo C; Carretta D; Nosi D; Granato A. 2010. Alterations of the cortico-cortical network in sensori-motor areas of dystrophin deficient mice. Neuroscience 166(4):1129-39. PubMed: 20109538 MGI: J:159718
Miranda R; Nudel U; Laroche S; Vaillend C. 2011. Altered presynaptic ultrastructure in excitatory hippocampal synapses of mice lacking dystrophins Dp427 or Dp71. Neurobiol Dis 43(1):134-41. PubMed: 21397023 MGI: J:174331
Miranda R; Sebrie C; Degrouard J; Gillet B; Jaillard D; Laroche S; Vaillend C. 2009. Reorganization of inhibitory synapses and increased PSD length of perforated excitatory synapses in hippocampal area CA1 of dystrophin-deficient mdx mice. Cereb Cortex 19(4):876-88. PubMed: 18794205 MGI: J:174113
Mitsui T; Kawai H; Kawajiri M; Kunishige M; Aki K; Saito S. 1996. Induction of dystrophin-associated proteins together with nicotinic acetylcholine receptors by denervation in the absence of dystrophin in skeletal muscles of mdx mice. Biochem Biophys Res Commun 224(3):802-7. PubMed: 8713126 MGI: J:34495
Miyagoe-Suzuki Y; Masubuchi N; Miyamoto K; Wada MR; Yuasa S; Saito F; Matsumura K; Kanesaki H; Kudo A; Manya H; Endo T; Takeda S. 2008. Reduced proliferative activity of primary POMGnT1-null myoblasts in vitro. Mech Dev :. PubMed: 19114101 MGI: J:144928
Miyazaki D; Nakamura A; Fukushima K; Yoshida K; Takeda S; Ikeda S. 2011. Matrix metalloproteinase-2 ablation in dystrophin-deficient mdx muscles reduces angiogenesis resulting in impaired growth of regenerated muscle fibers. Hum Mol Genet 20(9):1787-99. PubMed: 21320869 MGI: J:170485
Mizunoya W; Upadhaya R; Burczynski FJ; Wang G; Anderson JE. 2011. Nitric oxide donors improve prednisone effects on muscular dystrophy in the mdx mouse diaphragm. Am J Physiol Cell Physiol 300(5):C1065-77. PubMed: 21270295 MGI: J:174258
Moghadaszadeh B; Albrechtsen R; Guo LT; Zaik M; Kawaguchi N; Borup RH; Kronqvist P; Schroder HD; Davies KE; Voit T; Nielsen FC; Engvall E; Wewer UM. 2003. Compensation for dystrophin-deficiency: ADAM12 overexpression in skeletal muscle results in increased alpha 7 integrin, utrophin and associated glycoproteins. Hum Mol Genet 12(19):2467-79. PubMed: 12915458 MGI: J:85973
Mohri I; Aritake K; Taniguchi H; Sato Y; Kamauchi S; Nagata N; Maruyama T; Taniike M; Urade Y. 2009. Inhibition of prostaglandin D synthase suppresses muscular necrosis. Am J Pathol 174(5):1735-44. PubMed: 19359520 MGI: J:148025
Mojumdar K; Giordano C; Lemaire C; Liang F; Divangahi M; Qureshi ST; Petrof BJ. 2016. Divergent impact of Toll-like receptor 2 deficiency on repair mechanisms in healthy muscle versus Duchenne muscular dystrophy. J Pathol 239(1):10-22. PubMed: 26800321 MGI: J:241107
Mokalled MH; Johnson AN; Creemers EE; Olson EN. 2012. MASTR directs MyoD-dependent satellite cell differentiation during skeletal muscle regeneration. Genes Dev 26(2):190-202. PubMed: 22279050 MGI: J:179880
Mokhtarian A; Lefaucheur JP; Even PC; Sebille A. 1999. Hindlimb immobilization applied to 21-day-old mdx mice prevents the occurrence of muscle degeneration. J Appl Physiol 86(3):924-31. PubMed: 10066706 MGI: J:103296
Montagna C; Di Giacomo G; Rizza S; Cardaci S; Ferraro E; Grumati P; De Zio D; Maiani E; Muscoli C; Lauro F; Ilari S; Bernardini S; Cannata S; Gargioli C; Ciriolo MR; Cecconi F; Bonaldo P; Filomeni G. 2014. S-nitrosoglutathione reductase deficiency-induced S-nitrosylation results in neuromuscular dysfunction. Antioxid Redox Signal 21(4):570-87. PubMed: 24684653 MGI: J:225227
Montanaro F; Carbonetto S; Campbell KP; Lindenbaum M. 1995. Dystroglycan expression in the wild type and mdx mouse neural retina: synaptic colocalization with dystrophin, dystrophin-related protein but not laminin. J Neurosci Res 42(4):528-38. PubMed: 8568939 MGI: J:29769
Montgomery E; Pennington C; Isales CM; Hamrick MW. 2005. Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice. Anat Rec A Discov Mol Cell Evol Biol 286(1):814-22. PubMed: 16078270 MGI: J:174184
Moore K; Bulfield G. 1981. Research News (Dmd) Mouse News Lett 64:61. MGI: J:28684
Moorwood C; Barton ER. 2014. Caspase-12 ablation preserves muscle function in the mdx mouse. Hum Mol Genet 23(20):5325-41. PubMed: 24879640 MGI: J:214751
Morales MG; Gutierrez J; Cabello-Verrugio C; Cabrera D; Lipson KE; Goldschmeding R; Brandan E. 2013. Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy. Hum Mol Genet 22(24):4938-51. PubMed: 23904456 MGI: J:203131
Morgan JE; Pagel CN; Sherratt T; Partridge TA. 1993. Long-term persistence and migration of myogenic cells injected into pre-irradiated muscles of mdx mice. J Neurol Sci 115(2):191-200. PubMed: 7683332 MGI: J:4395
Morikawa Y; Zhang M; Heallen T; Leach J; Tao G; Xiao Y; Bai Y; Li W; Willerson JT; Martin JF. 2015. Actin cytoskeletal remodeling with protrusion formation is essential for heart regeneration in Hippo-deficient mice. Sci Signal 8(375):ra41. PubMed: 25943351 MGI: J:259346
Morin S; de la Porte S; Fiszman M; Koenig J. 1995. Inhibition of proliferation in 8-week-old mdx mouse muscle fibroblasts in vitro. Differentiation 59(3):145-54. PubMed: 7589898 MGI: J:29793
Morris CA; Selsby JT; Morris LD; Pendrak K; Sweeney HL. 2010. Bowman-Birk inhibitor attenuates dystrophic pathology in mdx mice. J Appl Physiol 109(5):1492-9. PubMed: 20847128 MGI: J:185904
Morrison J; Lu QL; Pastoret C; Partridge T; Bou-Gharios G. 2000. T-cell-dependent fibrosis in the mdx dystrophic mouse. Lab Invest 80(6):881-91. PubMed: 10879739 MGI: J:62881
Morrison J; Palmer DB; Cobbold S; Partridge T; Bou-Gharios G. 2005. Effects of T-Lymphocyte Depletion on Muscle Fibrosis in the mdx Mouse. Am J Pathol 166(6):1701-10. PubMed: 15920155 MGI: J:98815
Morrison J; Partridge T; Bou-Gharios G. 2005. Nude mutation influences limb skeletal muscle development. Matrix Biol 23(8):535-42. PubMed: 15694130 MGI: J:95776
Morrison-Nozik A; Anand P; Zhu H; Duan Q; Sabeh M; Prosdocimo DA; Lemieux ME; Nordsborg N; Russell AP; MacRae CA; Gerber AN; Jain MK; Haldar SM. 2015. Glucocorticoids enhance muscle endurance and ameliorate Duchenne muscular dystrophy through a defined metabolic program. Proc Natl Acad Sci U S A 112(49):E6780-9. PubMed: 26598680 MGI: J:228132
Mu X; Tang Y; Lu A; Takayama K; Usas A; Wang B; Weiss K; Huard J. 2015. The role of Notch signaling in muscle progenitor cell depletion and the rapid onset of histopathology in muscular dystrophy. Hum Mol Genet 24(10):2923-37. PubMed: 25678553 MGI: J:221156
Mu X; Tang Y; Takayama K; Chen W; Lu A; Wang B; Weiss K; Huard J. 2017. RhoA/ROCK inhibition improves the beneficial effects of glucocorticoid treatment in dystrophic muscle: implications for stem cell depletion. Hum Mol Genet 26(15):2813-2824. PubMed: 28549178 MGI: J:243648
Mu X; Usas A; Tang Y; Lu A; Wang B; Weiss K; Huard J. 2013. RhoA mediates defective stem cell function and heterotopic ossification in dystrophic muscle of mice. FASEB J 27(9):3619-31. PubMed: 23704088 MGI: J:201105
Mu X; Xiang G; Rathbone CR; Pan H; Bellayr IH; Walters TJ; Li Y. 2011. Slow-adhering stem cells derived from injured skeletal muscle have improved regenerative capacity. Am J Pathol 179(2):931-41. PubMed: 21684246 MGI: J:174133
Mueck T; Berger F; Buechsler I; Valchanova RS; Landuzzi L; Lollini PL; Klingel K; Munz B. 2011. TRAF6 regulates proliferation and differentiation of skeletal myoblasts. Differentiation 81(2):99-106. PubMed: 21131124 MGI: J:168480
Mule F; Vannucchi MG; Corsani L; Serio R; Faussone-Pellegrini MS. 2001. Myogenic NOS and endogenous NO production are defective in colon from dystrophic (mdx) mice. Am J Physiol Gastrointest Liver Physiol 281(5):G1264-70. PubMed: 11668035 MGI: J:72563
Muntoni F; Mateddu A; Marchei F; Clerk A; Serra G. 1993. Muscular weakness in the mdx mouse. J Neurol Sci 120(1):71-7. PubMed: 8289081 MGI: J:15976
Murphy KT; Ryall JG; Snell SM; Nair L; Koopman R; Krasney PA; Ibebunjo C; Holden KS; Loria PM; Salatto CT; Lynch GS. 2010. Antibody-directed myostatin inhibition improves diaphragm pathology in young but not adult dystrophic mdx mice. Am J Pathol 176(5):2425-34. PubMed: 20363926 MGI: J:160748
Murphy RM; Dutka TL; Horvath D; Bell JR; Delbridge LM; Lamb GD. 2013. Ca2+-dependent proteolysis of junctophilin-1 and junctophilin-2 in skeletal and cardiac muscle. J Physiol 591(Pt 3):719-29. PubMed: 23148318 MGI: J:205977
Nagaraju K; Rawat R; Veszelovszky E; Thapliyal R; Kesari A; Sparks S; Raben N; Plotz P; Hoffman EP. 2008. Dysferlin Deficiency Enhances Monocyte Phagocytosis: A Model for the Inflammatory Onset of Limb-Girdle Muscular Dystrophy 2B. Am J Pathol 172(3):774-785. PubMed: 18276788 MGI: J:132272
Nahirney PC; Dow PR; Ovalle WK. 1997. Quantitative morphology of mast cells in skeletal muscle of normal and genetically dystrophic mice. Anat Rec 247(3):341-9. PubMed: 9066911 MGI: J:38886
Nahirney PC; Ovalle WK. 1993. Distribution of dystrophin and neurofilament protein in muscle spindles of normal and Mdx-dystrophic mice: an immunocytochemical study. Anat Rec 235(4):501-10. PubMed: 8465985 MGI: J:4328
Nakagaki WR; Bertran CA; Matsumura CY; Santo-Neto H; Camilli JA. 2011. Mechanical, biochemical and morphometric alterations in the femur of mdx mice. Bone 48(2):372-9. PubMed: 20850579 MGI: J:170207
Nakagaki WR; Camilli JA. 2012. Spontaneous Healing Capacity of Calvarial Bone Defects in mdx Mice. Anat Rec (Hoboken) 295(4):590-6. PubMed: 22271453 MGI: J:181555
Nakagaki WR; Tomiosso TC; Pimentel ER; Camilli JA. 2013. Mechanical and morphological aspects of the calcaneal tendon of mdx mice at 21 days of age. Anat Rec (Hoboken) 296(10):1546-51. PubMed: 23934706 MGI: J:202862
Nakamura A; Harrod GV; Davies KE. 2001. Activation of calcineurin and stress activated protein kinase/p38-mitogen activated protein kinase in hearts of utrophin-dystrophin knockout mice. Neuromuscul Disord 11(3):251-9. PubMed: 11297940 MGI: J:112432
Nakamura A; Yoshida K; Takeda S; Dohi N; Ikeda S. 2002. Progression of dystrophic features and activation of mitogen-activated protein kinases and calcineurin by physical exercise, in hearts of mdx mice. FEBS Lett 520(1-3):18-24. PubMed: 12044863 MGI: J:119432
Nakatani M; Takehara Y; Sugino H; Matsumoto M; Hashimoto O; Hasegawa Y; Murakami T; Uezumi A; Takeda S; Noji S; Sunada Y; Tsuchida K. 2008. Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice. FASEB J 22(2):477-87. PubMed: 17893249 MGI: J:134809
Nanni S; Re A; Ripoli C; Gowran A; Nigro P; D'Amario D; Amodeo A; Crea F; Grassi C; Pontecorvi A; Farsetti A; Colussi C. 2016. The nuclear pore protein Nup153 associates with chromatin and regulates cardiac gene expression in dystrophic mdx hearts. Cardiovasc Res 112(2):555-567. PubMed: 28513807 MGI: J:256392
Narita S; Yorifuji H. 1999. Centrally nucleated fibers (CNFs) compensate the fragility of myofibers in mdx mouse. Neuroreport 10(15):3233-5. PubMed: 10574566 MGI: J:103724
Nelson CA; Hunter RB; Quigley LA; Girgenrath S; Weber WD; McCullough JA; Dinardo CJ; Keefe KA; Ceci L; Clayton NP; McVie-Wylie A; Cheng SH; Leonard JP; Wentworth BM. 2011. Inhibiting TGF-beta Activity Improves Respiratory Function in mdx Mice. Am J Pathol 178(6):2611-21. PubMed: 21641384 MGI: J:173295
Nelson CE; Hakim CH; Ousterout DG; Thakore PI; Moreb EA; Castellanos Rivera RM; Madhavan S; Pan X; Ran FA; Yan WX; Asokan A; Zhang F; Duan D; Gersbach CA. 2016. In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy. Science 351(6271):403-7. PubMed: 26721684 MGI: J:229478
Neuhaus P; Oustanina S; Loch T; Kruger M; Bober E; Dono R; Zeller R; Braun T. 2003. Reduced mobility of fibroblast growth factor (FGF)-deficient myoblasts might contribute to dystrophic changes in the musculature of FGF2/FGF6/mdx triple-mutant mice. Mol Cell Biol 23(17):6037-48. PubMed: 12917328 MGI: J:85088
Ng R; Metzger JM; Claflin DR; Faulkner JA. 2008. Poloxamer 188 reduces the contraction-induced force decline in lumbrical muscles from mdx mice. Am J Physiol Cell Physiol 295(1):C146-50. PubMed: 18495816 MGI: J:138653
Nguyen HH; Jayasinha V; Xia B; Hoyte K; Martin PT. 2002. Overexpression of the cytotoxic T cell GalNAc transferase in skeletal muscle inhibits muscular dystrophy in mdx mice. Proc Natl Acad Sci U S A 99(8):5616-21. PubMed: 11960016 MGI: J:76069
Nguyen-Tran DH; Hait NC; Sperber H; Qi J; Fischer K; Ieronimakis N; Pantoja M; Hays A; Allegood J; Reyes M; Spiegel S; Ruohola-Baker H. 2014. Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophy. Dis Model Mech 7(1):41-54. PubMed: 24077965 MGI: J:208735
Nico B; Corsi P; Ria R; Crivellato E; Vacca A; Roccaro AM; Mangieri D; Ribatti D; Roncali L. 2006. Increased matrix-metalloproteinase-2 and matrix-metalloproteinase-9 expression in the brain of dystrophic mdx mouse. Neuroscience 140(3):835-48. PubMed: 16650610 MGI: J:110290
Nico B; Frigeri A; Nicchia GP; Corsi P; Ribatti D; Quondamatteo F; Herken R; Girolamo F; Marzullo A; Svelto M; Roncali L. 2003. Severe alterations of endothelial and glial cells in the blood-brain barrier of dystrophic mdx mice. Glia 42(3):235-51. PubMed: 12673830 MGI: J:104866
Nico B; Mangieri D; De Luca A; Corsi P; Benagiano V; Tamma R; Annese T; Longo V; Crivellato E; Ribatti D. 2009. Nerve growth factor and its receptors TrkA and p75 are upregulated in the brain of mdx dystrophic mouse. Neuroscience 161(4):1057-66. PubMed: 19376199 MGI: J:152938
Nico B; Marzullo A; Corsi P; Vacca A; Roncali L; Ribatti D. 2004. A possible role of tryptase in angiogenesis in the brain of mdx mouse, a model of Duchenne muscular dystrophy. Neuroscience 123(3):585-8. PubMed: 14706770 MGI: J:89994
Nico B; Paola Nicchia G; Frigeri A; Corsi P; Mangieri D; Ribatti D; Svelto M; Roncali L. 2004. Altered blood-brain barrier development in dystrophic MDX mice. Neuroscience 125(4):921-35. PubMed: 15120852 MGI: J:89984
Nico B; Tamma R; Annese T; Mangieri D; De Luca A; Corsi P; Benagiano V; Longo V; Crivellato E; Salmaggi A; Ribatti D. 2010. Glial dystrophin-associated proteins, laminin and agrin, are downregulated in the brain of mdx mouse. Lab Invest 90(11):1645-60. PubMed: 20714324 MGI: J:165342
Nio Y; Tanaka M; Hirozane Y; Muraki Y; Okawara M; Hazama M; Matsuo T. 2017. Phosphodiesterase 4 inhibitor and phosphodiesterase 5 inhibitor combination therapy has antifibrotic and anti-inflammatory effects in mdx mice with Duchenne muscular dystrophy. FASEB J 31(12):5307-5320. PubMed: 28798156 MGI: J:256273
Nitahara-Kasahara Y; Hayashita-Kinoh H; Chiyo T; Nishiyama A; Okada H; Takeda S; Okada T. 2014. Dystrophic mdx mice develop severe cardiac and respiratory dysfunction following genetic ablation of the anti-inflammatory cytokine IL-10. Hum Mol Genet 23(15):3990-4000. PubMed: 24659498 MGI: J:211195
Novotny SA; Mader TL; Greising AG; Lin AS; Guldberg RE; Warren GL; Lowe DA. 2014. Low intensity, high frequency vibration training to improve musculoskeletal function in a mouse model of Duchenne muscular dystrophy. PLoS One 9(8):e104339. PubMed: 25121503 MGI: J:218986
Ogawa R; Ma Y; Yamaguchi M; Ito T; Watanabe Y; Ohtani T; Murakami S; Uchida S; De Gaspari P; Uezumi A; Nakamura M; Miyagoe-Suzuki Y; Tsujikawa K; Hashimoto N; Braun T; Tanaka T; Takeda S; Yamamoto H; Fukada S. 2015. Doublecortin marks a new population of transiently amplifying muscle progenitor cells and is required for myofiber maturation during skeletal muscle regeneration. Development 142(1):51-61. PubMed: 25480916 MGI: J:237438
Oh HJ; Abraham LS; van Hengel J; Stove C; Proszynski TJ; Gevaert K; DiMario JX; Sanes JR; van Roy F; Kim H. 2012. Interaction of alpha-catulin with dystrobrevin contributes to integrity of dystrophin complex in muscle. J Biol Chem 287(26):21717-28. PubMed: 22577143 MGI: J:192994
Ohlendieck K; Campbell KP. 1991. Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice. J Cell Biol 115(6):1685-94. PubMed: 1757468 MGI: J:1875
Okamoto Y; Takahashi K; Toriyama K; Takeda N; Kitagawa K; Hosokawa M; Takeda T. 1995. Femoral peak bone mass and osteoclast number in an animal model of age-related spontaneous osteopenia. Anat Rec 242(1):21-8. PubMed: 7604978 MGI: J:25058
Olichon-Berthe C; Gautier N; Van Obberghen E; Le Marchand-Brustel Y. 1993. Expression of the glucose transporter GLUT4 in the muscular dystrophic mdx mouse. Biochem J 291(Pt 1):257-61. PubMed: 8471042 MGI: J:4547
Pagel C; Watt D; Naudeer S; Partridge T; Morgan J. 1991. The change in dystrophin phenotype in heterozygous mdx mice. J Neuropathol Exp Neurol 50(3):278-80. PubMed: 2022969 MGI: J:121258
Palladino M; Gatto I; Neri V; Straino S; Smith RC; Silver M; Gaetani E; Marcantoni M; Giarretta I; Stigliano E; Capogrossi M; Hlatky L; Landolfi R; Pola R. 2013. Angiogenic impairment of the vascular endothelium: a novel mechanism and potential therapeutic target in muscular dystrophy. Arterioscler Thromb Vasc Biol 33(12):2867-76. PubMed: 24072696 MGI: J:222214
Pant M; Sopariwala DH; Bal NC; Lowe J; Delfin DA; Rafael-Fortney J; Periasamy M. 2015. Metabolic dysfunction and altered mitochondrial dynamics in the utrophin-dystrophin deficient mouse model of duchenne muscular dystrophy. PLoS One 10(4):e0123875. PubMed: 25859846 MGI: J:233516
Parames SF; Coletta-Yudice ED; Nogueira FM; Nering de Sousa MB; Hayashi MA; Lima-Landman MT; Lapa AJ; Souccar C. 2014. Altered acetylcholine release in the hippocampus of dystrophin-deficient mice. Neuroscience 269:173-83. PubMed: 24704431 MGI: J:210439
Park CW; Ryu HW; Ryu KY. 2012. Locus coeruleus neurons are resistant to dysfunction and degeneration by maintaining free ubiquitin levels although total ubiquitin levels decrease upon disruption of polyubiquitin gene Ubb. Biochem Biophys Res Commun 418(3):541-6. PubMed: 22285186 MGI: J:181255
Pastoret C; Sebille A. 1995. mdx mice show progressive weakness and muscle deterioration with age. J Neurol Sci 129(2):97-105. PubMed: 7608742 MGI: J:24527
Pastoret C; Sebille A. 1993. Further aspects of muscular dystrophy in mdx mice. Neuromuscul Disord 3(5-6):471-5. PubMed: 8186696 MGI: J:19034
Pastoret C; Sebille A. 1993. Time course study of the isometric contractile properties of mdx mouse striated muscles. J Muscle Res Cell Motil 14(4):423-31. PubMed: 8227301 MGI: J:15488
Pastoret C; Sebille A. 1995. Age-related differences in regeneration of dystrophic (mdx) and normal muscle in the mouse. Muscle Nerve 18(10):1147-54. PubMed: 7659109 MGI: J:29605
Pastoret C; Sebille A. 1993. Fibres of intermediate type 1C and 2C are found continuously in mdx soleus muscle up to 52 weeks. Histochemistry 100(4):271-6. PubMed: 8276641 MGI: J:17566
Pauly M; Angebault-Prouteau C; Dridi H; Notarnicola C; Scheuermann V; Lacampagne A; Matecki S; Fauconnier J. 2017. ER stress disturbs SR/ER-mitochondria Ca(2+) transfer: Implications in Duchenne muscular dystrophy. Biochim Biophys Acta 1863(9):2229-2239. PubMed: 28625916 MGI: J:256866
Pauly M; Daussin F; Burelle Y; Li T; Godin R; Fauconnier J; Koechlin-Ramonatxo C; Hugon G; Lacampagne A; Coisy-Quivy M; Liang F; Hussain S; Matecki S; Petrof BJ. 2012. AMPK Activation Stimulates Autophagy and Ameliorates Muscular Dystrophy in the mdx Mouse Diaphragm. Am J Pathol 181(2):583-92. PubMed: 22683340 MGI: J:187001
Peladeau C; Ahmed A; Amirouche A; Crawford Parks TE; Bronicki LM; Ljubicic V; Renaud JM; Jasmin BJ. 2016. Combinatorial therapeutic activation with heparin and AICAR stimulates additive effects on utrophin A expression in dystrophic muscles. Hum Mol Genet 25(1):24-43. PubMed: 26494902 MGI: J:227626
Percival JM; Siegel MP; Knowels G; Marcinek DJ. 2013. Defects in mitochondrial localization and ATP synthesis in the mdx mouse model of Duchenne muscular dystrophy are not alleviated by PDE5 inhibition. Hum Mol Genet 22(1):153-67. PubMed: 23049075 MGI: J:191136
Percival JM; Whitehead NP; Adams ME; Adamo CM; Beavo JA; Froehner SC. 2012. Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy. J Pathol 228(1):77-87. PubMed: 22653783 MGI: J:188433
Pereon Y; Dettbarn C; Navarro J; Noireaud J; Palade PT. 1997. Dihydropyridine receptor gene expression in skeletal muscle from mdx and control mice. Biochim Biophys Acta 1362(2-3):201-7. PubMed: 9540851 MGI: J:46983
Pereon Y; Elkhammari A; Noireaud J. 1993. Differential susceptibility to repetitive potassium induced contractures in diaphragm versus extensor digitorum longus muscles of mdx mice [letter] Muscle Nerve 16(12):1423-4. PubMed: 8232408 MGI: J:16472
Perronnet C; Chagneau C; Le Blanc P; Samson-Desvignes N; Mornet D; Laroche S; De La Porte S; Vaillend C. 2012. Upregulation of brain utrophin does not rescue behavioral alterations in dystrophin-deficient mice. Hum Mol Genet 21(10):2263-76. PubMed: 22343141 MGI: J:183789
Personius KE; Sawyer RP. 2006. Variability and failure of neurotransmission in the diaphragm of mdx mice. Neuromuscul Disord 16(3):168-77. PubMed: 16483776 MGI: J:112783
Peter AK; Marshall JL; Crosbie RH. 2008. Sarcospan reduces dystrophic pathology: stabilization of the utrophin-glycoprotein complex. J Cell Biol 183(3):419-27. PubMed: 18981229 MGI: J:141069
Peter AK; Miller G; Crosbie RH. 2007. Disrupted mechanical stability of the dystrophin-glycoprotein complex causes severe muscular dystrophy in sarcospan transgenic mice. J Cell Sci 120(Pt 6):996-1008. PubMed: 17311848 MGI: J:120731
Peters MF; Adams ME; Froehner SC. 1997. Differential association of syntrophin pairs with the dystrophin complex. J Cell Biol 138(1):81-93. PubMed: 9214383 MGI: J:41623
Petitprez S; Zmoos AF; Ogrodnik J; Balse E; Raad N; El-Haou S; Albesa M; Bittihn P; Luther S; Lehnart SE; Hatem SN; Coulombe A; Abriel H. 2011. SAP97 and dystrophin macromolecular complexes determine two pools of cardiac sodium channels Nav1.5 in cardiomyocytes. Circ Res 108(3):294-304. PubMed: 21164104 MGI: J:183504
Petrillo S; Pelosi L; Piemonte F; Travaglini L; Forcina L; Catteruccia M; Petrini S; Verardo M; D'Amico A; Musaro A; Bertini E. 2017. Oxidative stress in Duchenne muscular dystrophy: focus on the NRF2 redox pathway. Hum Mol Genet 26(14):2781-2790. PubMed: 28472288 MGI: J:243290
Phelps SF; Hauser MA; Cole NM; Rafael JA; Hinkle RT; Faulkner JA; Chamberlain JS. 1995. Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice. Hum Mol Genet 4(8):1251-8. PubMed: 7581361 MGI: J:27471
Pigozzo SR; Da Re L; Romualdi C; Mazzara PG; Galletta E; Fletcher S; Wilton SD; Vitiello L. 2013. Revertant fibers in the mdx murine model of Duchenne muscular dystrophy: an age- and muscle-related reappraisal. PLoS One 8(8):e72147. PubMed: 24015212 MGI: J:206411
Pillers DA; Weleber RG; Green DG; Rash SM; Dally GY; Howard PL ; Powers MR ; Hood DC ; Chapman VM ; Ray PN ; Woodward WR. 1999. Effects of dystrophin isoforms on signal transduction through neural retina: genotype-phenotype analysis of duchenne muscular dystrophy mouse mutants. Mol Genet Metab 66(2):100-10. PubMed: 10068512 MGI: J:53822
Pillers DM; Weleber RG; Woodward WR; Green DG; Chapman VM; Ray PN. 1995. mdxCv3 mouse is a model for electroretinography of Duchenne/Becker muscular dystrophy. Invest Ophthalmol Vis Sci 36(2):462-6. PubMed: 7843915 MGI: J:23375
Pines M; Levi O; Genin O; Lavy A; Angelini C; Allamand V; Halevy O. 2017. Elevated Expression of Moesin in Muscular Dystrophies. Am J Pathol 187(3):654-664. PubMed: 28082118 MGI: J:240408
Pinto ML; Tokunaga HH; Souccar C; Schoorlemmer GH; Lapa Rde C. 2007. Morphological changes in the trigemino-rubral pathway in dystrophic (mdx) mice. Neurosci Lett 416(2):175-9. PubMed: 17324512 MGI: J:141668
Pinto ML; Tokunaga HH; Souccar C; Schoorlemmer GH; da Silva Lapa Rde C. 2008. Loss of neuronal projections in the dystrophin-deficient mdx mouse is not progressive. Brain Res 1224:127-32. PubMed: 18603229 MGI: J:139873
Pistilli EE; Bogdanovich S; Goncalves MD; Ahima RS; Lachey J; Seehra J; Khurana T. 2011. Targeting the Activin Type IIB Receptor to Improve Muscle Mass and Function in the mdx Mouse Model of Duchenne Muscular Dystrophy. Am J Pathol 178(3):1287-97. PubMed: 21356379 MGI: J:169683
Pistoni M; Shiue L; Cline MS; Bortolanza S; Neguembor MV; Xynos A; Ares M Jr; Gabellini D. 2013. Rbfox1 downregulation and altered calpain 3 splicing by FRG1 in a mouse model of Facioscapulohumeral muscular dystrophy (FSHD). PLoS Genet 9(1):e1003186. PubMed: 23300487 MGI: J:195085
Ponnusamy S; Sullivan RD; You D; Zafar N; He Yang C; Thiyagarajan T; Johnson DL; Barrett ML; Koehler NJ; Star M; Stephenson EJ; Bridges D; Cormier SA; Pfeffer LM; Narayanan R. 2017. Androgen receptor agonists increase lean mass, improve cardiopulmonary functions and extend survival in preclinical models of Duchenne muscular dystrophy. Hum Mol Genet 26(13):2526-2540. PubMed: 28453658 MGI: J:243042
Pons F; Robert A; Marini JF; Leger JJ. 1994. Does utrophin expression in muscles of mdx mice during postnatal development functionally compensate for dystrophin deficiency? J Neurol Sci 122(2):162-70. PubMed: 8021701 MGI: J:17298
Porter JD; Khanna S; Kaminski HJ; Rao JS; Merriam AP; Richmonds CR; Leahy P; Li J; Guo W; Andrade FH. 2002. A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. Hum Mol Genet 11(3):263-72. PubMed: 11823445 MGI: J:74738
Porter JD; Merriam AP; Khanna S; Andrade FH; Richmonds CR; Leahy P; Cheng G; Karathanasis P; Zhou X; Kusner LL; Adams ME; Willem M; Mayer U; Kaminski HJ. 2003. Constitutive properties, not molecular adaptations, mediate extraocular muscle sparing in dystrophic mdx mice. FASEB J 17(8):893-5. PubMed: 12670877 MGI: J:118481
Porter JD; Merriam AP; Leahy P; Gong B; Feuerman J; Cheng G; Khanna S. 2004. Temporal gene expression profiling of dystrophin-deficient (mdx) mouse diaphragm identifies conserved and muscle group-specific mechanisms in the pathogenesis of muscular dystrophy. Hum Mol Genet 13(3):257-69. PubMed: 14681298 MGI: J:119422
Porter JD; Rafael JA; Ragusa RJ; Brueckner JK; Trickett JI; Davies KE. 1998. The sparing of extraocular muscle in dystrophinopathy is lost in mice lacking utrophin and dystrophin. J Cell Sci 111(Pt 13):1801-11. PubMed: 9625743 MGI: J:48675
Pratt SJ; Shah SB; Ward CW; Inacio MP; Stains JP; Lovering RM. 2013. Effects of in vivo injury on the neuromuscular junction in healthy and dystrophic muscles. J Physiol 591(Pt 2):559-70. PubMed: 23109110 MGI: J:205097
Prattis SM; Horton SB; van Camp SD; Kornegay JN. 1994. Immunohistochemical detection of neural cell adhesion molecule and laminin in X-linked dystrophic dogs and mdx mice. J Comp Pathol 110(3):253-66. PubMed: 8040390 MGI: J:20707
Pressmar J; Brinkmeier H; Seewald MJ; Naumann T; Rudel R. 1994. Intracellular Ca2+ concentrations are not elevated in resting cultured muscle from Duchenne (DMD) patients and in MDX mouse muscle fibres. Pflugers Arch 426(6):499-505. PubMed: 8052519 MGI: J:20764
Pribiag H; Peng H; Shah WA; Stellwagen D; Carbonetto S. 2014. Dystroglycan mediates homeostatic synaptic plasticity at GABAergic synapses. Proc Natl Acad Sci U S A 111(18):6810-5. PubMed: 24753587 MGI: J:211088
Price FD; von Maltzahn J; Bentzinger CF; Dumont NA; Yin H; Chang NC; Wilson DH; Frenette J; Rudnicki MA. 2014. Inhibition of JAK-STAT signaling stimulates adult satellite cell function. Nat Med 20(10):1174-81. PubMed: 25194569 MGI: J:227594
Prins KW; Humston JL; Mehta A; Tate V; Ralston E; Ervasti JM. 2009. Dystrophin is a microtubule-associated protein. J Cell Biol 186(3):363-9. PubMed: 19651889 MGI: J:153847
Prins KW; Lowe DA; Ervasti JM. 2008. Skeletal muscle-specific ablation of gamma(cyto)-actin does not exacerbate the mdx phenotype. PLoS One 3(6):e2419. PubMed: 18545671 MGI: J:137146
Prosser BL; Ward CW; Lederer WJ. 2011. X-ROS signaling: rapid mechano-chemo transduction in heart. Science 333(6048):1440-5. PubMed: 21903813 MGI: J:176664
Quattrocelli M; Barefield DY; Warner JL; Vo AH; Hadhazy M; Earley JU; Demonbreun AR; McNally EM. 2017. Intermittent glucocorticoid steroid dosing enhances muscle repair without eliciting muscle atrophy. J Clin Invest 127(6):2418-2432. PubMed: 28481224 MGI: J:244797
Quinlan JG; Cambier D; Lyden S; Dalvi A; Upputuri RK; Gartside P; Michaels SE; Denman D. 1997. Regeneration-blocked mdx muscle: in vivo model for testing treatments. Muscle Nerve 20(8):1016-23. PubMed: 9236793 MGI: J:116234
Quinlan JG; Hahn HS; Wong BL; Lorenz JN; Wenisch AS; Levin LS. 2004. Evolution of the mdx mouse cardiomyopathy: physiological and morphological findings. Neuromuscul Disord 14(8-9):491-6. PubMed: 15336690 MGI: J:102071
Quinlan JG; Lyden SP; Cambier DM; Johnson SR; Michaels SE; Denman DL. 1995. Radiation inhibition of mdx mouse muscle regeneration: dose and age factors. Muscle Nerve 18(2):201-6. PubMed: 7823979 MGI: J:115864
Quirico-Santos T; Ribeiro MM; Savino W. 1995. Increased deposition of extracellular matrix components in the thymus gland of MDX mouse: correlation with the muscular lesion. J Neuroimmunol 59(1-2):9-18. PubMed: 7797624 MGI: J:28353
Radley-Crabb HG; Marini JC; Sosa HA; Castillo LI; Grounds MD; Fiorotto ML. 2014. Dystropathology increases energy expenditure and protein turnover in the mdx mouse model of duchenne muscular dystrophy. PLoS One 9(2):e89277. PubMed: 24586653 MGI: J:213836
Rae C; Griffin JL; Blair DH; Bothwell JH; Bubb WA; Maitland A; Head S. 2002. Abnormalities in brain biochemistry associated with lack of dystrophin: studies of the mdx mouse. Neuromuscul Disord 12(2):121-9. PubMed: 11738353 MGI: J:102988
Rafael JA; Cox GA; Corrado K; Jung D; Campbell KP; Chamberlain JS. 1996. Forced expression of dystrophin deletion constructs reveals structure-function correlations. J Cell Biol 134(1):93-102. PubMed: 8698825 MGI: J:34069
Rafael JA; Nitta Y; Peters J; Davies KE. 2000. Testing of SHIRPA, a mouse phenotypic assessment protocol, on Dmd(mdx) and Dmd(mdx3cv) dystrophin-deficient mice. Mamm Genome 11(9):725-8. PubMed: 10967129 MGI: J:64319
Rafael JA; Sunada Y; Cole NM; Campbell KP; Faulkner JA; Chamberlain JS. 1994. Prevention of dystrophic pathology in mdx mice by a truncated dystrophin isoform. Hum Mol Genet 3(10):1725-33. PubMed: 7849695 MGI: J:20979
Rafael JA; Tinsley JM; Potter AC; Deconinck AE; Davies KE. 1998. Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice. Nat Genet 19(1):79-82. PubMed: 9590295 MGI: J:47311
Ragusa RJ; Chow CK; St. Clair DK; Porter JD. 1996. Extraocular, limb and diaphragm muscle group-specific antioxidant enzyme activity patterns in control and mdx mice. J Neurol Sci 139(2):180-6. PubMed: 8856650 MGI: J:34574
Ramachandran J; Schneider JS; Crassous PA; Zheng R; Gonzalez JP; Xie LH; Beuve A; Fraidenraich D; Peluffo RD. 2013. Nitric oxide signalling pathway in Duchenne muscular dystrophy mice: up-regulation of L-arginine transporters. Biochem J 449(1):133-42. PubMed: 23009292 MGI: J:192880
Ramaswamy KS; Palmer ML; van der Meulen JH; Renoux A; Kostrominova TY; Michele DE; Faulkner JA. 2011. Lateral transmission of force is impaired in skeletal muscles of dystrophic mice and very old rats. J Physiol 589(Pt 5):1195-208. PubMed: 21224224 MGI: J:183137
Randolph ME; Phillips BL; Choo HJ; Vest KE; Vera Y; Pavlath GK. 2015. Pharyngeal Satellite Cells Undergo Myogenesis Under Basal Conditions and Are Required for Pharyngeal Muscle Maintenance. Stem Cells 33(12):3581-95. PubMed: 26178867 MGI: J:228838
Rawat R; Cohen TV; Ampong B; Francia D; Henriques-Pons A; Hoffman EP; Nagaraju K. 2010. Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle. Am J Pathol 176(6):2891-900. PubMed: 20413686 MGI: J:161333
Rayagiri SS; Ranaldi D; Raven A; Mohamad Azhar NIF; Lefebvre O; Zammit PS; Borycki AG. 2018. Basal lamina remodeling at the skeletal muscle stem cell niche mediates stem cell self-renewal. Nat Commun 9(1):1075. PubMed: 29540680 MGI: J:260747
Raymackers JM; Debaix H; Colson-Van Schoor M; De Backer F; Tajeddine N; Schwaller B; Gailly P; Gillis JM. 2003. Consequence of parvalbumin deficiency in the mdx mouse: histological, biochemical and mechanical phenotype of a new double mutant. Neuromuscul Disord 13(5):376-87. PubMed: 12798793 MGI: J:102770
Reano S; Angelino E; Ferrara M; Malacarne V; Sustova H; Sabry O; Agosti E; Clerici S; Ruozi G; Zentilin L; Prodam F; Geuna S; Giacca M; Graziani A; Filigheddu N. 2017. Unacylated Ghrelin Enhances Satellite Cell Function and Relieves the Dystrophic Phenotype in Duchenne Muscular Dystrophy mdx Model. Stem Cells 35(7):1733-1746. PubMed: 28436144 MGI: J:253498
Reay DP; Yang M; Watchko JF; Daood M; O'Day TL; Rehman KK; Guttridge DC; Robbins PD; Clemens PR. 2011. Systemic delivery of NEMO binding domain/IKKgamma inhibitory peptide to young mdx mice improves dystrophic skeletal muscle histopathology. Neurobiol Dis :. PubMed: 21624467 MGI: J:173320
Rebolledo DL; Kim MJ; Whitehead NP; Adams ME; Froehner SC. 2016. Sarcolemmal targeting of nNOSmu improves contractile function of mdx muscle. Hum Mol Genet 25(1):158-66. PubMed: 26604149 MGI: J:227695
Reed P; Bloch RJ. 2005. Postnatal changes in sarcolemmal organization in the mdx mouse. Neuromuscul Disord 15(8):552-61. PubMed: 16051092 MGI: J:103939
Reeve JL; McArdle A; Jackson MJ. 1997. Age-related changes in muscle calcium content in dystrophin-deficient mdx mice. Muscle Nerve 20(3):357-60. PubMed: 9052816 MGI: J:116434
Reimann J; Irintchev A; Wernig A. 2000. Regenerative capacity and the number of satellite cells in soleus muscles of normal and mdx mice. Neuromuscul Disord 10(4-5):276-82. PubMed: 10838255 MGI: J:103095
Remmelink E; Aartsma-Rus A; Smit AB; Verhage M; Loos M; van Putten M. 2016. Cognitive flexibility deficits in a mouse model for the absence of full-length dystrophin. Genes Brain Behav 15(6):558-67. PubMed: 27220066 MGI: J:242942
Rezniczek GA; Konieczny P; Nikolic B; Reipert S; Schneller D; Abrahamsberg C; Davies KE; Winder SJ; Wiche G. 2007. Plectin 1f scaffolding at the sarcolemma of dystrophic (mdx) muscle fibers through multiple interactions with beta-dystroglycan. J Cell Biol 176(7):965-77. PubMed: 17389230 MGI: J:134710
Rhoads RP; Flann KL; Cardinal TR; Rathbone CR; Liu X; Allen RE. 2013. Satellite cells isolated from aged or dystrophic muscle exhibit a reduced capacity to promote angiogenesis in vitro. Biochem Biophys Res Commun 440(3):399-404. PubMed: 24070607 MGI: J:211416
Ribaux P; Bleicher F; Couble ML; Amsellem J; Cohen SA; Berthier C; Blaineau S. 2001. Voltage-gated sodium channel (SkM1) content in dystrophin-deficient muscle. Pflugers Arch 441(6):746-55. PubMed: 11316257 MGI: J:106474
Riquelme C; Acuna MJ; Torrejon J; Rebolledo D; Cabrera D; Santos RA; Brandan E. 2014. ACE2 is augmented in dystrophic skeletal muscle and plays a role in decreasing associated fibrosis. PLoS One 9(4):e93449. PubMed: 24695436 MGI: J:215035
Riquelme-Guzman C; Contreras O; Brandan E. 2018. Expression of CTGF/CCN2 in response to LPA is stimulated by fibrotic extracellular matrix via the integrin/FAK axis. Am J Physiol Cell Physiol 314(4):C415-C427. PubMed: 29351412 MGI: J:260648
Riuzzi F; Beccafico S; Sagheddu R; Chiappalupi S; Giambanco I; Bereshchenko O; Riccardi C; Sorci G; Donato R. 2017. Levels of S100B protein drive the reparative process in acute muscle injury and muscular dystrophy. Sci Rep 7(1):12537. PubMed: 28970581 MGI: J:256510
Roberts TC; Johansson HJ; McClorey G; Godfrey C; Blomberg KE; Coursindel T; Gait MJ; Smith CI; Lehtio J; El Andaloussi S; Wood MJ. 2015. Multi-level omics analysis in a murine model of dystrophin loss and therapeutic restoration. Hum Mol Genet 24(23):6756-68. PubMed: 26385637 MGI: J:226482
Roder IV; Strack S; Reischl M; Dahley O; Khan MM; Kassel O; Zaccolo M; Rudolf R. 2012. Participation of myosin Va and Pka type I in the regeneration of neuromuscular junctions. PLoS One 7(7):e40860. PubMed: 22815846 MGI: J:189610
Rodino-Klapac LR; Janssen PM; Shontz KM; Canan B; Montgomery CL; Griffin D; Heller K; Schmelzer L; Handy C; Clark KR; Sahenk Z; Mendell JR; Kaspar BK. 2013. Micro-dystrophin and follistatin co-delivery restores muscle function in aged DMD model. Hum Mol Genet 22(24):4929-37. PubMed: 23863459 MGI: J:203139
Rooney JE; Gurpur PB; Burkin DJ. 2009. Laminin-111 protein therapy prevents muscle disease in the mdx mouse model for Duchenne muscular dystrophy. Proc Natl Acad Sci U S A 106(19):7991-6. PubMed: 19416897 MGI: J:148396
Rooney JE; Welser JV; Dechert MA; Flintoff-Dye NL; Kaufman SJ; Burkin DJ. 2006. Severe muscular dystrophy in mice that lack dystrophin and alpha7 integrin. J Cell Sci 119(Pt 11):2185-95. PubMed: 16684813 MGI: J:110358
Rouger K; Le Cunff M; Steenman M; Potier MC; Gibelin N; Dechesne CA; Leger JJ. 2002. Global/temporal gene expression in diaphragm and hindlimb muscles of dystrophin-deficient (mdx) mice. Am J Physiol Cell Physiol 283(3):C773-84. PubMed: 12176734 MGI: J:107769
Rouillon J; Poupiot J; Zocevic A; Amor F; Leger T; Garcia C; Camadro JM; Wong B; Pinilla R; Cosette J; Coenen-Stass AM; Mcclorey G; Roberts TC; Wood MJ; Servais L; Udd B; Voit T; Richard I; Svinartchouk F. 2015. Serum proteomic profiling reveals fragments of MYOM3 as potential biomarkers for monitoring the outcome of therapeutic interventions in muscular dystrophies. Hum Mol Genet 24(17):4916-32. PubMed: 26060189 MGI: J:224761
Rucci N; Capulli M; Piperni SG; Cappariello A; Lau P; Frings-Meuthen P; Heer M; Teti A. 2015. Lipocalin 2: a new mechanoresponding gene regulating bone homeostasis. J Bone Miner Res 30(2):357-68. PubMed: 25112732 MGI: J:233371
Rufo A; Del Fattore A; Capulli M; Carvello F; De Pasquale L; Ferrari S; Pierroz D; Morandi L; De Simone M; Rucci N; Bertini E; Bianchi ML; De Benedetti F; Teti A. 2011. Mechanisms inducing low bone density in Duchenne muscular dystrophy in mice and humans. J Bone Miner Res 26(8):1891-903. PubMed: 21509823 MGI: J:184354
Rybalka E; Timpani CA; Cooke MB; Williams AD; Hayes A. 2014. Defects in mitochondrial ATP synthesis in dystrophin-deficient mdx skeletal muscles may be caused by complex I insufficiency. PLoS One 9(12):e115763. PubMed: 25541951 MGI: J:225383
Sacco A; Mourkioti F; Tran R; Choi J; Llewellyn M; Kraft P; Shkreli M; Delp S; Pomerantz JH; Artandi SE; Blau HM. 2010. Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx/mTR mice. Cell 143(7):1059-71. PubMed: 21145579 MGI: J:167294
Saccone V; Consalvi S; Giordani L; Mozzetta C; Barozzi I; Sandona M; Ryan T; Rojas-Munoz A; Madaro L; Fasanaro P; Borsellino G; De Bardi M; Frige G; Termanini A; Sun X; Rossant J; Bruneau BG; Mercola M; Minucci S; Puri PL. 2014. HDAC-regulated myomiRs control BAF60 variant exchange and direct the functional phenotype of fibro-adipogenic progenitors in dystrophic muscles. Genes Dev 28(8):841-57. PubMed: 24682306 MGI: J:209577
Saha M; Mitsuhashi S; Jones MD; Manko K; Reddy HM; Bruels C; Cho KA; Pacak CA; Draper I; Kang PB. 2017. Consequences of MEGF10 deficiency on myoblast function and Notch1 interactions. Hum Mol Genet :. PubMed: 28498977 MGI: J:241496
Sakamoto M; Yuasa K; Yoshimura M; Yokota T; Ikemoto T; Suzuki M; Dickson G; Miyagoe-Suzuki Y; Takeda S. 2002. Micro-dystrophin cDNA ameliorates dystrophic phenotypes when introduced into mdx mice as a transgene. Biochem Biophys Res Commun 293(4):1265-72. PubMed: 12054513 MGI: J:76949
Sali A; Many GM; Gordish-Dressman H; van der Meulen JH; Phadke A; Spurney CF; Cnaan A; Hoffman EP; Nagaraju K. 2013. The proton pump inhibitor lansoprazole improves the skeletal phenotype in dystrophin deficient mdx mice. PLoS One 8(7):e66617. PubMed: 23843959 MGI: J:204312
Salimena MC; Lagrota-Candido J; Quirico-Santos T. 2004. Gender dimorphism influences extracellular matrix expression and regeneration of muscular tissue in mdx dystrophic mice. Histochem Cell Biol 122(5):435-44. PubMed: 15452719 MGI: J:108178
Sandri M; Massimino ML; Cantini M; Giurisato E; Sandri C; Arslan P; Carraro U. 1998. Dystrophin deficient myotubes undergo apoptosis in mouse primary muscle cell culture after DNA damage. Neurosci Lett 252(2):123-6. PubMed: 9756337 MGI: J:51579
Sandri M; Podhorska-Okolow M; Geromel V; Rizzi C; Arslan P; Franceschi C; Carraro U. 1997. Exercise induces myonuclear ubiquitination and apoptosis in dystrophin-deficient muscle of mice. J Neuropathol Exp Neurol 56(1):45-57. PubMed: 8990128 MGI: J:38431
Sanford JL; Edwards JD; Mays TA; Gong B; Merriam AP; Rafael-Fortney JA. 2005. Claudin-5 localizes to the lateral membranes of cardiomyocytes and is altered in utrophin/dystrophin-deficient cardiomyopathic mice. J Mol Cell Cardiol 38(2):323-32. PubMed: 15698839 MGI: J:101912
Santo Neto H; Martins AJ; Minatel E; Marques MJ. 2003. Axonal sprouting in mdx mice and its relevance to cell and gene mediated therapies for Duchenne muscular dystrophy. Neurosci Lett 343(1):67-9. PubMed: 12749999 MGI: J:107959
Sawada H; Kikukawa Y; Ban S; Kakudo T; Yokosawa H. 2004. Expression of trypsin-like proteases and protease nexin-1 in mdx mouse muscles. Biochem Biophys Res Commun 314(2):654-8. PubMed: 14733957 MGI: J:113601
Sbriccoli A; Santarelli M; Carretta D; Pinto F; Granato A; Minciacchi D. 1995. Architectural changes of the cortico-spinal system in the dystrophin defective mdx mouse. Neurosci Lett 200(1):53-6. PubMed: 8584266 MGI: J:32173
Schafer R; Zweyer M; Knauf U; Mundegar RR; Wernig A. 2005. The ontogeny of soleus muscles in mdx and wild type mice. Neuromuscul Disord 15(1):57-64. PubMed: 15639122 MGI: J:101871
Schertzer JD; Gehrig SM; Ryall JG; Lynch GS. 2007. Modulation of insulin-like growth factor (IGF)-I and IGF-binding protein interactions enhances skeletal muscle regeneration and ameliorates the dystrophic pathology in mdx mice. Am J Pathol 171(4):1180-8. PubMed: 17823291 MGI: J:125517
Schertzer JD; van der Poel C; Shavlakadze T; Grounds MD; Lynch GS. 2008. Muscle-specific overexpression of IGF-I improves E-C coupling in skeletal muscle fibers from dystrophic mdx mice. Am J Physiol Cell Physiol 294(1):C161-8. PubMed: 17989207 MGI: J:130508
Schofield JN; Gorecki DC; Blake DJ; Davies K; Edwards YH. 1995. Dystroglycan mRNA expression during normal and mdx mouse embryogenesis: a comparison with utrophin and the apo-dystrophins. Dev Dyn 204(2):178-85. PubMed: 8589441 MGI: J:29265
Sedehizade F; Klocke R; Jockusch H. 1997. Expression of nerve-regulated genes in muscles of mouse mutants affected by spinal muscular atrophies and muscular dystrophies. Muscle Nerve 20(2):186-94. PubMed: 9040657 MGI: J:53205
Selbert S; Fischer P; Menke A; Jockusch H; Pongratz D; Noegel AA. 1996. Annexin VII relocalization as a result of dystrophin deficiency. Exp Cell Res 222(1):199-208. PubMed: 8549664 MGI: J:30883
Selsby JT; Ballmann CG; Spaulding HR; Ross JW; Quindry JC. 2016. Oral quercetin administration transiently protects respiratory function in dystrophin-deficient mice. J Physiol 594(20):6037-6053. PubMed: 27094343 MGI: J:260650
Selsby JT; Morine KJ; Pendrak K; Barton ER; Sweeney HL. 2012. Rescue of dystrophic skeletal muscle by PGC-1alpha involves a fast to slow fiber type shift in the mdx mouse. PLoS One 7(1):e30063. PubMed: 22253880 MGI: J:184310
Seo K; Rainer PP; Lee DI; Hao S; Bedja D; Birnbaumer L; Cingolani OH; Kass DA. 2014. Hyperactive adverse mechanical stress responses in dystrophic heart are coupled to transient receptor potential canonical 6 and blocked by cGMP-protein kinase G modulation. Circ Res 114(5):823-32. PubMed: 24449818 MGI: J:246152
Shao W; Chen X; Samulski RJ; Hirsch ML; Li C. 2018. Inhibition of antigen presentation during AAV gene therapy using virus peptides. Hum Mol Genet 27(4):601-613. PubMed: 29272432 MGI: J:257003
Sharma P; Basu S; Mitchell RW; Stelmack GL; Anderson JE; Halayko AJ. 2014. Role of dystrophin in airway smooth muscle phenotype, contraction and lung function. PLoS One 9(7):e102737. PubMed: 25054970 MGI: J:219008
Shavlakadze T; Boswell JM; Burt DW; Asante EA; Tomas FM; Davies MJ; White JD; Grounds MD; Goddard C. 2006. Rskalpha-actin/hIGF-1 transgenic mice with increased IGF-I in skeletal muscle and blood: impact on regeneration, denervation and muscular dystrophy. Growth Horm IGF Res 16(3):157-73. PubMed: 16716629 MGI: J:128230
Shavlakadze T; Chai J; Maley K; Cozens G; Grounds G; Winn N; Rosenthal N; Grounds MD. 2010. A growth stimulus is needed for IGF-1 to induce skeletal muscle hypertrophy in vivo. J Cell Sci 123(Pt 6):960-71. PubMed: 20179101 MGI: J:158766
Shi H; Boadu E; Mercan F; Le AM; Flach RJ; Zhang L; Tyner KJ; Olwin BB; Bennett AM. 2010. MAP kinase phosphatase-1 deficiency impairs skeletal muscle regeneration and exacerbates muscular dystrophy. FASEB J 24(8):2985-97. PubMed: 20371627 MGI: J:162340
Shi H; Verma M; Zhang L; Dong C; Flavell RA; Bennett AM. 2013. Improved regenerative myogenesis and muscular dystrophy in mice lacking Mkp5. J Clin Invest 123(5):2064-77. PubMed: 23543058 MGI: J:201351
Shiao T; Fond A; Deng B; Wehling-Henricks M; Adams ME; Froehner SC; Tidball JG. 2004. Defects in neuromuscular junction structure in dystrophic muscle are corrected by expression of a NOS transgene in dystrophin-deficient muscles, but not in muscles lacking {alpha}- and {beta}1-syntrophins. Hum Mol Genet 13(17):1873-1884. PubMed: 15238508 MGI: J:92094
Shiba N; Miyazaki D; Yoshizawa T; Fukushima K; Shiba Y; Inaba Y; Imamura M; Takeda S; Koike K; Nakamura A. 2015. Differential roles of MMP-9 in early and late stages of dystrophic muscles in a mouse model of Duchenne muscular dystrophy. Biochim Biophys Acta 1852(10 Pt A):2170-82. PubMed: 26170062 MGI: J:231193
Shibuya S; Wakayama Y; Inoue M; Oniki H; Kominami E. 2002. Changes in the distribution and density of caveolin 3 molecules at the plasma membrane of mdx mouse skeletal muscles: a fracture-label electron microscopic study. Neurosci Lett 325(3):171-4. PubMed: 12044648 MGI: J:108032
Shin JH; Hakim CH; Zhang K; Duan D. 2011. Genotyping mdx, mdx3cv, and mdx4cv mice by primer competition polymerase chain reaction. Muscle Nerve 43(2):283-6. PubMed: 21254096 MGI: J:169288
Shrager JB; Naji A; Kelly AM; Stedman HH. 1992. A PCR-based assay for the wild-type dystrophin gene transferred into the mdx mouse. Muscle Nerve 15(10):1133-7. PubMed: 1357549 MGI: J:22170
Sicinski P; Geng Y; Ryder-Cook AS; Barnard EA; Darlison MG; Barnard PJ. 1989. The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 244(4912):1578-80. PubMed: 2662404 MGI: J:9866
Sillitoe RV; Benson MA; Blake DJ; Hawkes R. 2003. Abnormal dysbindin expression in cerebellar mossy fiber synapses in the mdx mouse model of Duchenne muscular dystrophy. J Neurosci 23(16):6576-85. PubMed: 12878699 MGI: J:84703
Simoes GF; de Oliveira AL. 2012. Granulocyte-colony stimulating factor improves MDX mouse response to peripheral nerve injury. PLoS One 7(8):e42803. PubMed: 22912741 MGI: J:189980
Sinha M; Jang YC; Oh J; Khong D; Wu EY; Manohar R; Miller C; Regalado SG; Loffredo FS; Pancoast JR; Hirshman MF; Lebowitz J; Shadrach JL; Cerletti M; Kim MJ; Serwold T; Goodyear LJ; Rosner B; Lee RT; Wagers AJ. 2014. Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle. Science 344(6184):649-52. PubMed: 24797481 MGI: J:211283
Skrabek RQ; Anderson JE. 2001. Metabolic shifts and myocyte hypertrophy in deflazacort treatment of mdx mouse cardiomyopathy. Muscle Nerve 24(2):192-202. PubMed: 11180202 MGI: J:116202
Smith J; Fowkes G; Schofield PN. 1995. Programmed cell death in dystrophic (mdx) muscle is inhibited by IGF-II. Cell Death Differ 2(4):243-251. PubMed: 17180029 MGI: J:30276
Smith J; Goldsmith C; Ward A; LeDieu R. 2000. IGF-II ameliorates the dystrophic phenotype and coordinately down-regulates programmed cell death. Cell Death Differ 7(11):1109-18. PubMed: 11139285 MGI: J:114190
Smith J; Schofield PN. 1994. The effects of fibroblast growth factors in long-term primary culture of dystrophic (mdx) mouse muscle myoblasts. Exp Cell Res 210(1):86-93. PubMed: 8270001 MGI: J:16311
Smith LR; Barton ER. 2014. Collagen content does not alter the passive mechanical properties of fibrotic skeletal muscle in mdx mice. Am J Physiol Cell Physiol 306(10):C889-98. PubMed: 24598364 MGI: J:211001
Smythe GM; Fan Y; Grounds MD. 2000. Enhanced migration and fusion of donor myoblasts in dystrophic and normal host muscle. Muscle Nerve 23(4):560-74. PubMed: 10716768 MGI: J:116193
Sohn J; Lu A; Tang Y; Wang B; Huard J. 2015. Activation of non-myogenic mesenchymal stem cells during the disease progression in dystrophic dystrophin/utrophin knockout mice. Hum Mol Genet 24(13):3814-29. PubMed: 25859011 MGI: J:223346
Sonnemann KJ; Heun-Johnson H; Turner AJ; Baltgalvis KA; Lowe DA; Ervasti JM. 2009. Functional substitution by TAT-utrophin in dystrophin-deficient mice. PLoS Med 6(5):e1000083. PubMed: 19478831 MGI: J:207592
Souccar C; Goncalo Mdo C; Buck Hde S; Lima-Landman MT; Lapa AJ. 2005. Mild dystrophic damage in the androgen-sensitive levator ani muscle of the mdx mouse. Neuromuscul Disord 15(1):48-56. PubMed: 15639121 MGI: J:101885
Southard S; Kim JR; Low S; Tsika RW; Lepper C. 2016. Myofiber-specific TEAD1 overexpression drives satellite cell hyperplasia and counters pathological effects of dystrophin deficiency. Elife 5:. PubMed: 27725085 MGI: J:238753
Spaulding HR; Ballmann CG; Quindry JC; Selsby JT. 2016. Long-Term Quercetin Dietary Enrichment Partially Protects Dystrophic Skeletal Muscle. PLoS One 11(12):e0168293. PubMed: 27977770 MGI: J:254218
Spector I; Zilberstein Y; Lavy A; Genin O; Barzilai-Tutsch H; Bodanovsky A; Halevy O; Pines M. 2013. The involvement of collagen triple helix repeat containing 1 in muscular dystrophies. Am J Pathol 182(3):905-16. PubMed: 23274062 MGI: J:193271
Spencer MJ; Marino MW; Winckler WM. 2000. Altered pathological progression of diaphragm and quadriceps muscle in TNF-deficient, dystrophin-deficient mice. Neuromuscul Disord 10(8):612-9. PubMed: 11053690 MGI: J:103113
Spencer MJ; Mellgren RL. 2002. Overexpression of a calpastatin transgene in mdx muscle reduces dystrophic pathology. Hum Mol Genet 11(21):2645-55. PubMed: 12354790 MGI: J:118408
Spencer MJ; Tidball JG. 1996. Calpain translocation during muscle fiber necrosis and regeneration in dystrophin-deficient mice. Exp Cell Res 226(2):264-72. PubMed: 8806430 MGI: J:34594
Spinazzola JM; Smith TC; Liu M; Luna EJ; Barton ER. 2015. Gamma-sarcoglycan is required for the response of archvillin to mechanical stimulation in skeletal muscle. Hum Mol Genet 24(9):2470-81. PubMed: 25605665 MGI: J:220869
Spitali P; Grumati P; Hiller M; Chrisam M; Aartsma-Rus A; Bonaldo P. 2013. Autophagy is Impaired in the Tibialis Anterior of Dystrophin Null Mice. PLoS Curr 5(None):None. PubMed: 24292657 MGI: J:260653
Spurney CF; Knoblach S; Pistilli EE; Nagaraju K; Martin GR; Hoffman EP. 2008. Dystrophin-deficient cardiomyopathy in mouse: expression of Nox4 and Lox are associated with fibrosis and altered functional parameters in the heart. Neuromuscul Disord 18(5):371-81. PubMed: 18440230 MGI: J:139789
Squire S; Raymackers JM; Vandebrouck C; Potter A; Tinsley J; Fisher R; Gillis JM; Davies KE. 2002. Prevention of pathology in mdx mice by expression of utrophin: analysis using an inducible transgenic expression system. Hum Mol Genet 11(26):3333-44. PubMed: 12471059 MGI: J:80809
Stapleton DI; Lau X; Flores M; Trieu J; Gehrig SM; Chee A; Naim T; Lynch GS; Koopman R. 2014. Dysfunctional muscle and liver glycogen metabolism in mdx dystrophic mice. PLoS One 9(3):e91514. PubMed: 24626262 MGI: J:215117
Stedman HH; Sweeney HL; Shrager JB; Maguire HC; Panettieri RA; Petrof B; Narusawa M; Leferovich JM; Sladky JT; Kelly AM. 1991. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 352(6335):536-9. PubMed: 1865908 MGI: J:152891
Stelter Z; Strakova J; Yellamilli A; Fischer K; Sharpe K; Townsend D. 2016. Hypoxia-induced cardiac injury in dystrophic mice. Am J Physiol Heart Circ Physiol 310(7):H938-48. PubMed: 26851247 MGI: J:232802
Stevens ED; Faulkner JA. 2000. The capacity of mdx mouse diaphragm muscle to do oscillatory work. J Physiol 522 Pt 3:457-66. PubMed: 10713969 MGI: J:106297
Stewart R; Flechner L; Montminy M; Berdeaux R. 2011. CREB is activated by muscle injury and promotes muscle regeneration. PLoS One 6(9):e24714. PubMed: 21931825 MGI: J:177923
Straub V; Rafael JA; Chamberlain JS; Campbell KP. 1997. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J Cell Biol 139(2):375-85. PubMed: 9334342 MGI: J:43676
Stuckey DJ; Carr CA; Camelliti P; Tyler DJ; Davies KE; Clarke K. 2012. In vivo MRI characterization of progressive cardiac dysfunction in the mdx mouse model of muscular dystrophy. PLoS One 7(1):e28569. PubMed: 22235247 MGI: J:184154
Stupka N; Michell BJ; Kemp BE; Lynch GS. 2006. Differential calcineurin signalling activity and regeneration efficacy in diaphragm and limb muscles of dystrophic mdx mice. Neuromuscul Disord 16(5):337-46. PubMed: 16621557 MGI: J:112803
Stupka N; Plant DR; Schertzer JD; Emerson TM; Bassel-Duby R; Olson EN; Lynch GS. 2006. Activated calcineurin ameliorates contraction-induced injury to skeletal muscles of mdx dystrophic mice. J Physiol 575(Pt 2):645-56. PubMed: 16793906 MGI: J:133049
Stupka N; Schertzer JD; Bassel-Duby R; Olson EN; Lynch GS. 2008. Stimulation of calcineurin A{alpha} activity attenuates muscle pathophysiology in mdx dystrophic mice. Am J Physiol Regul Integr Comp Physiol 294(3):R983-92. PubMed: 18199592 MGI: J:132018
Suelves M; Vidal B; Serrano AL; Tjwa M; Roma J; Lopez-Alemany R; Luttun A; de Lagran MM; Diaz-Ramos A; Jardi M; Roig M; Dierssen M; Dewerchin M; Carmeliet P; Munoz-Canoves P. 2007. uPA deficiency exacerbates muscular dystrophy in MDX mice. J Cell Biol 178(6):1039-51. PubMed: 17785520 MGI: J:134802
Sugimoto S; Takenaka H; Yamashita S; Matsukura S; Hamada M. 1990. Kinetic properties and isozyme composition of myosin in the mdx mutant mouse. J Neurol Sci 97(2-3):207-19. PubMed: 2144875 MGI: J:152750
Suh JG; Yamazaki A; Tomita T. 1994. Breeding of the gad-mdx mouse: influence of genetically induced denervation on dystrophic muscle fibers. Lab Anim Sci 44(1):42-6. PubMed: 8007658 MGI: J:28545
Tabebordbar M; Zhu K; Cheng JK; Chew WL; Widrick JJ; Yan WX; Maesner C; Wu EY; Xiao R; Ran FA; Cong L; Zhang F; Vandenberghe LH; Church GM; Wagers AJ. 2016. In vivo gene editing in dystrophic mouse muscle and muscle stem cells. Science 351(6271):407-11. PubMed: 26721686 MGI: J:229477
Takagi A; Kojima S; Ida M; Araki M. 1992. Increased leakage of calcium ion from the sarcoplasmic reticulum of the mdx mouse. J Neurol Sci 110(1-2):160-4. PubMed: 1506855 MGI: J:1413
Tamaki T; Sekine T; Akatsuka A; Uchiyama S; Nakano S. 1993. Three-dimensional cytoarchitecture of complex branched fibers in soleus muscle from mdx mutant mice. Anat Rec 237(3):338-44. PubMed: 8291687 MGI: J:15295
Tamma R; Annese T; Capogrosso RF; Cozzoli A; Benagiano V; Sblendorio V; Ruggieri S; Crivellato E; Specchia G; Ribatti D; De Luca A; Nico B. 2013. Effects of prednisolone on the dystrophin-associated proteins in the blood-brain barrier and skeletal muscle of dystrophic mdx mice. Lab Invest 93(5):592-610. PubMed: 23528847 MGI: J:196197
Tan N; Lansman JB. 2014. Utrophin regulates modal gating of mechanosensitive ion channels in dystrophic skeletal muscle. J Physiol 592(15):3303-23. PubMed: 24879867 MGI: J:243942
Tanabe Y; Esaki K; Nomura T. 1986. Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse. Acta Neuropathol (Berl) 69(1-2):91-5. PubMed: 3962599 MGI: J:8256
Tebebi PA; Burks SR; Kim SJ; Williams RA; Nguyen BA; Venkatesh P; Frenkel V; Frank JA. 2015. Cyclooxygenase-2 or tumor necrosis factor-alpha inhibitors attenuate the mechanotransductive effects of pulsed focused ultrasound to suppress mesenchymal stromal cell homing to healthy and dystrophic muscle. Stem Cells 33(4):1173-86. PubMed: 25534849 MGI: J:224044
Teichmann MD; Wegner FV; Fink RH; Chamberlain JS; Launikonis BS; Martinac B; Friedrich O. 2008. Inhibitory control over Ca(2+) sparks via mechanosensitive channels is disrupted in dystrophin deficient muscle but restored by mini-dystrophin expression. PLoS One 3(11):e3644. PubMed: 18982068 MGI: J:143913
Terada M; Kawano F; Ohira T; Nakai N; Nishimoto N; Ohira Y. 2012. Effects of mechanical over-loading on the properties of soleus muscle fibers, with or without damage, in wild type and mdx mice. PLoS One 7(4):e34557. PubMed: 22523551 MGI: J:187212
Terrill JR; Pinniger GJ; Nair KV; Grounds MD; Arthur PG. 2017. Beneficial effects of high dose taurine treatment in juvenile dystrophic mdx mice are offset by growth restriction. PLoS One 12(11):e0187317. PubMed: 29095865 MGI: J:257200
Thomas GD; Ye J; De Nardi C; Monopoli A; Ongini E; Victor RG. 2012. Treatment with a nitric oxide-donating NSAID alleviates functional muscle ischemia in the mouse model of Duchenne muscular dystrophy. PLoS One 7(11):e49350. PubMed: 23139842 MGI: J:195358
Tidball JG; Albrecht DE; Lokensgard BE; Spencer MJ. 1995. Apoptosis precedes necrosis of dystrophin-deficient muscle. J Cell Sci 108(Pt 6):2197-204. PubMed: 7673339 MGI: J:26255
Tidball JG; Wehling-Henricks M. 2004. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins. Mol Genet Metab 82(4):312-20. PubMed: 15308129 MGI: J:94166
Tierney MT; Aydogdu T; Sala D; Malecova B; Gatto S; Puri PL; Latella L; Sacco A. 2014. STAT3 signaling controls satellite cell expansion and skeletal muscle repair. Nat Med 20(10):1182-6. PubMed: 25194572 MGI: J:227746
Tinsley J; Deconinck N; Fisher R; Kahn D; Phelps S; Gillis JM; Davies K. 1998. Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Nat Med 4(12):1441-4. PubMed: 9846586 MGI: J:51364
Tinsley JM; Potter AC; Phelps SR; Fisher R; Trickett JI; Davies KE. 1996. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene [see comments] Nature 384(6607):349-53. PubMed: 8934518 MGI: J:36822
Tjondrokoesoemo A; Schips T; Kanisicak O; Sargent MA; Molkentin JD. 2016. Genetic overexpression of Serpina3n attenuates muscular dystrophy in mice. Hum Mol Genet :. PubMed: 26744329 MGI: J:228636
Tjondrokoesoemo A; Schips TG; Sargent MA; Vanhoutte D; Kanisicak O; Prasad V; Lin SJ; Maillet M; Molkentin JD. 2016. Cathepsin S contributes to the pathogenesis of muscular dystrophy in mice. J Biol Chem :. PubMed: 26966179 MGI: J:230788
Tkatchenko AV; Le Cam G; Leger JJ; Dechesne CA. 2000. Large-scale analysis of differential gene expression in the hindlimb muscles and diaphragm of mdx mouse. Biochim Biophys Acta 1500(1):17-30. PubMed: 10564714 MGI: J:58586
Tohma H; Hepworth AR; Shavlakadze T; Grounds MD; Arthur PG. 2011. Quantification of ceroid and lipofuscin in skeletal muscle. J Histochem Cytochem 59(8):769-79. PubMed: 21804079 MGI: J:181062
Torrente Y; D'Angelo MG; Li Z; Del Bo R; Corti S; Mericskay M; DeLiso A; Fassati A; Paulin D; Comi GP; Scarlato G; Bresolin N. 2000. Transplacental injection of somite-derived cells in mdx mouse embryos for the correction of dystrophin deficiency Hum Mol Genet 9(12):1843-52. PubMed: 10915773 MGI: J:63753
Townsend D; Yasuda S; McNally E; Metzger JM. 2011. Distinct pathophysiological mechanisms of cardiomyopathy in hearts lacking dystrophin or the sarcoglycan complex. FASEB J 25(9):3106-14. PubMed: 21665956 MGI: J:175721
Tracey I; Dunn JF; Parkes HG; Radda GK. 1996. An in vivo and in vitro H-magnetic resonance spectroscopy study of mdx mouse brain: abnormal development or neural necrosis? J Neurol Sci 141(1-2):13-8. PubMed: 8880686 MGI: J:35421
Tracey I; Dunn JF; Radda GK. 1996. Brain metabolism is abnormal in the mdx model of Duchenne muscular dystrophy. Brain 119(Pt 3):1039-44. PubMed: 8673481 MGI: J:34730
Trensz F; Haroun S; Cloutier A; Richter MV; Grenier G. 2010. A muscle resident cell population promotes fibrosis in hindlimb skeletal muscles of mdx mice through the Wnt canonical pathway. Am J Physiol Cell Physiol 299(5):C939-47. PubMed: 20810909 MGI: J:165822
Trivedi RA; Dickson G. 1995. Liposome-mediated gene transfer into normal and dystrophin-deficient mouse myoblasts. J Neurochem 64(5):2230-8. PubMed: 7722508 MGI: J:24504
Turczynska KM; Sward K; Hien TT; Wohlfahrt J; Mattisson IY; Ekman M; Nilsson J; Sjogren J; Murugesan V; Hultgardh-Nilsson A; Cidad P; Hellstrand P; Perez-Garcia MT; Albinsson S. 2015. Regulation of smooth muscle dystrophin and synaptopodin 2 expression by actin polymerization and vascular injury. Arterioscler Thromb Vasc Biol 35(6):1489-97. PubMed: 25857312 MGI: J:241621
Turk R; Sterrenburg E; de Meijer EJ; van Ommen GJ; den Dunnen JT; 't Hoen PA. 2005. Muscle regeneration in dystrophin-deficient mdx mice studied by gene expression profiling. BMC Genomics 6:98. PubMed: 16011810 MGI: J:123873
Turk R; Sterrenburg E; van der Wees CG; de Meijer EJ; de Menezes RX; Groh S; Campbell KP; Noguchi S; van Ommen GJ; den Dunnen JT; 't Hoen PA. 2006. Common pathological mechanisms in mouse models for muscular dystrophies. FASEB J 20(1):127-9. PubMed: 16306063 MGI: J:104560
Turner PR; Fong PY; Denetclaw WF; Steinhardt RA. 1991. Increased calcium influx in dystrophic muscle. J Cell Biol 115(6):1701-12. PubMed: 1661733 MGI: J:1876
Turner PR; Schultz R; Ganguly B; Steinhardt RA. 1993. Proteolysis results in altered leak channel kinetics and elevated free calcium in mdx muscle. J Membr Biol 133(3):243-51. PubMed: 8392585 MGI: J:21447
Uchino M; Yoshioka K; Miike T; Tokunaga M; Uyama E; Teramoto H; Naoe H; Ando M. 1994. Dystrophin and dystrophin-related protein in the brains of normal and mdx mice. Muscle Nerve 17(5):533-8. PubMed: 8159184 MGI: J:19067
Ullrich ND; Fanchaouy M; Gusev K; Shirokova N; Niggli E. 2009. Hypersensitivity of excitation-contraction coupling in dystrophic cardiomyocytes. Am J Physiol Heart Circ Physiol 297(6):H1992-2003. PubMed: 19783774 MGI: J:158238
Umansky KB; Gruenbaum-Cohen Y; Tsoory M; Feldmesser E; Goldenberg D; Brenner O; Groner Y. 2015. Runx1 Transcription Factor Is Required for Myoblasts Proliferation during Muscle Regeneration. PLoS Genet 11(8):e1005457. PubMed: 26275053 MGI: J:228807
Vaghy PL; Fang J; Wu W; Vaghy LP. 1998. Increased caveolin-3 levels in mdx mouse muscles. FEBS Lett 431(1):125-7. PubMed: 9684879 MGI: J:48804
Vaillend C; Billard JM; Claudepierre T; Rendon A; Dutar P; Ungerer A. 1998. Spatial discrimination learning and CA1 hippocampal synaptic plasticity in mdx and mdx3cv mice lacking dystrophin gene products. Neuroscience 86(1):53-66. PubMed: 9692743 MGI: J:48768
Vaillend C; Billard JM; Laroche S. 2004. Impaired long-term spatial and recognition memory and enhanced CA1 hippocampal LTP in the dystrophin-deficient Dmd(mdx) mouse. Neurobiol Dis 17(1):10-20. PubMed: 15350961 MGI: J:92466
Vaillend C; Chaussenot R. 2017. Relationships linking emotional, motor, cognitive and GABAergic dysfunctions in dystrophin-deficient mdx mice. Hum Mol Genet 26(6):1041-1055. PubMed: 28087735 MGI: J:241668
Vaillend C; Rendon A; Misslin R; Ungerer A. 1995. Influence of dystrophin-gene mutation on mdx mouse behavior. I. Retention deficits at long delays in spontaneous alternation and bar-pressing tasks. Behav Genet 25(6):569-79. PubMed: 8540895 MGI: J:29805
Vaillend C; Ungerer A. 1999. Behavioral characterization of mdx3cv mice deficient in C-terminal dystrophins. Neuromuscul Disord 9(5):296-304. PubMed: 10407849 MGI: J:56477
Valladares D; Almarza G; Contreras A; Pavez M; Buvinic S; Jaimovich E; Casas M. 2013. Electrical stimuli are anti-apoptotic in skeletal muscle via extracellular ATP. Alteration of this signal in Mdx mice is a likely cause of dystrophy. PLoS One 8(11):e75340. PubMed: 24282497 MGI: J:209771
Vanhoutte D; Schips TG; Kwong JQ; Davis J; Tjondrokoesoemo A; Brody MJ; Sargent MA; Kanisicak O; Yi H; Gao QQ; Rabinowitz JE; Volk T; McNally EM; Molkentin JD. 2016. Thrombospondin expression in myofibers stabilizes muscle membranes. Elife 5:. PubMed: 27669143 MGI: J:238094
Vannucchi MG; Corsani L; Faussone-Pellegrini MS. 2003. Synaptic vesicle morphology and recycling are altered in myenteric neurons of mice lacking dystrophin (mdx mice). J Cell Physiol 197(2):232-42. PubMed: 14502563 MGI: J:85623
Vannucchi MG; Garella R; Cipriani G; Baccari MC. 2011. Relaxin counteracts the altered gastric motility of dystrophic (mdx) mice: functional and immunohistochemical evidence for the involvement of nitric oxide. Am J Physiol Endocrinol Metab 300(2):E380-91. PubMed: 21081707 MGI: J:172322
Vasquez I; Tan N; Boonyasampant M; Koppitch KA; Lansman JB. 2012. Partial opening and subconductance gating of mechanosensitive ion channels in dystrophic skeletal muscle. J Physiol 590(Pt 23):6167-85. PubMed: 22966155 MGI: J:203025
Veal EA; Jackson MJ. 1995. Expression of c-fos and c-myc in satellite cell cultures from dystrophic mdx and control mouse muscle. Biochem Soc Trans 23(3):456S. PubMed: 8566348 MGI: J:29286
Veal EA; Jackson MJ. 1995. Expression of the proto-oncogenes c-fos and c-myc in mdx dystrophic mouse muscle. Biochem Soc Trans 23(1):131S. PubMed: 7758695 MGI: J:23308
Veltrop M; van Vliet L; Hulsker M; Claassens J; Brouwers C; Breukel C; van der Kaa J; Linssen MM; den Dunnen JT; Verbeek S; Aartsma-Rus A; van Putten M. 2018. A dystrophic Duchenne mouse model for testing human antisense oligonucleotides. PLoS One 13(2):e0193289. PubMed: 29466448 MGI: J:257449
Vercherat C; Chung TK; Yalcin S; Gulbagci N; Gopinadhan S; Ghaffari S; Taneja R. 2009. Stra13 regulates oxidative stress mediated skeletal muscle degeneration. Hum Mol Genet 18(22):4304-16. PubMed: 19679564 MGI: J:153720
Vetrone SA; Montecino-Rodriguez E; Kudryashova E; Kramerova I; Hoffman EP; Liu SD; Miceli MC; Spencer MJ. 2009. Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta. J Clin Invest 119(6):1583-94. PubMed: 19451692 MGI: J:150572
Vianello S; Bouyon S; Benoit E; Sebrie C; Boerio D; Herbin M; Roulot M; Fromes Y; de la Porte S. 2014. Arginine butyrate per os protects mdx mice against cardiomyopathy, kyphosis and changes in axonal excitability. Neurobiol Dis 71:325-33. PubMed: 25167832 MGI: J:218459
Vidal B; Serrano AL; Tjwa M; Suelves M; Ardite E; De Mori R; Baeza-Raja B; Martinez de Lagran M; Lafuste P; Ruiz-Bonilla V; Jardi M; Gherardi R; Christov C; Dierssen M; Carmeliet P; Degen JL; Dewerchin M; Munoz-Canoves P. 2008. Fibrinogen drives dystrophic muscle fibrosis via a TGF{beta}/alternative macrophage activation pathway. Genes Dev 22(13):1747-52. PubMed: 18593877 MGI: J:137450
Villalta SA; Deng B; Rinaldi C; Wehling-Henricks M; Tidball JG. 2011. IFN-gamma promotes muscle damage in the mdx mouse model of Duchenne muscular dystrophy by suppressing M2 macrophage activation and inhibiting muscle cell proliferation. J Immunol 187(10):5419-28. PubMed: 22013114 MGI: J:179601
Villalta SA; Nguyen HX; Deng B; Gotoh T; Tidball JG. 2009. Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Hum Mol Genet 18(3):482-96. PubMed: 18996917 MGI: J:143545
Villalta SA; Rosenthal W; Martinez L; Kaur A; Sparwasser T; Tidball JG; Margeta M; Spencer MJ; Bluestone JA. 2014. Regulatory T cells suppress muscle inflammation and injury in muscular dystrophy. Sci Transl Med 6(258):258ra142. PubMed: 25320234 MGI: J:225777
Vilquin JT; Brussee V; Asselin I; Kinoshita I; Gingras M; Tremblay JP. 1998. Evidence of mdx mouse skeletal muscle fragility in vivo by eccentric running exercise. Muscle Nerve 21(5):567-76. PubMed: 9572235 MGI: J:117426
Viola HM; Adams AM; Davies SM; Fletcher S; Filipovska A; Hool LC. 2014. Impaired functional communication between the L-type calcium channel and mitochondria contributes to metabolic inhibition in the mdx heart. Proc Natl Acad Sci U S A 111(28):E2905-14. PubMed: 24969422 MGI: J:212163
Viola HM; Davies SM; Filipovska A; Hool LC. 2013. L-type Ca(2+) channel contributes to alterations in mitochondrial calcium handling in the mdx ventricular myocyte. Am J Physiol Heart Circ Physiol 304(6):H767-75. PubMed: 23335798 MGI: J:196422
Voit A; Patel V; Pachon R; Shah V; Bakhutma M; Kohlbrenner E; McArdle JJ; Dell'Italia LJ; Mendell JR; Xie LH; Hajjar RJ; Duan D; Fraidenraich D; Babu GJ. 2017. Reducing sarcolipin expression mitigates Duchenne muscular dystrophy and associated cardiomyopathy in mice. Nat Commun 8(1):1068. PubMed: 29051551 MGI: J:251091
Vulin A; Wein N; Simmons TR; Rutherford AM; Findlay AR; Yurkoski JA; Kaminoh Y; Flanigan KM. 2015. The first exon duplication mouse model of Duchenne muscular dystrophy: A tool for therapeutic development. Neuromuscul Disord 25(11):827-34. PubMed: 26365037 MGI: J:233298
Wagner KR; Liu X; Chang X; Allen RE. 2005. Muscle regeneration in the prolonged absence of myostatin. Proc Natl Acad Sci U S A 102(7):2519-24. PubMed: 15699335 MGI: J:96635
Wagner KR; McPherron AC; Winik N; Lee SJ. 2002. Loss of myostatin attenuates severity of muscular dystrophy in mdx mice. Ann Neurol 52(6):832-6. PubMed: 12447939 MGI: J:97521
Wakefield PM; Tinsley JM; Wood MJ; Gilbert R; Karpati G; Davies KE. 2000. Prevention of the dystrophic phenotype in dystrophin/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene. Gene Ther 7(3):201-4. PubMed: 10694796 MGI: J:61318
Wakeford S; Watt DJ; Partridge TA. 1991. X-irradiation improves mdx mouse muscle as a model of myofiber loss in DMD. Muscle Nerve 14(1):42-50. PubMed: 1992296 MGI: J:116018
Wang W; Landstrom AP; Wang Q; Munro ML; Beavers D; Ackerman MJ; Soeller C; Wehrens XH. 2014. Reduced junctional Na+/Ca2+-exchanger activity contributes to sarcoplasmic reticulum Ca2+ leak in junctophilin-2-deficient mice. Am J Physiol Heart Circ Physiol 307(9):H1317-26. PubMed: 25193470 MGI: J:218693
Wang X; Weisleder N; Collet C; Zhou J; Chu Y; Hirata Y; Zhao X; Pan Z; Brotto M; Cheng H; Ma J. 2005. Uncontrolled calcium sparks act as a dystrophic signal for mammalian skeletal muscle. Nat Cell Biol 7(5):525-30. PubMed: 15834406 MGI: J:105418
Wardrop KE; Dominov JA. 2011. Proinflammatory signals and the loss of lymphatic vessel hyaluronan receptor-1 (LYVE-1) in the early pathogenesis of laminin alpha2-deficient skeletal muscle. J Histochem Cytochem 59(2):167-79. PubMed: 20876525 MGI: J:170192
Wasala NB; Bostick B; Yue Y; Duan D. 2013. Exclusive skeletal muscle correction does not modulate dystrophic heart disease in the aged mdx model of Duchenne cardiomyopathy. Hum Mol Genet 22(13):2634-41. PubMed: 23459935 MGI: J:198236
Wasala NB; Lai Y; Shin JH; Zhao J; Yue Y; Duan D. 2016. Genomic removal of a therapeutic mini-dystrophin gene from adult mice elicits a Duchenne muscular dystrophy-like phenotype. Hum Mol Genet 25(13):2633-2644. PubMed: 27106099 MGI: J:236997
Wasala NB; Zhang K; Wasala LP; Hakim CH; Duan D. 2015. The FVB Background Does Not Dramatically Alter the Dystrophic Phenotype of Mdx Mice. PLoS Curr 7(None):None. PubMed: 25737807 MGI: J:221708
Watt DJ; Karasinski J; England MA. 1993. Migration of lacZ positive cells from the tibialis anterior to the extensor digitorum longus muscle of the X-linked muscular dystrophic (mdx) mouse. J Muscle Res Cell Motil 14(1):121-32. PubMed: 8478422 MGI: J:12646
Wehling M; Spencer MJ; Tidball JG. 2001. A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. J Cell Biol 155(1):123-31. PubMed: 11581289 MGI: J:71898
Wehling-Henricks M; Jordan MC; Gotoh T; Grody WW; Roos KP; Tidball JG. 2010. Arginine metabolism by macrophages promotes cardiac and muscle fibrosis in mdx muscular dystrophy. PLoS One 5(5):e10763. PubMed: 20505827 MGI: J:160818
Wehling-Henricks M; Jordan MC; Roos KP; Deng B; Tidball JG. 2005. Cardiomyopathy in dystrophin-deficient hearts is prevented by expression of a neuronal nitric oxide synthase transgene in the myocardium. Hum Mol Genet 14(14):1921-33. PubMed: 15917272 MGI: J:182128
Wehling-Henricks M; Li Z; Lindsey C; Wang Y; Welc SS; Ramos JN; Khanlou N; Kuro-O M; Tidball JG. 2016. Klotho gene silencing promotes pathology in the mdx mouse model of Duchenne muscular dystrophy. Hum Mol Genet 25(12):2465-2482. PubMed: 27154199 MGI: J:236987
Wehling-Henricks M; Oltmann M; Rinaldi C; Myung KH; Tidball JG. 2009. Loss of positive allosteric interactions between neuronal nitric oxide synthase and phosphofructokinase contributes to defects in glycolysis and increased fatigability in muscular dystrophy. Hum Mol Genet 18(18):3439-51. PubMed: 19542095 MGI: J:151716
Wehling-Henricks M; Sokolow S; Lee JJ; Myung KH; Villalta SA; Tidball JG. 2008. Major basic protein-1 promotes fibrosis of dystrophic muscle and attenuates the cellular immune response in muscular dystrophy. Hum Mol Genet 17(15):2280-92. PubMed: 18430716 MGI: J:137633
Wehling-Henricks M; Tidball JG. 2011. Neuronal nitric oxide synthase-rescue of dystrophin/utrophin double knockout mice does not require nNOS localization to the cell membrane. PLoS One 6(10):e25071. PubMed: 22003386 MGI: J:179610
Wehling-Henricks M; Welc SS; Samengo G; Rinaldi C; Lindsey C; Wang Y; Lee J; Kuro-O M; Tidball JG. 2017. Macrophages escape Klotho gene silencing in the mdx mouse model of Duchenne muscular dystrophy and promote muscle growth and increase satellite cell numbers through a Klotho-mediated pathway. Hum Mol Genet None(None):None. PubMed: 29040534 MGI: J:254312
Weisleder N; Takizawa N; Lin P; Wang X; Cao C; Zhang Y; Tan T; Ferrante C; Zhu H; Chen PJ; Yan R; Sterling M; Zhao X; Hwang M; Takeshima M; Cai C; Cheng H; Takeshima H; Xiao RP; Ma J. 2012. Recombinant MG53 protein modulates therapeutic cell membrane repair in treatment of muscular dystrophy. Sci Transl Med 4(139):139ra85. PubMed: 22723464 MGI: J:186705
Wells DJ; Wells KE; Asante EA; Turner G; Sunada Y; Campbell KP; Walsh FS; Dickson G. 1995. Expression of human full-length and minidystrophin in transgenic mdx mice: implications for gene therapy of Duchenne muscular dystrophy. Hum Mol Genet 4(8):1245-50. PubMed: 7581360 MGI: J:27472
Wells DJ; Wells KE; Walsh FS; Davies KE; Goldspink G; Love DR; Chan-Thomas P; Dunckley MG; Piper T; Dickson G. 1992. Human dystrophin expression corrects the myopathic phenotype in transgenic mdx mice. Hum Mol Genet 1(1):35-40. PubMed: 1301134 MGI: J:2092
Wewer UM; Iba K; Durkin ME; Nielsen FC; Loechel F; Gilpin BJ; Kuang W; Engvall E; Albrechtsen R. 1998. Tetranectin is a novel marker for myogenesis during embryonic development, muscle regeneration, and muscle cell differentiation in vitro. Dev Biol 200(2):247-59. PubMed: 9705231 MGI: J:49427
Wheeler TM; Leger AJ; Pandey SK; MacLeod AR; Nakamori M; Cheng SH; Wentworth BM; Bennett CF; Thornton CA. 2012. Targeting nuclear RNA for in vivo correction of myotonic dystrophy. Nature 488(7409):111-5. PubMed: 22859208 MGI: J:186768
Whitehead NP; Kim MJ; Bible KL; Adams ME; Froehner SC. 2015. A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy. Proc Natl Acad Sci U S A 112(41):12864-9. PubMed: 26417069 MGI: J:227067
Whitehead NP; Yeung EW; Froehner SC; Allen DG. 2010. Skeletal muscle NADPH oxidase is increased and triggers stretch-induced damage in the mdx mouse. PLoS One 5(12):e15354. PubMed: 21187957 MGI: J:168678
Wieneke S; Heimann P; Leibovitz S; Nudel U; Jockusch H. 2003. Acute pathophysiological effects of muscle-expressed Dp71 transgene on normal and dystrophic mouse muscle. J Appl Physiol 95(5):1861-6. PubMed: 14555666 MGI: J:103011
Wilding JR; Schneider JE; Sang AE; Davies KE; Neubauer S; Clarke K. 2005. Dystrophin- and MLP-deficient mouse hearts: marked differences in morphology and function, but similar accumulation of cytoskeletal proteins. FASEB J 19(1):79-81. PubMed: 15494447 MGI: J:105036
Williams DA; Head SI; Lynch GS; Stephenson DG. 1993. Contractile properties of skinned muscle fibres from young and adult normal and dystrophic (mdx) mice. J Physiol 460:51-67. PubMed: 8487206 MGI: J:17900
Williams IA; Allen DG. 2007. Intracellular calcium handling in ventricular myocytes from mdx mice. Am J Physiol Heart Circ Physiol 292(2):H846-55. PubMed: 17012353 MGI: J:120592
Williams IA; Allen DG. 2007. The role of reactive oxygen species in the hearts of dystrophin-deficient mdx mice. Am J Physiol Heart Circ Physiol 293(3):H1969-77. PubMed: 17573457 MGI: J:126149
Williams MW; Bloch RJ. 1999. Extensive but coordinated reorganization of the membrane skeleton in myofibers of dystrophic (mdx) mice. J Cell Biol 144(6):1259-70. PubMed: 10087268 MGI: J:54110
Wilton SD; Dye DE; Laing NG. 1997. Dystrophin gene transcripts skipping the mdx mutation. Muscle Nerve 20(6):728-34. PubMed: 9149080 MGI: J:40541
Wilton SD; Lloyd F; Carville K; Fletcher S; Honeyman K; Agrawal S; Kole R. 1999. Specific removal of the nonsense mutation from the mdx dystrophin mRNA using antisense oligonucleotides. Neuromuscul Disord 9(5):330-8. PubMed: 10407856 MGI: J:57356
Wineinger MA; Walsh SA; Abresch RT. 1998. The effect of age and temperature on mdx muscle fatigue. Muscle Nerve 21(8):1075-7. PubMed: 9655128 MGI: J:116332
Wissing ER; Boyer JG; Kwong JQ; Sargent MA; Karch J; McNally EM; Otsu K; Molkentin JD. 2014. P38alpha MAPK underlies muscular dystrophy and myofiber death through a Bax-dependent mechanism. Hum Mol Genet 23(20):5452-63. PubMed: 24876160 MGI: J:219250
Wong A; Garrett KL; Anderson JE. 1999. Myoid cell density in the thymus is reduced during mdx dystrophy and after muscle crush. Biochem Cell Biol 77(1):33-40. PubMed: 10426284 MGI: J:55875
Woo M; Tanabe Y; Ishii H; Nonaka I; Yokoyama M; Esaki K. 1987. Muscle fiber growth and necrosis in dystrophic muscles: a comparative study between dy and mdx mice. J Neurol Sci 82(1-3):111-22. PubMed: 3440862 MGI: J:152525
Woods CE; Novo D; DiFranco M; Vergara JL. 2004. The action potential-evoked sarcoplasmic reticulum calcium release is impaired in mdx mouse muscle fibres. J Physiol 557(Pt 1):59-75. PubMed: 15004213 MGI: J:105267
Woolf PJ; Lu S; Cornford-Nairn R; Watson M; Xiao XH; Holroyd SM; Brown L; Hoey AJ. 2006. Alterations in dihydropyridine receptors in dystrophin-deficient cardiac muscle. Am J Physiol Heart Circ Physiol 290(6):H2439-45. PubMed: 16415078 MGI: J:111846
Wu B; Benrashid E; Lu P; Cloer C; Zillmer A; Shaban M; Lu QL. 2011. Targeted skipping of human dystrophin exons in transgenic mouse model systemically for antisense drug development. PLoS One 6(5):e19906. PubMed: 21611204 MGI: J:172587
Wu B; Moulton HM; Iversen PL; Jiang J; Li J; Li J; Spurney CF; Sali A; Guerron AD; Nagaraju K; Doran T; Lu P; Xiao X; Lu QL. 2008. Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer. Proc Natl Acad Sci U S A 105(39):14814-9. PubMed: 18806224 MGI: J:142846
Wu R; Li H; Zhai L; Zou X; Meng J; Zhong R; Li C; Wang H; Zhang Y; Zhu D. 2015. MicroRNA-431 accelerates muscle regeneration and ameliorates muscular dystrophy by targeting Pax7 in mice. Nat Commun 6:7713. PubMed: 26151913 MGI: J:224368
Xie X; Tsai SY; Tsai MJ. 2016. COUP-TFII regulates satellite cell function and muscular dystrophy. J Clin Invest 126(10):3929-3941. PubMed: 27617862 MGI: J:237380
Xiong D; Lee GH; Badorff C; Dorner A; Lee S; Wolf P; Knowlton KU. 2002. Dystrophin deficiency markedly increases enterovirus-induced cardiomyopathy: a genetic predisposition to viral heart disease. Nat Med 8(8):872-7. PubMed: 12118246 MGI: J:78276
Xu R; Camboni M; Martin PT. 2007. Postnatal overexpression of the CT GalNAc transferase inhibits muscular dystrophy in mdx mice without altering muscle growth or neuromuscular development: evidence for a utrophin-independent mechanism. Neuromuscul Disord 17(3):209-20. PubMed: 17300937 MGI: J:124487
Xu R; Chandrasekharan K; Yoon JH; Camboni M; Martin PT. 2007. Overexpression of the cytotoxic T cell (CT) carbohydrate inhibits muscular dystrophy in the dyW mouse model of congenital muscular dystrophy 1A. Am J Pathol 171(1):181-99. PubMed: 17591965 MGI: J:122854
Xu R; DeVries S; Camboni M; Martin PT. 2009. Overexpression of Galgt2 reduces dystrophic pathology in the skeletal muscles of alpha sarcoglycan-deficient mice. Am J Pathol 175(1):235-47. PubMed: 19498002 MGI: J:150058
Xu R; Salpeter MM. 1997. Acetylcholine receptors in innervated muscles of dystrophic mdx mice degrade as after denervation. J Neurosci 17(21):8194-200. PubMed: 9334395 MGI: J:43694
Xu R; Singhal N; Serinagaoglu Y; Chandrasekharan K; Joshi M; Bauer JA; Janssen PM; Martin PT. 2015. Deletion of Galgt2 (B4Galnt2) Reduces Muscle Growth in Response to Acute Injury and Increases Muscle Inflammation and Pathology in Dystrophin-Deficient Mice. Am J Pathol 185(10):2668-84. PubMed: 26435413 MGI: J:227206
Yamane A; Akutsu S; Diekwisch TG; Matsuda R. 2005. Satellite cells and utrophin are not directly correlated with the degree of skeletal muscle damage in mdx mice. Am J Physiol Cell Physiol 289(1):C42-8. PubMed: 15703201 MGI: J:101256
Yang B; Ibraghimov-Beskrovnaya O; Moomaw CR; Slaughter CA; Campbell KP. 1994. Heterogeneity of the 59-kDa dystrophin-associated protein revealed by cDNA cloning and expression. J Biol Chem 269(8):6040-4. PubMed: 8119949 MGI: J:16941
Yang L; Niu H; Gao X; Wang Q; Han G; Cao L; Cai C; Weiler J; Yin H. 2013. Effective exon skipping and dystrophin restoration by 2'-o-methoxyethyl antisense oligonucleotide in dystrophin-deficient mice. PLoS One 8(4):e61584. PubMed: 23658612 MGI: J:200540
Yang Q; Li Y; Zhang X; Chen D. 2018. Zac1/GPR39 phosphorylating CaMK-II contributes to the distinct roles of Pax3 and Pax7 in myogenic progression. Biochim Biophys Acta 1864(2):407-419. PubMed: 29079520 MGI: J:257542
Yeung D; Kharidia R; Brown SC; Gorecki DC. 2004. Enhanced expression of the P2X4 receptor in Duchenne muscular dystrophy correlates with macrophage invasion. Neurobiol Dis 15(2):212-20. PubMed: 15006691 MGI: J:121035
Yokota T; Lu QL; Morgan JE; Davies KE; Fisher R; Takeda S; Partridge TA. 2006. Expansion of revertant fibers in dystrophic mdx muscles reflects activity of muscle precursor cells and serves as an index of muscle regeneration. J Cell Sci 119(Pt 13):2679-87. PubMed: 16757519 MGI: J:110347
Yoshida M; Matsuzaki T; Date M; Wada K. 1997. Skeletal muscle fiber degeneration in mdx mice induced by electrical stimulation. Muscle Nerve 20(11):1422-32. PubMed: 9342159 MGI: J:116432
Yoshida M; Yonetani A; Shirasaki T; Wada K. 2006. Dietary NaCl supplementation prevents muscle necrosis in a mouse model of Duchenne muscular dystrophy. Am J Physiol Regul Integr Comp Physiol 290(2):R449-55. PubMed: 16179484 MGI: J:115746
Yoshihara Y; Onodera H; Iinuma K; itoyama Y. 2003. Abnormal kainic acid receptor density and reduced seizure susceptibility in dystrophin-deficient mdx mice. Neuroscience 117(2):391-5. PubMed: 12614679 MGI: J:110894
Yue Y; Skimming JW; Liu M; Strawn T; Duan D. 2004. Full-length dystrophin expression in half of the heart cells ameliorates beta-isoproterenol-induced cardiomyopathy in mdx mice. Hum Mol Genet 13(15):1669-75. PubMed: 15190010 MGI: J:118895
Zacharias JM; Anderson JE. 1991. Muscle regeneration after imposed injury is better in younger than older mdx dystrophic mice. J Neurol Sci 104(2):190-6. PubMed: 1940973 MGI: J:28686
Zanotti S; Gibertini S; Curcio M; Savadori P; Pasanisi B; Morandi L; Cornelio F; Mantegazza R; Mora M. 2015. Opposing roles of miR-21 and miR-29 in the progression of fibrosis in Duchenne muscular dystrophy. Biochim Biophys Acta 1852(7):1451-64. PubMed: 25892183 MGI: J:230533
Zanou N; Iwata Y; Schakman O; Lebacq J; Wakabayashi S; Gailly P. 2009. Essential role of TRPV2 ion channel in the sensitivity of dystrophic muscle to eccentric contractions. FEBS Lett 583(22):3600-4. PubMed: 19840792 MGI: J:154680
Zeman RJ; Peng H; Danon MJ; Etlinger JD. 2000. Clenbuterol reduces degeneration of exercised or aged dystrophic (mdx) muscle. Muscle Nerve 23(4):521-8. PubMed: 10716762 MGI: J:116194
Zhang H; Ryu D; Wu Y; Gariani K; Wang X; Luan P; D'Amico D; Ropelle ER; Lutolf MP; Aebersold R; Schoonjans K; Menzies KJ; Auwerx J. 2016. NAD(+) repletion improves mitochondrial and stem cell function and enhances life span in mice. Science 352(6292):1436-43. PubMed: 27127236 MGI: J:232793
Zhang M; Liu J; Cheng A; Deyoung SM; Saltiel AR. 2007. Identification of CAP as a costameric protein that interacts with filamin C. Mol Biol Cell 18(12):4731-40. PubMed: 17898075 MGI: J:145220
Zhang T; Gunther S; Looso M; Kunne C; Kruger M; Kim J; Zhou Y; Braun T. 2015. Prmt5 is a regulator of muscle stem cell expansion in adult mice. Nat Commun 6:7140. PubMed: 26028225 MGI: J:223040
Zhang W; ten Hove M; Schneider JE; Stuckey DJ; Sebag-Montefiore L; Bia BL; Radda GK; Davies KE; Neubauer S; Clarke K. 2008. Abnormal cardiac morphology, function and energy metabolism in the dystrophic mdx mouse: an MRI and MRS study. J Mol Cell Cardiol 45(6):754-60. PubMed: 18929569 MGI: J:143578
Zhang Y; Long C; Li H; McAnally JR; Baskin KK; Shelton JM; Bassel-Duby R; Olson EN. 2017. CRISPR-Cpf1 correction of muscular dystrophy mutations in human cardiomyocytes and mice. Sci Adv 3(4):e1602814. PubMed: 28439558 MGI: J:260372
Zhang Y; Yue Y; Li L; Hakim CH; Zhang K; Thomas GD; Duan D. 2013. Dual AAV therapy ameliorates exercise-induced muscle injury and functional ischemia in murine models of Duchenne muscular dystrophy. Hum Mol Genet 22(18):3720-9. PubMed: 23681067 MGI: J:199584
Zhao J; Kodippili K; Yue Y; Hakim CH; Wasala L; Pan X; Zhang K; Yang NN; Duan D; Lai Y. 2016. Dystrophin contains multiple independent membrane-binding domains. Hum Mol Genet 25(17):3647-3653. PubMed: 27378693 MGI: J:237864
Zhao J; Yoshioka K; Miike T; Miyatake M. 1993. Developmental studies of dystrophin-positive fibers in mdx, and DRP localization. J Neurol Sci 114(1):104-8. PubMed: 8433092 MGI: J:3667
Zhao X; Moloughney JG; Zhang S; Komazaki S; Weisleder N. 2012. Orai1 mediates exacerbated Ca(2+) entry in dystrophic skeletal muscle. PLoS One 7(11):e49862. PubMed: 23185465 MGI: J:195456
Zhou L; Porter JD; Cheng G; Gong B; Hatala DA; Merriam AP; Zhou X; Rafael JA; Kaminski HJ. 2006. Temporal and spatial mRNA expression patterns of TGF-beta1, 2, 3 and TbetaRI, II, III in skeletal muscles of mdx mice. Neuromuscul Disord 16(1):32-8. PubMed: 16373085 MGI: J:112758
Zhou L; Rafael-Fortney JA; Huang P; Zhao XS; Cheng G; Zhou X; Kaminski HJ; Liu L; Ransohoff RM. 2008. Haploinsufficiency of utrophin gene worsens skeletal muscle inflammation and fibrosis in mdx mice. J Neurol Sci 264(1-2):106-11. PubMed: 17889902 MGI: J:140282
Zhou L; Sun K; Zhao Y; Zhang S; Wang X; Li Y; Lu L; Chen X; Chen F; Bao X; Zhu X; Wang L; Tang LY; Esteban MA; Wang CC; Jauch R; Sun H; Wang H. 2015. Linc-YY1 promotes myogenic differentiation and muscle regeneration through an interaction with the transcription factor YY1. Nat Commun 6:10026. PubMed: 26658965 MGI: J:228292
Zhuang W; Eby JC; Cheong M; Mohapatra PK; Bredt DS; Disatnik MH; Rando TA. 2001. The susceptibility of muscle cells to oxidative stress is independent of nitric oxide synthase expression. Muscle Nerve 24(4):502-11. PubMed: 11268022 MGI: J:116198
van Deutekom JC; Cao B; Pruchnic R; Wickham TJ; Kovesdi I; Huard J. 1999. Extended tropism of an adenoviral vector does not circumvent the maturation-dependent transducibility of mouse skeletal muscle. J Gene Med 1(6):393-9. PubMed: 10753064 MGI: J:62398
van Putten M; Hulsker M; Nadarajah VD; van Heiningen SH; van Huizen E; van Iterson M; Admiraal P; Messemaker T; den Dunnen JT; 't Hoen PA; Aartsma-Rus A. 2012. The effects of low levels of dystrophin on mouse muscle function and pathology. PLoS One 7(2):e31937. PubMed: 22359642 MGI: J:185221
van Putten M; Hulsker M; Young C; Nadarajah VD; Heemskerk H; van der Weerd L; 't Hoen PA; van Ommen GJ; Aartsma-Rus AM. 2013. Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin/utrophin double-knockout mice. FASEB J 27(6):2484-95. PubMed: 23460734 MGI: J:199957
von Maltzahn J; Renaud JM; Parise G; Rudnicki MA. 2012. Wnt7a treatment ameliorates muscular dystrophy. Proc Natl Acad Sci U S A 109(50):20614-9. PubMed: 23185011 MGI: J:193128

Additional - Utrn^tm1Jrs related

Boppart MD; Burkin DJ; Kaufman SJ. 2011. Activation of AKT signaling promotes cell growth and survival in alpha7beta1 integrin-mediated alleviation of muscular dystrophy. Biochim Biophys Acta 1812(4):439-46. PubMed: 21216283 MGI: J:170661
Burkin DJ; Wallace GQ; Milner DJ; Chaney EJ; Mulligan JA; Kaufman SJ. 2005. Transgenic expression of {alpha}7{beta}1 integrin maintains muscle integrity, increases regenerative capacity, promotes hypertrophy, and reduces cardiomyopathy in dystrophic mice. Am J Pathol 166(1):253-63. PubMed: 15632017 MGI: J:96066
Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ. 2001. Enhanced Expression of the alpha7beta1 Integrin Reduces Muscular Dystrophy and Restores Viability in Dystrophic Mice. J Cell Biol 152(6):1207-18. PubMed: 11257121 MGI: J:68194
Capote J; DiFranco M; Vergara JL. 2010. Excitation-contraction coupling alterations in mdx and utrophin/dystrophin double knockout mice: a comparative study. Am J Physiol Cell Physiol 298(5):C1077-86. PubMed: 20130206 MGI: J:159256
Chadwick JA; Bhattacharya S; Lowe J; Weisleder N; Rafael-Fortney JA. 2017. Renin-angiotensin-aldosterone system inhibitors improve membrane stability and change gene-expression profiles in dystrophic skeletal muscles. Am J Physiol Cell Physiol 312(2):C155-C168. PubMed: 27881412 MGI: J:239401
Chadwick JA; Hauck JS; Gomez-Sanchez CE; Gomez-Sanchez EP; Rafael-Fortney JA. 2017. Gene expression effects of glucocorticoid and mineralocorticoid receptor agonists and antagonists on normal human skeletal muscle. Physiol Genomics 49(6):277-286. PubMed: 28432191 MGI: J:248404
Connolly AM; Keeling RM; Mehta S; Pestronk A; Sanes JR. 2001. Three mouse models of muscular dystrophy: the natural history of strength and fatigue in dystrophin-, dystrophin/utrophin-, and laminin alpha2-deficient mice. Neuromuscul Disord 11(8):703-12. PubMed: 11595512 MGI: J:103061
Crosbie RH; Lebakken CS; Holt KH; Venzke DP; Straub V; Lee JC; Grady RM; Chamberlain JS; Sanes JR; Campbell KP. 1999. Membrane targeting and stabilization of sarcospan is mediated by the sarcoglycan subcomplex. J Cell Biol 145(1):153-65. PubMed: 10189375 MGI: J:77615
Deconinck N; Rafael JA; Beckers-Bleukx G; Kahn D; Deconinck AE; Davies KE; Gillis JM. 1998. Consequences of the combined deficiency in dystrophin and utrophin on the mechanical properties and myosin composition of some limb and respiratory muscles of the mouse. Neuromuscul Disord 8(6):362-70. PubMed: 9713852 MGI: J:110988
Gaedigk R; Law DJ; Fitzgerald-Gustafson KM; McNulty SG; Nsumu NN; Modrcin AC; Rinaldi RJ; Pinson D; Fowler SC; Bilgen M; Burns J; Hauschka SD; White RA. 2006. Improvement in survival and muscle function in an mdx/utrn(-/-) double mutant mouse using a human retinal dystrophin transgene. Neuromuscul Disord 16(3):192-203. PubMed: 16487708 MGI: J:112787
Gehrig SM; van der Poel C; Sayer TA; Schertzer JD; Henstridge DC; Church JE; Lamon S; Russell AP; Davies KE; Febbraio MA; Lynch GS. 2012. Hsp72 preserves muscle function and slows progression of severe muscular dystrophy. Nature 484(7394):394-8. PubMed: 22495301 MGI: J:183833
Grady RM; Grange RW; Lau KS; Maimone MM; Nichol MC; Stull JT; Sanes JR. 1999. Role for alpha-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies. Nat Cell Biol 1(4):215-20. PubMed: 10559919 MGI: J:59675
Grady RM; Merlie JP; Sanes JR. 1997. Subtle neuromuscular defects in utrophin-deficient mice. J Cell Biol 136(4):871-82. PubMed: 9049252 MGI: J:39218
Grady RM; Teng H; Nichol MC; Cunningham JC; Wilkinson RS; Sanes JR. 1997. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell 90(4):729-38. PubMed: 9288752 MGI: J:42389
Grady RM; Zhou H; Cunningham JM; Henry MD; Campbell KP; Sanes JR. 2000. Maturation and maintenance of the neuromuscular synapse: genetic evidence for roles of the dystrophin--glycoprotein complex. Neuron 25(2):279-93. PubMed: 10719885 MGI: J:60776
Gregorevic P; Allen JM; Minami E; Blankinship MJ; Haraguchi M; Meuse L; Finn E; Adams ME; Froehner SC; Murry CE; Chamberlain JS. 2006. rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice. Nat Med 12(7):787-9. PubMed: 16819550 MGI: J:111980
Gutpell KM; Hrinivich WT; Hoffman LM. 2015. Skeletal muscle fibrosis in the mdx/utrn+/- mouse validates its suitability as a murine model of Duchenne muscular dystrophy. PLoS One 10(1):e0117306. PubMed: 25607927 MGI: J:225657
Haenggi T; Schaub MC; Fritschy JM. 2005. Molecular heterogeneity of the dystrophin-associated protein complex in the mouse kidney nephron: differential alterations in the absence of utrophin and dystrophin. Cell Tissue Res 319(2):299-313. PubMed: 15565469 MGI: J:105083
Haenggi T; Soontornmalai A; Schaub MC; Fritschy JM. 2004. The role of utrophin and Dp71 for assembly of different dystrophin-associated protein complexes (DPCs) in the choroid plexus and microvasculature of the brain. Neuroscience 129(2):403-13. PubMed: 15501597 MGI: J:94669
Hanft LM; Bogan DJ; Mayer U; Kaufman SJ; Kornegay JN; Ervasti JM. 2007. Cytoplasmic gamma-actin expression in diverse animal models of muscular dystrophy. Neuromuscul Disord 17(7):569-74. PubMed: 17475492 MGI: J:124551
Judge LM; Arnett AL; Banks GB; Chamberlain JS. 2011. Expression of the dystrophin isoform Dp116 preserves functional muscle mass and extends lifespan without preventing dystrophy in severely dystrophic mice. Hum Mol Genet 20(24):4978-90. PubMed: 21949353 MGI: J:177877
Knuesel I; Riban V; Zuellig RA; Schaub MC; Grady RM; Sanes JR; Fritschy JM. 2002. Increased vulnerability to kainate-induced seizures in utrophin-knockout mice. Eur J Neurosci 15(9):1474-84. PubMed: 12028357 MGI: J:89397
Koenig X; Dysek S; Kimbacher S; Mike AK; Cervenka R; Lukacs P; Nagl K; Dang XB; Todt H; Bittner RE; Hilber K. 2011. Voltage-gated ion channel dysfunction precedes cardiomyopathy development in the dystrophic heart. PLoS One 6(5):e20300. PubMed: 21677768 MGI: J:196253
Koenig X; Rubi L; Obermair GJ; Cervenka R; Dang XB; Lukacs P; Kummer S; Bittner RE; Kubista H; Todt H; Hilber K. 2014. Enhanced currents through L-type calcium channels in cardiomyocytes disturb the electrophysiology of the dystrophic heart. Am J Physiol Heart Circ Physiol 306(4):H564-73. PubMed: 24337461 MGI: J:208702
Krag TO; Bogdanovich S; Jensen CJ; Fischer MD; Hansen-Schwartz J; Javazon EH; Flake AW; Edvinsson L; Khurana TS. 2004. Heregulin ameliorates the dystrophic phenotype in mdx mice. Proc Natl Acad Sci U S A 101(38):13856-60. PubMed: 15365169 MGI: J:92602
Lai Y; Zhao J; Yue Y; Duan D. 2013. alpha2 and alpha3 helices of dystrophin R16 and R17 frame a microdomain in the alpha1 helix of dystrophin R17 for neuronal NOS binding. Proc Natl Acad Sci U S A 110(2):525-30. PubMed: 23185009 MGI: J:192576
Lansman JB. 2015. Utrophin suppresses low frequency oscillations and coupled gating of mechanosensitive ion channels in dystrophic skeletal muscle. Channels (Austin) 9(3):145-60. PubMed: 25941878 MGI: J:244475
Li D; Yue Y; Duan D. 2010. Marginal level dystrophin expression improves clinical outcome in a strain of dystrophin/utrophin double knockout mice. PLoS One 5(12):e15286. PubMed: 21187970 MGI: J:168677
Liu J; Milner DJ; Boppart MD; Ross RS; Kaufman SJ. 2012. beta1D chain increases alpha7beta1 integrin and laminin and protects against sarcolemmal damage in mdx mice. Hum Mol Genet 21(7):1592-603. PubMed: 22180459 MGI: J:181562
Marshall JL; Oh J; Chou E; Lee JA; Holmberg J; Burkin DJ; Crosbie-Watson RH. 2015. Sarcospan integration into laminin-binding adhesion complexes that ameliorate muscular dystrophy requires utrophin and alpha7 integrin. Hum Mol Genet 24(7):2011-22. PubMed: 25504048 MGI: J:219598
McDonald AA; Hebert SL; Kunz MD; Ralles SJ; McLoon LK. 2015. Disease course in mdx:utrophin+/- mice: comparison of three mouse models of Duchenne muscular dystrophy. Physiol Rep 3(4):. PubMed: 25921779 MGI: J:229245
McDonald AA; Kunz MD; McLoon LK. 2014. Dystrophic changes in extraocular muscles after gamma irradiation in mdx:utrophin(+/-) mice. PLoS One 9(1):e86424. PubMed: 24466085 MGI: J:212562
McNally EM; Kaltman JR; Benson DW; Canter CE; Cripe LH; Duan D; Finder JD; Groh WJ; Hoffman EP; Judge DP; Kertesz N; Kinnett K; Kirsch R; Metzger JM; Pearson GD; Rafael-Fortney JA; Raman SV; Spurney CF; Targum SL; Wagner KR; Markham LW. 2015. Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular Dystrophy. Circulation 131(18):1590-8. PubMed: 25940966 MGI: J:234452
Patton BL; Cunningham JM; Thyboll J; Kortesmaa J; Westerblad H; Edstrom L; Tryggvason K; Sanes JR. 2001. Properly formed but improperly localized synaptic specializations in the absence of laminin alpha4. Nat Neurosci 4(6):597-604. PubMed: 11369940 MGI: J:77657
Ponnusamy S; Sullivan RD; You D; Zafar N; He Yang C; Thiyagarajan T; Johnson DL; Barrett ML; Koehler NJ; Star M; Stephenson EJ; Bridges D; Cormier SA; Pfeffer LM; Narayanan R. 2017. Androgen receptor agonists increase lean mass, improve cardiopulmonary functions and extend survival in preclinical models of Duchenne muscular dystrophy. Hum Mol Genet 26(13):2526-2540. PubMed: 28453658 MGI: J:243042
Swiderski K; Shaffer SA; Gallis B; Odom GL; Arnett AL; Scott Edgar J; Baum DM; Chee A; Naim T; Gregorevic P; Murphy KT; Moody J; Goodlett DR; Lynch GS; Chamberlain JS. 2014. Phosphorylation within the cysteine-rich region of dystrophin enhances its association with beta-dystroglycan and identifies a potential novel therapeutic target for skeletal muscle wasting. Hum Mol Genet 23(25):6697-711. PubMed: 25082828 MGI: J:216212
Tan N; Lansman JB. 2014. Utrophin regulates modal gating of mechanosensitive ion channels in dystrophic skeletal muscle. J Physiol 592(15):3303-23. PubMed: 24879867 MGI: J:243942
Vasquez I; Tan N; Boonyasampant M; Koppitch KA; Lansman JB. 2012. Partial opening and subconductance gating of mechanosensitive ion channels in dystrophic skeletal muscle. J Physiol 590(Pt 23):6167-85. PubMed: 22966155 MGI: J:203025
Verma M; Asakura Y; Hirai H; Watanabe S; Tastad C; Fong GH; Ema M; Call JA; Lowe DA; Asakura A. 2010. Flt-1 haploinsufficiency ameliorates muscular dystrophy phenotype by developmentally increased vasculature in mdx mice. Hum Mol Genet 19(21):4145-59. PubMed: 20705734 MGI: J:164891
Voit A; Patel V; Pachon R; Shah V; Bakhutma M; Kohlbrenner E; McArdle JJ; Dell'Italia LJ; Mendell JR; Xie LH; Hajjar RJ; Duan D; Fraidenraich D; Babu GJ. 2017. Reducing sarcolipin expression mitigates Duchenne muscular dystrophy and associated cardiomyopathy in mice. Nat Commun 8(1):1068. PubMed: 29051551 MGI: J:251091
Wehling-Henricks M; Tidball JG. 2011. Neuronal nitric oxide synthase-rescue of dystrophin/utrophin double knockout mice does not require nNOS localization to the cell membrane. PLoS One 6(10):e25071. PubMed: 22003386 MGI: J:179610
Welser JV; Rooney JE; Cohen NC; Gurpur PB; Singer CA; Evans RA; Haines BA; Burkin DJ. 2009. Myotendinous junction defects and reduced force transmission in mice that lack alpha7 integrin and utrophin. Am J Pathol 175(4):1545-54. PubMed: 19729483 MGI: J:153056
Zhou L; Rafael-Fortney JA; Huang P; Zhao XS; Cheng G; Zhou X; Kaminski HJ; Liu L; Ransohoff RM. 2008. Haploinsufficiency of utrophin gene worsens skeletal muscle inflammation and fibrosis in mdx mice. J Neurol Sci 264(1-2):106-11. PubMed: 17889902 MGI: J:140282

Also Known As: mdx/utrn -

Donating Investigator

Genetic overview

Research Applications

Base Price

Detailed Description

Development

Control Suggestions

Additional Information

Selected References

Dmdmdx

Allele Symbol: Dmdmdx

Utrntm1Jrs

Allele Symbol: Utrntm1Jrs

Disease Terms

Research Areas By Genotype

This mouse can be used to support research in many areas including:

Genotype: Dmdmdx related

Mammalian Phenotype Terms by Genotype

Genotype: Dmdmdx/Dmdmdx Utrntm1Jrs/Utrntm1Jrsinvolves: 129S1/Sv * 129X1/SvJ * C57BL/10ScSn

mortality/aging

growth/size/body region phenotype

muscle phenotype

cardiovascular system phenotype

nervous system phenotype

limbs/digits/tail phenotype

skeleton phenotype

behavior/neurological phenotype

References

Additional - Dmdmdx related

Additional - Utrntm1Jrs related

Genotyping Protocols

Breeding Considerations

Citation

Animal Health Reports

Production of mice from cryopreserved embryos or sperm occurs in a maximum barrier room, G200

Live Mouse

Cryorecovery - Pricing

Related Products and Services

Payment Terms and Conditions

The Jackson Laboratory's Genotype Promise

Terms of Use

Additional Use Restrictions Apply

Licensing Information

JAX® Mice, Products & Services Conditions of Use

No Warranty

Credit for PRODUCTS or SERVICES

Animal Care and Use for SERVICES

No Liability

Dmd^mdx

Allele Symbol: Dmd^mdx

Utrn^tm1Jrs

Allele Symbol: Utrn^tm1Jrs

Genotype: Dmd^mdx related

Genotype: Dmd^mdx/Dmd^mdx Utrn^tm1Jrs/Utrn^tm1Jrs
involves: 129S1/Sv * 129X1/SvJ * C57BL/10ScSn

Additional - Dmd^mdx related

Additional - Utrn^tm1Jrs related